Unnamed: 0,activity_comment,activity_id,assay_chembl_id,assay_description,assay_type,bao_endpoint,bao_format,bao_label,canonical_smiles,document_chembl_id,document_journal,document_year,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_type,standard_units,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,toid,type,units,uo_units,value
31000,,20641994,CHEMBL4613443,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by paper disc diffusion technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613208,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3474051,=,1,1,=,MIC,ug.mL-1,3.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,3.9
31001,,20641995,CHEMBL4613444,Antibacterial activity against Klebsiella pneumoniae after 24 hrs by paper disc diffusion technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613208,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3474051,=,1,1,=,MIC,ug.mL-1,3.9,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,3.9
31002,,20641996,CHEMBL4613445,Antibacterial activity against Micrococcus luteus after 24 hrs by paper disc diffusion technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613208,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3474051,=,1,1,=,MIC,ug.mL-1,3.9,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,3.9
31003,,20643520,CHEMBL4613584,Cytotoxicity against CHO cells assessed as reduction in cell viability,F,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613209,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3474259,>,1,1,>,IC50,nM,150000.0,CHEMBL613853,Cricetulus griseus,CHO,10029.0,,IC50,uM,UO_0000065,150.0
31004,,20644273,CHEMBL4613841,Antimicrobial activity against Mycobacterium smegmatis incubated for 24 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613212,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3474685,=,1,1,=,MIC,ug.mL-1,0.8,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,MIC,mg/L,UO_0000274,0.8
31005,,20644281,CHEMBL4613842,Antimicrobial activity against Mycobacterium aurum incubated for 24 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613212,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3474685,<,1,1,<,MIC,ug.mL-1,0.05,CHEMBL612952,Mycolicibacterium aurum,Mycolicibacterium aurum,1791.0,,MIC,mg/L,UO_0000274,0.05
31006,,20644289,CHEMBL4613843,Antimicrobial activity against Mycobacterium vaccae incubated for 24 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613212,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3474685,=,1,1,=,MIC,ug.mL-1,0.4,CHEMBL613224,Mycolicibacterium vaccae,Mycolicibacterium vaccae,1810.0,,MIC,mg/L,UO_0000274,0.4
31007,,20644297,CHEMBL4613844,Antimicrobial activity against Mycobacterium fortuitum incubated for 24 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613212,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3474685,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,MIC,mg/L,UO_0000274,0.05
31008,,20644748,CHEMBL4613937,Antimicrobial activity against Mycobacterium leprae assessed as microbial growth at 1.5 ug/ml in presence of 0.1 ug/ml rifampin measured at 4 weeks (Rvb = 147 +/- 19.1%),F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613212,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3474685,=,1,0,=,Activity,%,28.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,Activity,%,UO_0000187,28.0
31009,,20644749,CHEMBL4613938,Antimicrobial activity against Mycobacterium leprae assessed as microbial growth at 1.5 ug/ml in presence of 0.2 ug/ml rifampin measured at 4 weeks (Rvb = 147 +/- 19.1%),F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613212,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3474685,=,1,0,=,Activity,%,0.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,Activity,%,UO_0000187,0.0
31010,,20644750,CHEMBL4613939,Antimicrobial activity against Mycobacterium leprae assessed as microbial growth at 1.5 ug/ml in presence of 0.05 ug/ml rifabutin measured at 4 weeks (Rvb = 147 +/- 19.1%),F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613212,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3474685,=,1,0,=,Activity,%,21.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,Activity,%,UO_0000187,21.0
31011,,20644751,CHEMBL4613940,Antimicrobial activity against Mycobacterium leprae assessed as microbial growth at 1.5 ug/ml in presence of 0.1 ug/ml rifabutin measured at 4 weeks (Rvb = 147 +/- 19.1%),F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613212,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3474685,=,1,0,=,Activity,%,0.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,Activity,%,UO_0000187,0.0
31012,,20644752,CHEMBL4613941,Antimicrobial activity against Mycobacterium leprae assessed as microbial growth at 1.5 ug/ml in presence of 0.0125 ug/ml KRM-1648 measured at 4 weeks (Rvb = 147 +/- 19.1%),F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613212,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3474685,=,1,0,=,Activity,%,19.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,Activity,%,UO_0000187,19.0
31013,,20644753,CHEMBL4613942,Antimicrobial activity against Mycobacterium leprae assessed as microbial growth at 1.5 ug/ml in presence of 0.025 ug/ml KRM-1648 measured at 4 weeks (Rvb = 147 +/- 19.1%),F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613212,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3474685,=,1,0,=,Activity,%,0.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,Activity,%,UO_0000187,0.0
31014,,20644763,CHEMBL4613952,Antimicrobial activity against Mycobacterium leprae assessed as fractional inhibitory concentration index at 1.5 ug/ml in presence of 0.2 ug/ml rifampin measured at 4 weeks,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613212,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3474685,=,1,0,=,FICI,,1.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,FICI,,,1.0
31015,,20644764,CHEMBL4613953,Antimicrobial activity against Mycobacterium leprae assessed as fractional inhibitory concentration index at 1.5 ug/ml in presence of 0.1 ug/ml rifabutin measured at 4 weeks,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613212,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3474685,=,1,0,=,FICI,,1.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,FICI,,,1.0
31016,,20644765,CHEMBL4613954,Antimicrobial activity against Mycobacterium leprae assessed as fractional inhibitory concentration index at 1.5 ug/ml in presence of 0.025 ug/ml KRM-1648 measured at 4 weeks,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613212,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3474685,=,1,0,=,FICI,,1.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,FICI,,,1.0
31017,,20654441,CHEMBL4616756,Antibacterial activity against Bacillus subtilis MTCC 121 after 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616582,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3476982,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,6.25
31018,,20666584,CHEMBL4619534,Inhibition of recombinant full-length C-terminal His6-tagged Escherichia coli DNA gyrase AB supercoiling activity using relaxed DNA as substrate preincubated for 30 mins followed by substrate addition and measured after 2 hrs in presence of ATP by size exclusion HPLC analysis,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3479930,=,1,1,=,IC50,nM,490.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,IC50,uM,UO_0000065,0.49
31019,,20666588,CHEMBL4619535,Inhibition of recombinant full-length C-terminal His6-tagged Escherichia coli DNA topoisomerase 4 subunit ParC/ParE using kinetoplast DNA as substrate preincubated for 30 mins followed by substrate addition and measured after 1 hr in presence of ATP by size exclusion chromatography,B,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3479930,=,1,1,=,IC50,nM,2710.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,2.71
31020,,20666592,CHEMBL4619530,Antibacterial activity against wild type Escherichia coli ATCC 25922 at pH 7.4 by CLSI-based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
31021,,20666596,CHEMBL4619536,Antibacterial activity against wild type Klebsiella pneumoniae ATCC 43816 by CLSI-based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.03
31022,,20666600,CHEMBL4619531,Antibacterial activity against wild type Pseudomonas aeruginosa PAO1 K767 by CLSI-based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.125
31023,,20666604,CHEMBL4619537,Antibacterial activity against Pseudomonas aeruginosa K1542/K767 harboring MexB/MexXY deletion mutant by CLSI-based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.03
31024,,20666608,CHEMBL4619538,Antibacterial activity against Pseudomonas aeruginosa NB52023 harboring gyrA T83I mutant/ParC S87L mutant by CLSI-based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
31025,,20666666,CHEMBL4619558,Antibacterial activity against wild type Escherichia coli ATCC 25922 at pH 5.8 by CLSI-based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
31026,,20666673,CHEMBL4619559,Ratio of MIC for antibacterial activity against wild type Escherichia coli ATCC 25922 at pH 5.8 to MIC for antibacterial activity against wild type Escherichia coli ATCC 25922 at pH 7.4,F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3479930,=,1,0,=,Ratio,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,16.0
31027,,20666844,CHEMBL4619562,"Clearance in mouse at 5 mg/kg, iv or 10 mg/kg, po measured up to 24 hrs by LC-MS/MS analysis",A,BAO_0002759,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3479930,=,1,1,=,CL,mL.min-1.kg-1,63.0,CHEMBL612558,,ADMET,,,CL,ml/min.kg,,63.0
31028,,20666845,CHEMBL4619563,"Volume of distribution at steady state in mouse at 5 mg/kg, iv or 10 mg/kg, po measured up to 24 hrs by LC-MS/MS analysis",A,BAO_0003041,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3479930,=,1,1,=,Vdss,L.kg-1,2.2,CHEMBL612558,,ADMET,,,Vdss,L/Kg,UO_0000197,2.2
31029,,20666846,CHEMBL4619564,"Terminal half life in mouse at 5 mg/kg, iv measured up to 24 hrs by LC-MS/MS analysis",A,BAO_0002115,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Hour,3479930,=,1,1,=,T1/2,hr,0.46,CHEMBL612558,,ADMET,,,beta t1/2,hr,UO_0000032,0.46
31030,,20666851,CHEMBL4619560,"Clearance in rat at 5 mg/kg, iv or 10 mg/kg, po measured up to 24 hrs by LC-MS/MS analysis",A,BAO_0002759,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3479930,=,1,1,=,CL,mL.min-1.kg-1,40.0,CHEMBL612558,,ADMET,,,CL,ml/min.kg,,40.0
31031,,20666853,CHEMBL4619561,"Volume of distribution at steady state in rat at 5 mg/kg, iv or 10 mg/kg, po measured up to 24 hrs by LC-MS/MS analysis",A,BAO_0003041,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3479930,=,1,1,=,Vdss,L.kg-1,3.4,CHEMBL612558,,ADMET,,,Vdss,L/Kg,UO_0000197,3.4
31032,,20666855,CHEMBL4619569,"Terminal half life in rat at 5 mg/kg, iv measured up to 24 hrs by LC-MS/MS analysis",A,BAO_0002115,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Hour,3479930,=,1,1,=,T1/2,hr,1.2,CHEMBL612558,,ADMET,,,beta t1/2,hr,UO_0000032,1.2
31033,,20666872,CHEMBL4619581,Antibacterial activity against Escherichia coli ATCC 25922 infected in mouse model of neutropenic thigh infection compound administered subcutaneously 2 hrs post infection and measured after 24 hrs by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
31034,,20666874,CHEMBL4619582,Bacteriostatic activity against Escherichia coli ATCC 25922 infected in mouse model of neutropenic thigh infection assessed as static dose compound administered subcutaneously 2 hrs post infection and measured after 24 hrs by serial dilution method,F,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3479930,=,1,0,=,Activity,mg/kg/day,6.4,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,mg/kg/day,UO_0000311,6.4
31035,,20666876,CHEMBL4619584,Antibacterial activity against Citrobacter clinical isolates by CLSI-based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL614437,Citrobacter,Citrobacter,544.0,,MIC,ug ml-1,UO_0000274,0.03
31036,,20666877,CHEMBL4619584,Antibacterial activity against Citrobacter clinical isolates by CLSI-based broth microdilution assay,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL614437,Citrobacter,Citrobacter,544.0,,MIC50,ug ml-1,UO_0000274,8.0
31037,,20666878,CHEMBL4619584,Antibacterial activity against Citrobacter clinical isolates by CLSI-based broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL614437,Citrobacter,Citrobacter,544.0,,MIC90,ug ml-1,UO_0000274,32.0
31038,,20666882,CHEMBL4619585,Antibacterial activity against Enterobacter clinical isolates by CLSI-based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL614439,Enterobacter,Enterobacter,547.0,,MIC,ug ml-1,UO_0000274,0.03
31039,,20666883,CHEMBL4619585,Antibacterial activity against Enterobacter clinical isolates by CLSI-based broth microdilution assay,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL614439,Enterobacter,Enterobacter,547.0,,MIC50,ug ml-1,UO_0000274,8.0
31040,,20666884,CHEMBL4619585,Antibacterial activity against Enterobacter clinical isolates by CLSI-based broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL614439,Enterobacter,Enterobacter,547.0,,MIC90,ug ml-1,UO_0000274,32.0
31041,,20666888,CHEMBL4619586,Antibacterial activity against Klebsiella oxytoca clinical isolates by CLSI-based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC,ug ml-1,UO_0000274,0.03
31042,,20666889,CHEMBL4619586,Antibacterial activity against Klebsiella oxytoca clinical isolates by CLSI-based broth microdilution assay,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC50,ug ml-1,UO_0000274,8.0
31043,,20666890,CHEMBL4619586,Antibacterial activity against Klebsiella oxytoca clinical isolates by CLSI-based broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC90,ug ml-1,UO_0000274,32.0
31044,,20666894,CHEMBL4619587,Antibacterial activity against Morganella morganii clinical isolates by CLSI-based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC,ug ml-1,UO_0000274,0.03
31045,,20666895,CHEMBL4619587,Antibacterial activity against Morganella morganii clinical isolates by CLSI-based broth microdilution assay,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC50,ug ml-1,UO_0000274,8.0
31046,,20666896,CHEMBL4619587,Antibacterial activity against Morganella morganii clinical isolates by CLSI-based broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC90,ug ml-1,UO_0000274,32.0
31047,,20666900,CHEMBL4619588,Antibacterial activity against Proteus mirabilis clinical isolates by CLSI-based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,0.03
31048,,20666901,CHEMBL4619588,Antibacterial activity against Proteus mirabilis clinical isolates by CLSI-based broth microdilution assay,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC50,ug ml-1,UO_0000274,8.0
31049,,20666902,CHEMBL4619588,Antibacterial activity against Proteus mirabilis clinical isolates by CLSI-based broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC90,ug ml-1,UO_0000274,32.0
31050,,20666906,CHEMBL4619589,Antibacterial activity against Serratia marcescens clinical isolates by CLSI-based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,0.03
31051,,20666907,CHEMBL4619589,Antibacterial activity against Serratia marcescens clinical isolates by CLSI-based broth microdilution assay,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC50,ug ml-1,UO_0000274,8.0
31052,,20666908,CHEMBL4619589,Antibacterial activity against Serratia marcescens clinical isolates by CLSI-based broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC90,ug ml-1,UO_0000274,32.0
31053,,20666912,CHEMBL4619590,Antibacterial activity against Escherichia coli clinical isolates by CLSI-based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
31054,,20666913,CHEMBL4619590,Antibacterial activity against Escherichia coli clinical isolates by CLSI-based broth microdilution assay,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,>,1,1,>,MIC50,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,32.0
31055,,20666914,CHEMBL4619590,Antibacterial activity against Escherichia coli clinical isolates by CLSI-based broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,32.0
31056,,20666918,CHEMBL4619591,Antibacterial activity against Klebsiella pneumoniae clinical isolates by CLSI-based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.03
31057,,20666919,CHEMBL4619591,Antibacterial activity against Klebsiella pneumoniae clinical isolates by CLSI-based broth microdilution assay,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,8.0
31058,,20666920,CHEMBL4619591,Antibacterial activity against Klebsiella pneumoniae clinical isolates by CLSI-based broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,32.0
31059,,20666924,CHEMBL4619592,Antibacterial activity against Pseudomonas aeruginosa clinical isolates by CLSI-based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,>=,1,1,>=,MIC,ug.mL-1,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.125
31060,,20666925,CHEMBL4619592,Antibacterial activity against Pseudomonas aeruginosa clinical isolates by CLSI-based broth microdilution assay,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC50,ug ml-1,UO_0000274,8.0
31061,,20666926,CHEMBL4619592,Antibacterial activity against Pseudomonas aeruginosa clinical isolates by CLSI-based broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4616724,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3479930,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,ug ml-1,UO_0000274,32.0
31062,,20668385,CHEMBL4620140,Antimicrobial activity against Escherichia coli ATCC 25922 by CLSI and EUCAST protocol based assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4619716,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3480294,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,0.03
31063,,20683860,CHEMBL4623709,Antibacterial activity against Bacillus cereus,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4622868,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3483658,=,1,1,=,MIC,nM,700.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,uM,UO_0000065,0.7
31064,,20683871,CHEMBL4623708,Bactericidal activity against Staphylococcus aureus ATCC 209p,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4622868,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3483658,=,1,0,=,MBC,uM,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,uM,UO_0000064,1.5
31065,,20683882,CHEMBL4623707,Antibacterial activity against Staphylococcus aureus ATCC 209p,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4622868,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3483658,=,1,1,=,MIC,nM,700.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.7
31066,,20683900,CHEMBL4623710,Bactericidal activity against Bacillus cereus,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4622868,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3483658,=,1,0,=,MBC,uM,1.5,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MBC,uM,UO_0000064,1.5
31067,,20683950,CHEMBL4623715,Antibacterial activity against clinical isolate amoxicillin and ciprofloxacin resistance Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4622868,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3483658,=,1,1,=,MIC,nM,377200.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,377.2
31068,,20683961,CHEMBL4623716,Bactericidal activity against clinical isolate amoxicillin and ciprofloxacin resistance Staphylococcus aureus,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4622868,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3483658,=,1,0,=,MBC,uM,754.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,uM,UO_0000064,754.4
31069,,20691994,CHEMBL4625775,"Resistance index, ratio of IC50 for antimalarial activity against CQ-resistant Plasmodium falciparum W2 infected in human erythrocytes after 48 hrs to IC50 for antimalarial activity against CQ-sensitive Plasmodium falciparum 3D7 infected in human erythrocytes after 48 hrs by SYBR Green1 dye based fluorescence assay",F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4622966,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3485172,=,1,0,=,Ratio IC50,,1.62,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Ratio IC50,,,1.62
31070,,20691996,CHEMBL4625774,Antimalarial activity against CQ-resistant Plasmodium falciparum W2 infected in human erythrocytes after 96 hrs by SYBR Green1 dye based fluorescence assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4622966,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3485172,=,1,1,=,IC50,nM,22850.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,22850.0
31071,,20692008,CHEMBL4625772,Antimalarial activity against CQ-resistant Plasmodium falciparum W2 infected in human erythrocytes after 48 hrs by SYBR Green1 dye based fluorescence assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4622966,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3485172,=,1,1,=,IC50,nM,37080.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,37080.0
31072,,20692011,CHEMBL4625773,Antimalarial activity against CQ-sensitive Plasmodium falciparum 3D7 infected in human erythrocytes after 96 hrs by SYBR Green1 dye based fluorescence assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4622966,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3485172,=,1,1,=,IC50,nM,26260.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,26260.0
31073,,20692016,CHEMBL4625771,Antimalarial activity against CQ-sensitive Plasmodium falciparum 3D7 infected in human erythrocytes after 48 hrs by SYBR Green1 dye based fluorescence assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4622966,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3485172,=,1,1,=,IC50,nM,45350.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,45350.0
31074,Active,20692045,CHEMBL4625788,Binding affinity to Gyrase in Plasmodium falciparum assessed as accumulation of single-stranded DNA binding protein at 15 uM after 96 hrs by Western blot analysis,B,BAO_0000375,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4622966,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3485172,,1,0,,Activity,,,CHEMBL612545,,Unchecked,,,Activity,,,
31075,Not Active,20692052,CHEMBL4625777,Binding affinity to monomeric heme at 100 nM to 4.5 uM after 24 hrs by UV-Visible Spectroscopic analysis,B,BAO_0000375,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4622966,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3485172,,1,0,,Activity,,,CHEMBL4651321,,Heme,,,Activity,,,
31076,Not Active,20692063,CHEMBL4625795,Antimalarial activity against Plasmodium falciparum infected in human erythrocytes assessed as parasitemia at 1 to 15 uM after 48 hrs by SYBR Green1 dye based fluorescence assay,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4622966,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3485172,,1,0,,Activity,,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Activity,,,
31077,Active,20692064,CHEMBL4625796,Antimalarial activity against Plasmodium falciparum infected in human erythrocytes assessed as parasitemia at 1 to 15 uM after 96 hrs by SYBR Green1 dye based fluorescence assay,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4622966,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3485172,,1,0,,Activity,,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Activity,,,
31078,,20708462,CHEMBL4628698,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis isolate 574 assessed as bacterial growth inhibition measured after 18 hrs by CLSI protocol based two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4627327,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3487806,=,1,1,=,MIC,nM,386300.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,386.3
31079,,20708471,CHEMBL4628699,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis isolate 602 assessed as bacterial growth inhibition measured after 18 hrs by CLSI protocol based two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4627327,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3487806,=,1,1,=,MIC,nM,48290.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,48.29
31080,,20708480,CHEMBL4628700,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis isolate 603 assessed as bacterial growth inhibition measured after 18 hrs by CLSI protocol based two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4627327,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3487806,=,1,1,=,MIC,nM,48290.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,48.29
31081,,20708489,CHEMBL4628701,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis isolate 609 assessed as bacterial growth inhibition measured after 18 hrs by CLSI protocol based two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4627327,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3487806,=,1,1,=,MIC,nM,193150.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,193.15
31082,,20708498,CHEMBL4628702,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis isolate 610 assessed as bacterial growth inhibition measured after 18 hrs by CLSI protocol based two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4627327,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3487806,=,1,1,=,MIC,nM,96570.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,96.57
31083,,20708507,CHEMBL4628703,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis isolate 654 assessed as bacterial growth inhibition measured after 18 hrs by CLSI protocol based two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4627327,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3487806,=,1,1,=,MIC,nM,193150.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,193.15
31084,,20708516,CHEMBL4628704,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis isolate 660 assessed as bacterial growth inhibition measured after 18 hrs by CLSI protocol based two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4627327,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3487806,=,1,1,=,MIC,nM,193150.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,193.15
31085,,20708525,CHEMBL4628705,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 583 assessed as bacterial growth inhibition measured after 18 hrs by CLSI protocol based two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4627327,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3487806,=,1,1,=,MIC,nM,1510.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,1.51
31086,,20708534,CHEMBL4628706,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 584 assessed as bacterial growth inhibition measured after 18 hrs by CLSI protocol based two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4627327,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3487806,=,1,1,=,MIC,nM,386300.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,386.3
31087,,20708543,CHEMBL4628707,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 612 assessed as bacterial growth inhibition measured after 18 hrs by CLSI protocol based two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4627327,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3487806,=,1,1,=,MIC,nM,386300.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,386.3
31088,,20708552,CHEMBL4628708,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 620 assessed as bacterial growth inhibition measured after 18 hrs by CLSI protocol based two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4627327,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3487806,=,1,1,=,MIC,nM,750.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.75
31089,,20708561,CHEMBL4628709,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 621 assessed as bacterial growth inhibition measured after 18 hrs by CLSI protocol based two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4627327,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3487806,=,1,1,=,MIC,nM,386300.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,386.3
31090,,20708570,CHEMBL4628710,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 750 assessed as bacterial growth inhibition measured after 18 hrs by CLSI protocol based two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4627327,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3487806,=,1,1,=,MIC,nM,193150.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,193.15
31091,,20708579,CHEMBL4628711,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 770 assessed as bacterial growth inhibition measured after 18 hrs by CLSI protocol based two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4627327,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3487806,=,1,1,=,MIC,nM,193150.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,193.15
31092,Active,20708587,CHEMBL4628712,Inhibition of biofilm formation in Staphylococcus epidermidis ATCC 35984 at 1 to 8 ug/ml measured after 24 hrs by crystal violet staining based assay,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4627327,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3487806,,1,0,,Inhibition,%,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,INH,,UO_0000187,
31093,Active,20708595,CHEMBL4628713,Inhibition of biofilm formation in Staphylococcus epidermidis ATCC 12228 at 1 to 8 ug/ml measured after 24 hrs by crystal violet staining based assay,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4627327,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3487806,,1,0,,Inhibition,%,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,INH,,UO_0000187,
31094,,20711613,CHEMBL4629221,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4627364,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3488313,=,1,1,=,MIC,ug.mL-1,0.078,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.078
31095,,20711628,CHEMBL4629220,Antibacterial activity against Bacillus subtilis ATCC 6633 assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4627364,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3488313,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.125
31096,,20711643,CHEMBL4629219,Antibacterial activity against Enterococcus faecalis ATCC 29212 assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4627364,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3488313,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
31097,,20711658,CHEMBL4629218,Antibacterial activity against Escherichia coli ATCC 25922 assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4627364,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3488313,=,1,1,=,MIC,ug.mL-1,0.00625,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.00625
31098,Not Determined,20711673,CHEMBL4629217,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4627364,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3488313,,1,0,,MIC,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,,,
31099,Not Determined,20711688,CHEMBL4629216,Antifungal activity against Candida albicans ATCC 10231 assessed as fungal growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4627364,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3488313,,1,0,,MIC,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,,,
31100,,22074156,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4495565,,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3362666,=,52,1,=,Inhibition,%,0.08,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,0.08
31101,,22075663,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4495565,,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3364173,=,52,1,=,Inhibition,%,0.14,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,0.14
31102,,22387446,CHEMBL4666293,Antibacterial activity against outer membrane impaired Escherichia coli JD17464 harboring lpxC mutant assessed as minimum inhibitory concentration required for >=90% inhibition of bacterial growth by CLSI protocol based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665629,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3507201,=,1,1,=,MIC,nM,121.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.121
31103,,22387447,CHEMBL4666294,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as minimum inhibitory concentration required for >=90% inhibition of bacterial growth by CLSI protocol based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665629,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3507201,=,1,1,=,MIC,nM,1810.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,1.81
31104,,22387448,CHEMBL4666295,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 assessed as minimum inhibitory concentration required for >=90% inhibition of bacterial growth by CLSI protocol based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665629,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3507201,=,1,1,=,MIC,nM,50.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,uM,UO_0000065,0.05
31105,,22387449,CHEMBL4666296,Antibacterial activity against Enterobacter aerogenes ATCC 13408 assessed as minimum inhibitory concentration required for >=90% inhibition of bacterial growth by CLSI protocol based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665629,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3507201,=,1,1,=,MIC,nM,113.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,uM,UO_0000065,0.113
31106,,22387450,CHEMBL4666297,Antibacterial activity against Acinetobacter baumannii ATCC 19606 assessed as minimum inhibitory concentration required for >=90% inhibition of bacterial growth by CLSI protocol based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665629,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3507201,=,1,1,=,MIC,nM,3620.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,uM,UO_0000065,3.62
31107,,22387824,CHEMBL4666331,Antibacterial activity against efflux pump d effect ive Escherichia coli JW5503 harbouring tolC mutant assessed as minimum inhibitory concentration required for >=90% inhibition of bacterial growth by CLSI protocol based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665629,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3507201,=,1,1,=,MIC,nM,15.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.015
31108,,22387832,CHEMBL4666332,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as minimum inhibitory concentration required for >=90% inhibition of bacterial growth by CLSI protocol based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665629,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3507201,=,1,1,=,MIC,nM,1510.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,1.51
31109,,22387848,CHEMBL4666334,Antibacterial activity against Enterococcus faecalis ATCC 29212 assessed as minimum inhibitory concentration required for >=90% inhibition of bacterial growth by CLSI protocol based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665629,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3507201,=,1,1,=,MIC,nM,3020.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,uM,UO_0000065,3.02
31110,,22387936,CHEMBL4666345,Antibacterial activity against Escherichia coli MG1655 harboring GyrB R136C mutant assessed as minimum inhibitory concentration required for >=90% inhibition of bacterial growth in presence of 50 ug/ml phenylalanine-arginine beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665629,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3507201,=,1,1,=,MIC,nM,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.01
31111,,22387938,CHEMBL4666346,Antibacterial activity against Escherichia coli MG1655 harboring GyrB S83L mutant assessed as minimum inhibitory concentration required for >=90% inhibition of bacterial growth in presence of 50 ug/ml phenylalanine-arginine beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665629,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3507201,=,1,1,=,MIC,nM,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.01
31112,,22387940,CHEMBL4666347,Antibacterial activity against Escherichia coli MG1655 harboring GyrB S83L/D87N mutant assessed as minimum inhibitory concentration required for >=90% inhibition of bacterial growth in presence of 50 ug/ml phenylalanine-arginine beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665629,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3507201,=,1,1,=,MIC,nM,190.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.19
31113,,22387942,CHEMBL4666348,Antibacterial activity against Escherichia coli MG1655 harboring GyrB S83L/D87N and ParC S80I mutants assessed as minimum inhibitory concentration required for >=90% inhibition of bacterial growth in presence of 50 ug/ml phenylalanine-arginine beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665629,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3507201,=,1,1,=,MIC,nM,8000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,8.0
31114,,22387944,CHEMBL4666349,Antibacterial activity against Escherichia coli MG1655 harboring GyrB S83L/D87N and ParC S80I/E84G mutants assessed as minimum inhibitory concentration required for >=90% inhibition of bacterial growth in presence of 50 ug/ml phenylalanine-arginine beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665629,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3507201,>,1,1,>,MIC,nM,32000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,32.0
31115,,22396479,CHEMBL4668601,Elimination half life in po dosed human serum,A,BAO_0002115,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665681,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Hour,3508375,=,1,1,=,T1/2,hr,4.0,CHEMBL612558,,ADMET,,,beta t1/2,hr,UO_0000032,4.0
31116,,22398706,CHEMBL4669065,Antibacterial activity against Escherichia coli 25922 assessed as ratio of MIC before and after 6 passages,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665709,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3508848,=,1,0,=,FC,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,32.0
31117,,22412268,CHEMBL4671681,Antibacterial activity against Pseudomonas aeruginosa PAO750 harboring mexAB-oprM/mexCD-oprJ/mexEF-oprN/mexJK/mexXY/opmH efflux deficient mutant,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665836,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3511674,=,1,1,=,MIC,ug.mL-1,0.0078,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.0078
31118,,22412277,CHEMBL4671682,Antibacterial activity against Pseudomonas aeruginosa PAO200 harboring mexAB-oprM efflux deficient mutant,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665836,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3511674,=,1,1,=,MIC,ug.mL-1,0.0156,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.0156
31119,,22412291,CHEMBL4671683,Antibacterial activity against wild type Pseudomonas aeruginosa PAO1,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665836,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3511674,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.125
31120,,22413916,CHEMBL4672051,Inhibition of MmA1 in Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth incubated for 5 days by MABA assay,B,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665851,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3511938,=,1,1,=,MIC,ug.mL-1,3.12,CHEMBL612545,,Unchecked,,,MIC,ug ml-1,UO_0000274,3.12
31121,Not Active,22414648,CHEMBL4672202,Inhibition of ftsZ in Bacillus subtilis assessed as increase in enzyme polymerization kinetics at 10 ug/ml measured for 30 mins by microtiter plate-based light scattering assay,B,BAO_0000201,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665863,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3512151,,1,0,,Inhibition,%,,CHEMBL612545,,Unchecked,,,INH,,UO_0000187,
31122,,22414714,CHEMBL4672218,Antibacterial activity against Pseudomonas aeruginosa ATCC27853 incubated for 24 hrs by CLSI-based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665863,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3512151,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
31123,,22414765,CHEMBL4672219,Antibacterial activity against Escherichia coli ATCC25922 incubated for 24 hrs by CLSI-based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665863,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3512151,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
31124,,22414816,CHEMBL4672220,Antibacterial activity against Staphylococcus aureus clinical isolate incubated for 24 hrs by CLSI-based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665863,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3512151,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
31125,,22414868,CHEMBL4672221,Antibacterial activity against penicillin-resistant Staphylococcus aureus incubated for 24 hrs by CLSI-based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665863,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3512151,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
31126,,22414920,CHEMBL4672222,Antibacterial activity against Bacillus pumilus CMCC63202 incubated for 24 hrs by CLSI-based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665863,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3512151,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL612429,Bacillus pumilus,Bacillus pumilus,1408.0,,MIC,ug ml-1,UO_0000274,8.0
31127,,22414971,CHEMBL4672223,Antibacterial activity against Staphylococcus aureus ATCC25923 incubated for 24 hrs by CLSI-based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665863,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3512151,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
31128,,22415023,CHEMBL4672224,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC43300 incubated for 24 hrs by CLSI-based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665863,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3512151,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
31129,,22415075,CHEMBL4672225,Antibacterial activity against Bacillus subtilis ATCC9372 incubated for 24 hrs by CLSI-based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665863,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3512151,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,2.0
31130,,22418745,CHEMBL4672923,Antibacterial activity against Clostridium difficile ATCC 43255 incubated for 46 hrs in anaerobic condition by CLSI-based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665898,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3512844,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
31131,,22418756,CHEMBL4672924,Antibacterial activity against Clostridium difficile ATCC 700057 incubated for 46 hrs in anaerobic condition by CLSI-based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665898,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3512844,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
31132,,22418767,CHEMBL4672925,Antibacterial activity against Clostridium difficile BAA-1805 incubated for 46 hrs in anaerobic condition by CLSI-based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665898,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3512844,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
31133,,22418778,CHEMBL4672926,Antibacterial activity against Clostridium difficile BAA-1875 incubated for 46 hrs in anaerobic condition by CLSI-based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665898,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3512844,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
31134,,22418789,CHEMBL4672927,Antibacterial activity against Clostridium difficile ATCC 9689 incubated for 46 hrs in anaerobic condition by CLSI-based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665898,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3512844,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
31135,,22418800,CHEMBL4672928,Antibacterial activity against Clostridium difficile 8260 incubated for 46 hrs in anaerobic condition by CLSI-based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665898,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3512844,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
31136,,22418811,CHEMBL4672929,Antibacterial activity against Clostridium difficile 8282 incubated for 46 hrs in anaerobic condition by CLSI-based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665898,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3512844,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
31137,,22418822,CHEMBL4672930,Antibacterial activity against Clostridium difficile 5680 incubated for 46 hrs in anaerobic condition by CLSI-based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665898,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3512844,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
31138,,22418833,CHEMBL4672931,Antibacterial activity against Clostridium difficile 8264 incubated for 46 hrs in anaerobic condition by CLSI-based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665898,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3512844,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
31139,,22418844,CHEMBL4672932,Antibacterial activity against Clostridium difficile 8290 incubated for 46 hrs in anaerobic condition by CLSI-based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665898,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3512844,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
31140,,22418855,CHEMBL4672933,Antimycobacterial activity against recombinant Mycobacterium tuberculosis H37Rv expressed in green fluorescence protein by measuring increase in fluorescence after 10 days in presence of middlebrook 7H9/OADC medium by GFP reporter gene assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665898,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3512844,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC90,ug ml-1,UO_0000274,1.0
31141,Not Determined,22418866,CHEMBL4672934,Antibacterial activity against Staphylococcus aureus ATCC 29213 incubated overnight by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665898,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3512844,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
31142,Not Determined,22418877,CHEMBL4672935,Antibacterial activity against Bacillus subtilis DSM3256 incubated overnight by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665898,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3512844,,1,0,,MIC,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,,,
31143,,22418992,CHEMBL4672948,Antibacterial activity against Enterococcus faecalis ATCC 29212 assessed as minimum inhibitory concentration required for >=90% inhibition of bacterial growth after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665899,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3512875,=,1,1,=,MIC,nM,3020.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,uM,UO_0000065,3.02
31144,,22419010,CHEMBL4672949,Antibacterial activity against Escherichia coli ATCC 25922 assessed as minimum inhibitory concentration required for >=90% inhibition of bacterial growth measured after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665899,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3512875,=,1,1,=,MIC,nM,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.05
31145,,22419028,CHEMBL4672950,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as minimum inhibitory concentration required for >=90% inhibition of bacterial growth measured after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665899,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3512875,=,1,1,=,MIC,nM,3020.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,3.02
31146,,22419046,CHEMBL4672951,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as minimum inhibitory concentration required for >=90% inhibition of bacterial growth measured after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665899,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3512875,=,1,1,=,MIC,nM,1510.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,1.51
31147,,22419064,CHEMBL4672952,Antibacterial activity against outer membrane impaired Escherichia coli JD17464 harboring lpxC mutant assessed as minimum inhibitory concentration required for >=90% inhibition of bacterial growth measured after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665899,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3512875,=,1,1,=,MIC,nM,121.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.121
31148,,22419082,CHEMBL4672953,Antibacterial activity against efflux pump defective Escherichia coli JW5503 harbouring tolC mutant assessed as minimum inhibitory concentration required for >=90% inhibition of bacterial growth measured after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4665899,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3512875,=,1,1,=,MIC,nM,15.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.015
31149,,22428346,CHEMBL4675658,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in microbial growth incubated for 7 days by alamar blue assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673231,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3514490,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.56
31150,Not Determined,22430168,CHEMBL4676158,Clearance in human liver microsomes,A,BAO_0002759,BAO_0000251,microsome format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673246,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3514757,,1,0,,CL,,,CHEMBL612558,,ADMET,,,CL,,,
31151,,22430174,CHEMBL4676160,Half life in human plasma at 40 uM measured up to 150 mins by LC-MS/MS analysis,A,BAO_0002115,BAO_0000366,cell-free format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673246,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Hour,3514757,>,1,1,>,T1/2,hr,2.5,CHEMBL612558,,ADMET,,,t1/2,min,UO_0000032,150.0
31152,Not Determined,22430177,CHEMBL4676161,Clearance in mouse liver microsomes,A,BAO_0002759,BAO_0000251,microsome format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673246,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3514757,,1,0,,CL,,,CHEMBL612558,,ADMET,,,CL,,,
31153,Active,22430180,CHEMBL4676162,Antibiofilm activity against Pseudomonas aeruginosa PAO1 assessed as biofilm disruption at 100 uM incubated for 5 to 10 mins by LC-MS/MS analysis,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673246,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3514757,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
31154,,22430183,CHEMBL4676163,Inhibition of Escherichia coli DNA gyrase using relaxed PBR322 plasmid DNA as substrate incubated for 30 mins by ethidium bromide staining based agarose gel electrophoresis method,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673246,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,1,http://www.openphacts.org/units/Nanomolar,3514757,=,1,1,=,IC50,nM,200.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,IC50,uM,UO_0000065,0.2
31155,,22430188,CHEMBL4676164,Antibacterial activity against Pseudomonas aeruginosa PAO1 assessed as growth inhibition after 18 to 20 hrs in presence of PMBN by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673246,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3514757,=,1,1,=,MIC,ug.mL-1,0.025,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.025
31156,,22430200,CHEMBL4676165,Antibacterial activity against Pseudomonas aeruginosa PAO1 assessed as growth inhibition after 18 to 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673246,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3514757,=,1,1,=,MIC,ug.mL-1,0.025,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.025
31157,,22430212,CHEMBL4676166,Antibacterial activity against Pseudomonas aeruginosa PA14 harboring LecB deletion mutant assessed as growth inhibition after 18 to 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673246,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3514757,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.05
31158,,22430224,CHEMBL4676167,Antibacterial activity against Pseudomonas aeruginosa PA14 harboring LecA deletion mutant assessed as growth inhibition after 18 to 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673246,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3514757,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.05
31159,,22430236,CHEMBL4676168,Antibacterial activity against Pseudomonas aeruginosa PA14 assessed as growth inhibition after 18 to 20 hrs in presence of PMBN by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673246,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3514757,=,1,1,=,MIC,ug.mL-1,0.025,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.025
31160,,22430248,CHEMBL4676169,Antibacterial activity against Pseudomonas aeruginosa PA14 assessed as growth inhibition after 18 to 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673246,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3514757,=,1,1,=,MIC,ug.mL-1,0.025,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.025
31161,,22430260,CHEMBL4676170,Antibacterial activity against Staphylococcus carnosus DSM 20501 assessed as growth inhibition after 18 to 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673246,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3514757,<,1,1,<,MIC,ug.mL-1,0.125,CHEMBL614618,Staphylococcus carnosus,Staphylococcus carnosus,1281.0,,MIC,ug ml-1,UO_0000274,0.125
31162,,22430272,CHEMBL4676171,Antibacterial activity against Escherichia coli DSM 1116 assessed as growth inhibition after 18 to 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673246,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3514757,<,1,1,<,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
31163,,22430284,CHEMBL4676172,Antibacterial activity against Escherichia coli K-12 MG1655 assessed as growth inhibition after 18 to 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673246,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3514757,<,1,1,<,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
31164,,22434303,CHEMBL4677249,Antibacterial activity against Staphylococcus aureus SA-1199B,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673276,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3515519,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
31165,,22441200,CHEMBL4678566,Growth inhibition of Escherichia coli DSM 2840 measured every 5 mins for 24 hrs by turbidometric analysis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673343,J Nat Prod,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3517016,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,100.0
31166,,22441201,CHEMBL4678567,Growth inhibition of Escherichia coli 0147:K89:K88 measured every 5 mins for 24 hrs by turbidometric analysis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673343,J Nat Prod,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3517016,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,100.0
31167,Not Active,22444642,CHEMBL4679312,Inhibition of biofilm formation in Candida albicans MTCC 3017 incubated for 24 hrs by crystal violet staining based microtiter plate method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673372,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3517651,,1,0,,IC50,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,IC50,,,
31168,,22444654,CHEMBL4679313,Inhibition of biofilm formation in Pseudomonas aeruginosa MTCC 2453 incubated for 24 hrs by crystal violet staining based microtiter plate method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673372,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3517651,=,1,1,=,IC50,nM,500.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IC50,uM,UO_0000065,0.5
31169,,22444666,CHEMBL4679314,Inhibition of biofilm formation in Escherichia coli MTCC 739 incubated for 24 hrs by crystal violet staining based microtiter plate method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673372,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3517651,=,1,1,=,IC50,nM,600.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IC50,uM,UO_0000065,0.6
31170,,22444678,CHEMBL4679315,Inhibition of biofilm formation in Klebsiella planticola MTCC 530 incubated for 24 hrs by crystal violet staining based microtiter plate method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673372,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3517651,=,1,1,=,IC50,nM,800.0,CHEMBL613271,Raoultella planticola,Raoultella planticola,575.0,,IC50,uM,UO_0000065,0.8
31171,,22444690,CHEMBL4679316,Inhibition of biofilm formation in Micrococcus luteus MTCC 2470 incubated for 24 hrs by crystal violet staining based microtiter plate method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673372,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3517651,=,1,1,=,IC50,nM,800.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,IC50,uM,UO_0000065,0.8
31172,,22444702,CHEMBL4679317,Inhibition of biofilm formation in Bacillus subtilis MTCC 121 incubated for 24 hrs by crystal violet staining based microtiter plate method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673372,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3517651,=,1,1,=,IC50,nM,700.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,IC50,uM,UO_0000065,0.7
31173,,22444714,CHEMBL4679318,Inhibition of biofilm formation in Staphylococcus aureus MLS16 MTCC 2940 incubated for 24 hrs by crystal violet staining based microtiter plate method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673372,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3517651,=,1,1,=,IC50,nM,700.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,uM,UO_0000065,0.7
31174,,22444726,CHEMBL4679319,Inhibition of biofilm formation in Staphylococcus aureus MTCC 92 incubated for 24 hrs by crystal violet staining based microtiter plate method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673372,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3517651,=,1,1,=,IC50,nM,600.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,uM,UO_0000065,0.6
31175,,22444829,CHEMBL4679342,Bactericidal activity against Pseudomonas aeruginosa MTCC 2453,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673372,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3517651,=,1,0,=,MBC,uM,2.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MBC,uM,UO_0000064,2.7
31176,,22444835,CHEMBL4679343,Bactericidal activity against Klebsiella planticola MTCC 530,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673372,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3517651,=,1,0,=,MBC,uM,2.7,CHEMBL613271,Raoultella planticola,Raoultella planticola,575.0,,MBC,uM,UO_0000064,2.7
31177,,22444840,CHEMBL4679344,Bactericidal activity against Escherichia coli MTCC 739,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673372,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3517651,=,1,0,=,MBC,uM,2.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,uM,UO_0000064,2.7
31178,,22444848,CHEMBL4679345,Bactericidal activity against Micrococcus luteus MTCC 2470,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673372,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3517651,=,1,0,=,MBC,uM,2.7,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MBC,uM,UO_0000064,2.7
31179,,22444855,CHEMBL4679346,Bactericidal activity against Bacillus subtilis MTCC 121,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673372,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3517651,=,1,0,=,MBC,uM,2.7,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MBC,uM,UO_0000064,2.7
31180,,22444861,CHEMBL4679347,Bactericidal activity against Staphylococcus aureus MLS16 MTCC 2940,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673372,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3517651,=,1,0,=,MBC,uM,2.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,uM,UO_0000064,2.7
31181,,22444873,CHEMBL4679348,Bactericidal activity against Staphylococcus aureus MTCC 96,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673372,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3517651,=,1,0,=,MBC,uM,2.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,uM,UO_0000064,2.7
31182,,22444887,CHEMBL4679351,Antibacterial activity against Pseudomonas aeruginosa MTCC 2453 assessed as inhibition of bacterial growth by microtiter broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673372,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3517651,=,1,1,=,MIC,nM,2700.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,2.7
31183,,22444906,CHEMBL4679352,Antibacterial activity against Escherichia coli MTCC 739 assessed as inhibition of bacterial growth by microtiter broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673372,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3517651,=,1,1,=,MIC,nM,2700.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,2.7
31184,,22444925,CHEMBL4679353,Antibacterial activity against Klebsiella planticola MTCC 530 assessed as inhibition of bacterial growth by microtiter broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673372,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3517651,=,1,1,=,MIC,nM,2700.0,CHEMBL613271,Raoultella planticola,Raoultella planticola,575.0,,MIC,uM,UO_0000065,2.7
31185,,22444944,CHEMBL4679354,Antibacterial activity against Micrococcus luteus MTCC 2470 assessed as inhibition of bacterial growth by microtiter broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673372,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3517651,=,1,1,=,MIC,nM,2700.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,uM,UO_0000065,2.7
31186,,22444963,CHEMBL4679355,Antibacterial activity against Bacillus subtilis MTCC 121 assessed as inhibition of bacterial growth by microtiter broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673372,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3517651,=,1,1,=,MIC,nM,2700.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,uM,UO_0000065,2.7
31187,,22444982,CHEMBL4679356,Antibacterial activity against Staphylococcus aureus MLS16 MTCC 2940 assessed as inhibition of bacterial growth by microtiter broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673372,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3517651,=,1,1,=,MIC,nM,2700.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,2.7
31188,,22445001,CHEMBL4679357,Antibacterial activity against Staphylococcus aureus MTCC 96 assessed as inhibition of bacterial growth by microtiter broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4673372,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3517651,=,1,1,=,MIC,nM,2700.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,2.7
31189,,22448569,CHEMBL4680395,Potentiation of conjugate 10-induced antibacterial activity against wild type Pseudomonas aeruginosa PAO1 assessed as conjugate 10 MIC measured after 18 hrs by CLSI protocol based microbroth dilution method (Rvb = 64 to 128 ug/ml),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680060,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3518428,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
31190,,22448572,CHEMBL4680396,Potentiation of conjugate 11-induced antibacterial activity against wild type Pseudomonas aeruginosa PAO1 assessed as conjugate 11 MIC measured after 18 hrs by CLSI protocol based microbroth dilution method (Rvb = 64 to 128 ug/ml),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680060,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3518428,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
31191,,22448575,CHEMBL4680397,Potentiation of conjugate 12-induced antibacterial activity against wild type Pseudomonas aeruginosa PAO1 assessed as conjugate 12 MIC measured after 18 hrs by CLSI protocol based microbroth dilution method (Rvb = 64 to 128 ug/ml),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680060,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3518428,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
31192,,22457946,CHEMBL4682482,Antibacterial activity against Escherichia coli ATCC 25922 assessed as bacterial growth inhibition measured after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680121,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3519807,<,1,1,<,MIC,ug.mL-1,0.0625,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.0625
31193,,22458118,CHEMBL4682505,Antibacterial activity against Staphylococcus epidermidis ATCC 35984/RP62A assessed as bacterial growth inhibition measured after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680121,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3519807,=,1,1,=,MIC,ug.mL-1,0.0625,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.0625
31194,,22458146,CHEMBL4682506,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 assessed as bacterial growth inhibition measured after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680121,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3519807,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
31195,,22458174,CHEMBL4682507,Antibacterial activity against Staphylococcus epidermidis ATCC 1457 assessed as bacterial growth inhibition measured after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680121,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3519807,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
31196,,22458202,CHEMBL4682508,Antibacterial activity against Staphylococcus aureus ATCC 6538 assessed as bacterial growth inhibition measured after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680121,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3519807,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
31197,,22458230,CHEMBL4682509,Antibacterial activity against Staphylococcus aureus NCTC 4163 assessed as bacterial growth inhibition measured after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680121,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3519807,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
31198,,22458258,CHEMBL4682510,Antibacterial activity against Pseudomonas aeruginosa NCTC 6749 assessed as bacterial growth inhibition measured after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680121,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3519807,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.125
31199,,22458286,CHEMBL4682511,Antibacterial activity against Pseudomonas aeruginosa PAO1 assessed as bacterial growth inhibition measured after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680121,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3519807,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.125
31200,,22458314,CHEMBL4682512,Antibacterial activity against Klebsiella pneumoniae ATCC 10031 assessed as bacterial growth inhibition measured after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680121,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3519807,<,1,1,<,MIC,ug.mL-1,0.0625,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.0625
31201,,22458342,CHEMBL4682513,Antibacterial activity against Proteus vulgaris NCTC 4635 assessed as bacterial growth inhibition measured after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680121,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3519807,<,1,1,<,MIC,ug.mL-1,0.0625,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.0625
31202,,22462097,CHEMBL4683209,Antimycobacterial activity against dormant form of Mycobacterium tuberculosis H37Rv assessed as log fold reduction in bacterial count at 10 ug/ml under nutrient starvation condition after 7 days by MPN assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680141,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3520351,=,1,0,=,FC,,1.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,FC,,,1.5
31203,Active,22463244,CHEMBL4683454,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 43300 persisters assessed as reduction in colony formation at 40 ug/ml incubated for 8 hrs by colony counting method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680149,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3520574,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
31204,,22463246,CHEMBL4683456,"Resistance index, ratio of MIC for antibacterial activity against Staphylococcus aureus ATCC 25923 measured after 60 days of serial passage to MIC for antibacterial activity against Staphylococcus aureus ATCC25923 measured after 16 hrs",F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680149,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3520574,=,1,0,=,Ratio,,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,50.0
31205,,22464318,CHEMBL4683683,Inhibition of Staphylococcus aureus DNA gyrase using relaxed pBR322 DNA as substrate incubated for 45 mins by agarose gel electrophoresis method,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680155,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3520703,=,1,1,=,IC50,nM,26430.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,IC50,uM,UO_0000065,26.43
31206,,22476094,CHEMBL4686368,Antimicrobial activity against methicillin-resistant Staphylococcus aureus CCARM 3089 assessed as reduction in microbial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680234,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522741,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,512.0
31207,,22476099,CHEMBL4686369,Antimicrobial activity against methicillin-resistant Staphylococcus aureus CCARM 3090 assessed as reduction in microbial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680234,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522741,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,512.0
31208,,22476104,CHEMBL4686370,Antimicrobial activity against methicillin-resistant Staphylococcus aureus CCARM 3095 assessed as reduction in microbial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680234,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522741,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,512.0
31209,,22476109,CHEMBL4686371,Antimicrobial activity against multidrug-resistant Pseudomonas aeruginosa CCARM 2095 assessed as reduction in microbial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680234,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522741,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612545,,Unchecked,,,MIC,ug ml-1,UO_0000274,128.0
31210,,22476114,CHEMBL4686372,Antimicrobial activity against multidrug-resistant Pseudomonas aeruginosa CCARM 2109 assessed as reduction in microbial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680234,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522741,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL612545,,Unchecked,,,MIC,ug ml-1,UO_0000274,16.0
31211,,22476342,CHEMBL4686398,Antibacterial activity against Erythromycin-susceptible Streptococcus pneumoniae ATCC 49619 assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522806,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
31212,,22476433,CHEMBL4686401,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae PU09 harboring mef gene assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522806,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
31213,,22476525,CHEMBL4686404,Antibacterial activity against MLSB-resistant Streptococcus pneumoniae 07P390 harboring ermB gene assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522806,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
31214,,22476609,CHEMBL4686407,Antibacterial activity against MLSB/methicillin/ciprofloxacin-resistant Staphylococcus aureus PU32 harboring ermA gene assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522806,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,256.0
31215,,22476641,CHEMBL4686408,Bactericidal activity against MLSB/methicillin/ciprofloxacin-resistant Staphylococcus aureus PU32 harboring ermA gene,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522806,>,1,0,>,MBC,ug ml-1,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,256.0
31216,,22476663,CHEMBL4686409,Ratio of MBC to MIC against MLSB/methicillin/ciprofloxacin-resistant Staphylococcus aureus PU32 harboring ermA gene,F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3522806,>,1,0,>,Ratio,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,4.0
31217,,22476693,CHEMBL4686410,Antibacterial activity against MLSB/methicillin-resistant Staphylococcus aureus 15B196 assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522806,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
31218,,22476720,CHEMBL4686411,Bactericidal activity against MLSB/methicillin-resistant Staphylococcus aureus 15B196,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522806,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.5
31219,,22476726,CHEMBL4686412,Ratio of MBC to MIC against MLSB/methicillin-resistant Staphylococcus aureus 15B196,F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3522806,=,1,0,=,Ratio,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,1.0
31220,,22476755,CHEMBL4686413,Antibacterial activity against azithromycin-susceptible Haemophilus influenzae ATCC 49247 assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522806,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.004
31221,,22476787,CHEMBL4686414,Bactericidal activity against azithromycin-susceptible Haemophilus influenzae ATCC 49247,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522806,=,1,0,=,MBC,ug ml-1,0.008,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MBC,ug ml-1,UO_0000274,0.008
31222,,22476816,CHEMBL4686415,Ratio of MBC to MIC against azithromycin-susceptible Haemophilus influenzae ATCC 49247,F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3522806,=,1,0,=,Ratio,,2.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Ratio,,,2.0
31223,,22476884,CHEMBL4686432,Antibacterial activity against MLSB-resistant Streptococcus pyogenes 12-206 harboring ermA gene assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522806,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.5
31224,,22476946,CHEMBL4686438,Inhibition of Escherichia coli DNA gyrase using relaxed DNA as substrate incubated for 15 mins by ethidium bromide-based agarose gel electrophoresis,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3522806,=,1,1,=,IC50,nM,440.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,IC50,uM,UO_0000065,0.44
31225,,22476954,CHEMBL4686441,Antibacterial activity against Escherichia coli BW25113 depletion of toIC efflux gene assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522806,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
31226,,22476958,CHEMBL4686442,Antibacterial activity against Escherichia coli JW5503-1 depletion of toIC efflux gene assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522806,<=,1,1,<=,MIC,ug.mL-1,0.064,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.064
31227,,22476962,CHEMBL4686443,Antibacterial activity against Escherichia coli JW5503-KanS depletion of toIC efflux gene assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522806,<=,1,1,<=,MIC,ug.mL-1,0.064,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.064
31228,,22478761,CHEMBL4686831,Antibacterial activity against Pseudomonas aeruginosa PAO1 planktonic cells assessed as reduction in bacterial growth after 18 hrs by resazurin dye based assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680247,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3523304,=,1,1,=,MIC,ug.mL-1,0.08,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.08
31229,,22478768,CHEMBL4686832,Antibacterial activity against Pseudomonas aeruginosa PAO1 biofilm cells assessed as reduction in bacterial growth after 2 days by resazurin dye based assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680247,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3523304,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
31230,,22481293,CHEMBL4687414,Antibacterial activity against hospital-acquired methicillin/ciprofloxacin and moxifloxacin resistant Staphylococcus aureus SA481 assessed as reduction in bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680268,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3523840,=,1,1,=,MIC,nM,770000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,770.0
31231,,22489160,CHEMBL4689331,Antibacterial activity against Staphylococcus aureus MRSA-1 assessed as bacterial growth inhibition in Mueller-Hinton broth 2 measured every 24 hrs for 5 days by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680351,Bioorg Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3525376,=,1,1,=,MIC,nM,377300.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,377.3
31232,,22489165,CHEMBL4689332,Antibacterial activity against Staphylococcus aureus MRSA-2 assessed as bacterial growth inhibition in Mueller-Hinton broth 2 measured every 24 hrs for 5 days by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680351,Bioorg Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3525376,=,1,1,=,MIC,nM,2700.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,2.7
31233,,22489167,CHEMBL4689333,Antibacterial activity against Staphylococcus aureus 209P assessed as bacterial growth inhibition in Mueller-Hinton broth 2 measured every 24 hrs for 5 days by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680351,Bioorg Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3525376,=,1,1,=,MIC,nM,1500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,1.5
31234,,22489175,CHEMBL4689335,Bactericidal activity against Staphylococcus aureus MRSA-1 measured every 24 hrs for 5 days by serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680351,Bioorg Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3525376,=,1,0,=,MBC,uM,754.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,uM,UO_0000064,754.6
31235,,22489180,CHEMBL4689336,Bactericidal activity against Staphylococcus aureus MRSA-2 measured every 24 hrs for 5 days by serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680351,Bioorg Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3525376,=,1,0,=,MBC,uM,2.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,uM,UO_0000064,2.7
31236,,22489185,CHEMBL4689337,Bactericidal activity against Staphylococcus aureus 209P measured every 24 hrs for 5 days by serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4680351,Bioorg Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3525376,=,1,0,=,MBC,uM,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,uM,UO_0000064,1.5
31237,,22754238,CHEMBL4700463,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as reduction in bacterial growth by CLSI method based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699432,RSC Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531744,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
31238,,22754311,CHEMBL4700467,Antibacterial activity against methicillin-resistant Staphylococcus aureus NRS74 assessed as reduction in bacterial growth by CLSI method based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699432,RSC Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531744,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
31239,,22754316,CHEMBL4700468,Antibacterial activity against methicillin-resistant Staphylococcus aureus VRS8 assessed as reduction in bacterial growth by CLSI method based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699432,RSC Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531744,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
31240,,22754807,CHEMBL4700608,Antibacterial activity against Pseudomonas aeruginosa 12 incubated for 20 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,0.0063,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.0063
31241,,22754816,CHEMBL4700609,Antibacterial activity against Escherichia coli NIHJ JC2 incubated for 20 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,0.0063,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.0063
31242,,22754915,CHEMBL4700616,Antibacterial activity against Staphylococcus aureus by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
31243,,22754928,CHEMBL4700617,Antibacterial activity against Bacillus cereus by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,2.0
31244,,22754941,CHEMBL4700618,Antibacterial activity against Escherichia coli by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
31245,,22754954,CHEMBL4700619,Antibacterial activity against Pseudomonas aeruginosa by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
31246,,22754965,CHEMBL4700620,Antibacterial activity against Escherichia coli ATCC 25922 incubated for 24 hrs by tube dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,5.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,5.5
31247,,22754976,CHEMBL4700621,Antibacterial activity against Klebsiella pneumoniae ATCC 15380 incubated for 24 hrs by tube dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,5.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,5.5
31248,,22754987,CHEMBL4700622,Antibacterial activity against Pseudomonas aeruginosa ATCC 12454 incubated for 24 hrs by tube dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,5.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,5.5
31249,,22754998,CHEMBL4700623,Antibacterial activity against Staphylococcus aureus ATCC 25923 incubated for 24 hrs by tube dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,5.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,5.5
31250,,22755009,CHEMBL4700624,Antibacterial activity against Streptococcus pyogenes ATCC 35552 incubated for 24 hrs by tube dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,5.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,5.5
31251,,22755018,CHEMBL4700625,Antibacterial activity against Streptococcus pneumoniae RCMB 010010 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,>=,1,1,>=,MIC,ug.mL-1,5.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,5.0
31252,,22755027,CHEMBL4700626,Antibacterial activity against Bacillus subtilis RCMB 010067 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,>=,1,1,>=,MIC,ug.mL-1,5.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,5.0
31253,,22755036,CHEMBL4700627,Antibacterial activity against Staphylococcus aureus RCMB 010025 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,>=,1,1,>=,MIC,ug.mL-1,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,5.0
31254,,22755045,CHEMBL4700628,Antibacterial activity against Pseudomonas aeruginosa RCMB 010043 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,>=,1,1,>=,MIC,ug.mL-1,5.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,5.0
31255,,22755054,CHEMBL4700629,Antibacterial activity against Escherichia coli RCMB 010052 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,>=,1,1,>=,MIC,ug.mL-1,5.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,5.0
31256,,22755063,CHEMBL4700630,Antibacterial activity against Klebsiella pneumonia RCMB 010058 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,>=,1,1,>=,MIC,ug.mL-1,5.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,5.0
31257,,22755136,CHEMBL4700639,Antibacterial activity against Bacillus cereus ATCC 10876 incubated for 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,1.0
31258,,22755145,CHEMBL4700640,Antibacterial activity against Enterococcus faecalis ATCC 29212 incubated for 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
31259,,22755154,CHEMBL4700641,Antibacterial activity against Staphylococcus aureus ATCC 25923 incubated for 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
31260,,22755163,CHEMBL4700642,Antibacterial activity against Proteus mirabilis ATCC 35659 incubated for 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,1.0
31261,,22755172,CHEMBL4700643,Antibacterial activity against Escherichia coli ATCC 25922 incubated for 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
31262,,22755181,CHEMBL4700644,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 incubated for 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
31263,,22755223,CHEMBL4700655,Antibacterial activity against Bacillus subtilis MTCC 441 incubated for 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,0.0377,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.0377
31264,,22755227,CHEMBL4700656,Antibacterial activity against Staphylococcus aureus MTCC 7443 incubated for 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,0.0377,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.0377
31265,,22755231,CHEMBL4700657,Antibacterial activity against Pseudomonas aeruginosa MTCC 424 incubated for 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,0.0377,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.0377
31266,,22755235,CHEMBL4700658,Antibacterial activity against Escherichia coli MTCC 1652 incubated for 48 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,0.0377,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.0377
31267,,22755251,CHEMBL4700665,Antibacterial activity against Escherichia coli MTCC 16521 by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3531984,=,1,1,=,MIC,nM,4.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,nM,UO_0000065,4.7
31268,,22755268,CHEMBL4700666,Antibacterial activity against Bacillus subtilis MTCC 441 by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3531984,=,1,1,=,MIC,nM,4.7,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,nM,UO_0000065,4.7
31269,,22755285,CHEMBL4700667,Antibacterial activity against Staphylococcus epidermidis MTCC 6880 by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3531984,=,1,1,=,MIC,nM,4.7,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,nM,UO_0000065,4.7
31270,,22755319,CHEMBL4700669,Antibacterial activity against Pseudomonas aeruginosa MTCC 424 by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3531984,=,1,1,=,MIC,nM,4.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,nM,UO_0000065,4.7
31271,,22755449,CHEMBL4700677,Antibacterial activity against Salmonella enterica MTCC 3224 incubated overnight by broth dilution technique,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,IC50,ug.mL-1,0.012,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,IC50,ug ml-1,UO_0000274,0.012
31272,,22755459,CHEMBL4700678,Antibacterial activity against Pseudomonas aeruginosa MTCC 2453 incubated overnight by broth dilution technique,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,IC50,ug.mL-1,0.012,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IC50,ug ml-1,UO_0000274,0.012
31273,,22755469,CHEMBL4700679,Antibacterial activity against Enterococcus faecalis MTCC 439 incubated overnight by broth dilution technique,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,IC50,ug.mL-1,0.012,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,IC50,ug ml-1,UO_0000274,0.012
31274,,22755479,CHEMBL4700680,Antibacterial activity against Streptococcus pneumoniae MTCC 655 incubated overnight by broth dilution technique,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,IC50,ug.mL-1,0.012,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,IC50,ug ml-1,UO_0000274,0.012
31275,,22755662,CHEMBL4700694,Antibacterial activity against Escherichia coli ATCC 25922 after overnight incubation by CLSI M7-A9 based method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
31276,,22755673,CHEMBL4700695,Antibacterial activity against Enterococcus faecalis ATCC 29212 after overnight incubation by CLSI M7-A9 based method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.03
31277,,22755692,CHEMBL4700697,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 incubated overnight by broth dilution technique,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,IC50,ug.mL-1,0.012,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,IC50,ug ml-1,UO_0000274,0.012
31278,,22755702,CHEMBL4700698,Antibacterial activity against Escherichia coli ATCC 25922 incubated overnight by broth dilution technique,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,IC50,ug.mL-1,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IC50,ug ml-1,UO_0000274,0.012
31279,,22755929,CHEMBL4700712,Antibacterial activity against Staphylococcus aureus MTCC 96 incubated for 24 hrs by macrodilution tube method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,6.25
31280,,22755944,CHEMBL4700713,Antibacterial activity against Bacillus cereus MTCC 430 incubated for 24 hrs by macrodilution tube method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,6.25
31281,,22755959,CHEMBL4700714,Antibacterial activity against Bacillus subtilis MTCC 441 incubated for 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,0.39,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.39
31282,,22755962,CHEMBL4700715,Antibacterial activity against Staphylococcus aureus MTCC 96 incubated for 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.39
31283,,22755965,CHEMBL4700716,Antibacterial activity against Staphylococcus epidermidis incubated for 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,0.39,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.39
31284,,22755968,CHEMBL4700717,Antibacterial activity against Escherichia coli MTCC 443 incubated for 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,0.39,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.39
31285,,22755971,CHEMBL4700718,Antibacterial activity against Pseudomonas aeruginosa MTCC 741 incubated for 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,0.39,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.39
31286,,22755974,CHEMBL4700719,Antibacterial activity against Klebsiella pneumoniae MTCC 618 incubated for 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,0.39,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.39
31287,,22755978,CHEMBL4700720,Antibacterial activity against Staphylococcus aureus 209P JC1 incubated for 20 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,0.0063,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.0063
31288,,22755997,CHEMBL4700726,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 13-3,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.03
31289,,22756000,CHEMBL4700727,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.03
31290,,22756003,CHEMBL4700728,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis ATCC 12228,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.03
31291,,22756006,CHEMBL4700729,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.03
31292,,22756009,CHEMBL4700730,Antibacterial activity against Enterococcus faecalis ATCC 51299,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.03
31293,,22756012,CHEMBL4700731,Antibacterial activity against Enterococcus faecium ATCC 700221,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,128.0
31294,,22756015,CHEMBL4700732,Antibacterial activity against Enterococcus faecium 13-7,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,128.0
31295,,22756018,CHEMBL4700733,Antibacterial activity against Escherichia coli 14-11,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
31296,,22756021,CHEMBL4700734,Antibacterial activity against Klebsiella pneumoniae ATCC 700603,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.03
31297,,22756024,CHEMBL4700735,Antibacterial activity against Klebsiella pneumoniae 7,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.03
31298,,22756027,CHEMBL4700736,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.03
31299,,22756030,CHEMBL4700737,Antibacterial activity against Acinetobacter calcoaceticus ATCC 19606,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,MIC,ug ml-1,UO_0000274,0.03
31300,,22756033,CHEMBL4700738,Antibacterial activity against Enterobacter cloacae ATCC 43560,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.03
31301,,22756036,CHEMBL4700739,Antibacterial activity against Enterobacter aerogenes ATCC 13048,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,0.03
31302,,22756039,CHEMBL4700740,Antibacterial activity against Serratia marcescens ATCC 21074,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,0.03
31303,,22756042,CHEMBL4700741,Antibacterial activity against Morganella morganii ATCC 25830,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC,ug ml-1,UO_0000274,0.03
31304,,22756045,CHEMBL4700742,Antibacterial activity against Providencia rettgeri ATCC 31052,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,MIC,ug ml-1,UO_0000274,0.03
31305,,22756048,CHEMBL4700743,Antibacterial activity against Proteus vulgaris ATCC 29905,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.03
31306,,22756051,CHEMBL4700744,Antibacterial activity against Proteus mirabilis 13-1,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,0.03
31307,,22756054,CHEMBL4700745,Antibacterial activity against Stenotrophomonas maltophilia ATCC 13636,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,0.03
31308,,22756057,CHEMBL4700746,Antibacterial activity against Citrobacter freundii ATCC 43864,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3531984,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,0.03
31309,,22758520,CHEMBL4701486,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth by MABA assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699471,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3532713,=,1,1,=,MIC,nM,940.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.94
31310,,22760680,CHEMBL4701990,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699493,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3533169,=,1,1,=,MIC,ug.mL-1,0.15,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.15
31311,,22760694,CHEMBL4701991,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis RP62A,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699493,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3533169,=,1,1,=,MIC,ug.mL-1,0.15,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.15
31312,,22760708,CHEMBL4701992,Antibacterial activity against Escherichia coli ATCC 25922,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699493,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3533169,=,1,1,=,MIC,ug.mL-1,0.07,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.07
31313,,22760722,CHEMBL4701993,Antibacterial activity against Klebsiella pneumoniae ATCC 13383,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699493,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3533169,=,1,1,=,MIC,ug.mL-1,0.3,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.3
31314,,22763806,CHEMBL4702856,Inhibition of InhA in Mycobacterium tuberculosis H37Rv assessed antitubercular activity by measuring inhibition of bacterial growth incubated for 7 days by MABA assay,B,BAO_0002146,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699525,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3533785,=,1,1,=,MIC,nM,1560.0,CHEMBL1849,Mycobacterium tuberculosis,Enoyl-[acyl-carrier-protein] reductase,1773.0,,MIC,uM,UO_0000065,1.56
31315,,22767566,CHEMBL4703500,Antibacterial activity against hospital-acquired Methicillin -resistant Staphylococcus aureus ATCC BAA-811 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534535,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
31316,,22767578,CHEMBL4703501,Antibacterial activity against community-acquired Methicillin -resistant Staphylococcus aureus ATCC BAA-1556 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534535,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
31317,,22767691,CHEMBL4703506,Antibacterial activity against Escherichia coli ATCC 25922 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534535,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
31318,,22767764,CHEMBL4703508,Antibacterial activity against Staphylococcus aureus ATCC 29213 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534535,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
31319,,22767776,CHEMBL4703509,Antibacterial activity against Enterococcus faecium ATCC 35667 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534535,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,4.0
31320,,22767788,CHEMBL4703510,Antibacterial activity against vancomycin-resistant Enterococcus faecium ATCC 51559 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534535,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
31321,,22767800,CHEMBL4703511,Antibacterial activity against Enterococcus faecalis ATCC 29212 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534535,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
31322,,22767812,CHEMBL4703512,Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51575 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534535,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
31323,,22767824,CHEMBL4703513,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534535,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
31324,,22767836,CHEMBL4703514,Antibacterial activity against Streptococcus anginosus ATCC 33397 by CLSI method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534535,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL612545,,Unchecked,,,MIC,ug ml-1,UO_0000274,1.0
31325,,22767848,CHEMBL4703515,Antibacterial activity against Haemophilus influenzae ATCC 43095 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534535,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.008
31326,,22767875,CHEMBL4703520,Antibacterial activity against Clostridioides difficile ATCC 700057 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534535,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
31327,,22767882,CHEMBL4703521,Antibacterial activity against Peptostreptococcus anaerobius ATCC 27337 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534535,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,MIC,ug ml-1,UO_0000274,1.0
31328,,22767889,CHEMBL4703522,Antibacterial activity against Bacteroides fragilis ATCC 25285 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534535,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC,ug ml-1,UO_0000274,4.0
31329,,22767896,CHEMBL4703523,Antibacterial activity against Prevotella melaninogenica JCM6325 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534535,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,MIC,ug ml-1,UO_0000274,2.0
31330,,22767903,CHEMBL4703524,Antibacterial activity against Porphyromonas gingivalis JCM8525 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534535,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614414,Porphyromonas gingivalis,Porphyromonas gingivalis,837.0,,MIC,ug ml-1,UO_0000274,0.5
31331,,22767910,CHEMBL4703525,Antibacterial activity against Fusobacterium nucleatum JCM8532 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534535,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,MIC,ug ml-1,UO_0000274,2.0
31332,Not Determined,22768632,CHEMBL4703688,Antimicrobial activity against Staphylococcus aureus ATCC 12600 assessed as zone of inhibition at 2 mg/ml after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699571,J Nat Prod,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3534736,,1,0,,DIZ,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,,,
31333,Not Determined,22768640,CHEMBL4703689,Antimicrobial activity against Staphylococcus epidermidis ATCC 14990 assessed as zone of inhibition at 2 mg/ml after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699571,J Nat Prod,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3534736,,1,0,,DIZ,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,DIZ,,,
31334,,22768648,CHEMBL4703690,Antimicrobial activity against Pseudomonas aeruginosa ATCC 15692 assessed as zone of inhibition at 2 mg/ml after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699571,J Nat Prod,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3534736,=,1,1,=,IZ,mm,35.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,35.0
31335,Not Determined,22768656,CHEMBL4703691,Antimicrobial activity against Bacillus subtilis subsp. spizizenii ATCC 6633 assessed as zone of inhibition at 2 mg/ml after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699571,J Nat Prod,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3534736,,1,0,,DIZ,,,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,DIZ,,,
31336,,22772640,CHEMBL4704787,Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition by MABA relative to control,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699610,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3535626,=,1,1,=,MIC,ug.mL-1,3.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,3.125
31337,,22773610,CHEMBL4705060,Antibacterial activity against Staphylococcus aureus ATCC 11632 assessed as reduction in bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699627,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3535905,=,1,1,=,MIC,nM,3125.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,3.125
31338,,22773622,CHEMBL4705061,Antibacterial activity against Bacillus subtilis ATCC 11774 assessed as reduction in bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699627,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3535905,=,1,1,=,MIC,nM,3125.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,uM,UO_0000065,3.125
31339,,22773634,CHEMBL4705062,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 assessed as reduction in bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699627,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3535905,=,1,1,=,MIC,nM,3125.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,3.125
31340,,22773646,CHEMBL4705063,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699627,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3535905,=,1,1,=,MIC,nM,1560.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,1.56
31341,,22773666,CHEMBL4705064,Antibacterial activity against Pseudomonas aeruginosa ATCC 25923 assessed as reduction in bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699627,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3535905,=,1,1,=,MIC,nM,1560.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,1.56
31342,,22773674,CHEMBL4705065,Antibacterial activity against Klebsiella pneumoniae ATCC 4352 assessed as reduction in bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699627,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3535905,=,1,1,=,MIC,nM,1560.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,uM,UO_0000065,1.56
31343,,22773678,CHEMBL4705066,Antibacterial activity against Salmonella typhimurium ATCC 14028 assessed as reduction in bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4699627,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3535905,=,1,1,=,MIC,nM,1560.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,uM,UO_0000065,1.56
31344,,22788038,CHEMBL4708885,Ratio of MIC for methicillin-resistant Staphylococcus aureus USA400 NRS123 measured after 14th passage to MIC for methicillin-resistant Staphylococcus aureus USA400 NRS123 measured after 18 to 20 hrs by broth microdilution assay,F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4706519,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3538335,=,1,0,=,Ratio,,127.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,127.0
31345,,22788041,CHEMBL4708888,Ratio of MIC for methicillin-resistant Staphylococcus aureus USA400 NRS123 measured after 2nd passage to MIC for methicillin-resistant Staphylococcus aureus USA400 NRS123 measured after 18 to 20 hrs by broth microdilution assay,F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4706519,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3538335,=,1,0,=,Ratio,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,1.0
31346,,22807985,CHEMBL4712967,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4706653,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3542355,<,1,1,<,MIC,nM,1000.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,1.0
31347,,22808019,CHEMBL4712968,Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4706653,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3542355,=,1,1,=,MIC,nM,1000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,1.0
31348,,22808053,CHEMBL4712969,Antimicrobial activity against Staphylococcus aureus ATCC 29213 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4706653,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3542355,=,1,1,=,MIC,nM,1000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,1.0
31349,,22808087,CHEMBL4712970,Antimicrobial activity against Bacillus subtilis ATCC 23857 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4706653,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3542355,<,1,1,<,MIC,nM,1000.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,uM,UO_0000065,1.0
31350,,22808121,CHEMBL4712971,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 75 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4706653,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3542355,=,1,1,=,MIC,nM,128000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,128.0
31351,,22808155,CHEMBL4712972,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 113 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4706653,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3542355,<,1,1,<,MIC,nM,1000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,1.0
31352,Not Active,22808446,CHEMBL4713003,Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as bacterial killing preincubated for 4 hrs followed by replating on MHB agar and measured after 24 hrs by time kill assay,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4706653,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3542355,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
31353,,22808457,CHEMBL4713007,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as ratio of MIC after and before 7 serial passages at 0.5 times MIC by broth microdilution method,F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4706653,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3542355,=,1,0,=,Ratio,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,64.0
31354,,22808458,CHEMBL4713008,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 assessed as ratio of MIC after and before 4 serial passages at 0.5 times MIC by broth microdilution method,F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4706653,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3542355,=,1,0,=,Ratio,,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Ratio,,,32.0
31355,Active,22808519,CHEMBL4713037,Antibiofilm activity against Staphylococcus aureus ATCC 25923 at 0.5 to 8 uM after 24 hrs by crystal violet staining based assay,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4706653,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3542355,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
31356,Active,22808524,CHEMBL4713038,Antibiofilm activity against ciprofloxacin-resistant Staphylococcus aureus ATCC 25923 at 0.5 to 8 uM after 24 hrs by crystal violet staining based assay,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4706653,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3542355,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
31357,Not Active,22808549,CHEMBL4713049,Binding affinity to LPS (unknown origin) assessed as bacterial killing at 2 times MIC preincubated for 1 hr followed by Staphylococcus aureus ATCC 25923 addition and measured after 2 hrs by colony counting method,B,BAO_0000375,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4706653,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3542355,,1,0,,Activity,,,CHEMBL3580508,Bacteria,Lipopolysaccharide (LPS),2.0,,Activity,,,
31358,Not Active,22808554,CHEMBL4713050,Binding affinity to LTA (unknown origin) assessed as bacterial killing at 2 times MIC preincubated for 1 hr followed by Staphylococcus aureus ATCC 25923 addition and measured after 2 hrs by colony counting method,B,BAO_0000375,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4706653,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3542355,,1,0,,Activity,,,CHEMBL612545,,Unchecked,,,Activity,,,
31359,Not Active,22808559,CHEMBL4713052,Induction of cytoplasmic membrane disruption in Staphylococcus aureus ATCC 25923 measured for 15 mins by DiSC3-5 dye based fluorescence assay,B,BAO_0000375,BAO_0000220,subcellular format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4706653,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3542355,,1,0,,Activity,,,CHEMBL2364031,Bacteria,Cell membrane,2.0,,Activity,,,
31360,Not Active,22808564,CHEMBL4713053,Induction of membrane disruption in Staphylococcus aureus ATCC 25923 measured after 2 hrs by propidium iodide staining based confocal laser scanning microscopic analysis,B,BAO_0000375,BAO_0000220,subcellular format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4706653,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3542355,,1,0,,Activity,,,CHEMBL2364031,Bacteria,Cell membrane,2.0,,Activity,,,
31361,Not Active,22808574,CHEMBL4713057,Induction of membrane disruption in Staphylococcus aureus ATCC 25923 measured after 2 hrs by propidium iodide staining based flow cytometry,B,BAO_0000375,BAO_0000220,subcellular format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4706653,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3542355,,1,0,,Activity,,,CHEMBL2364031,Bacteria,Cell membrane,2.0,,Activity,,,
31362,Active,22808593,CHEMBL4713065,Induction of reactive oxygen species generation in Staphylococcus aureus ATCC 25923 by DCFH-DH dye based fluorescence assay,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4706653,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3542355,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
31363,Active,22808598,CHEMBL4713066,Induction of nucleic acid leakage in Staphylococcus aureus ATCC 25923 at 4 times MIC,F,BAO_0000375,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4706653,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3542355,,1,0,,Activity,,,CHEMBL612545,,Unchecked,,,Activity,,,
31364,Active,22808623,CHEMBL4713087,"Antimicrobial activity against Staphylococcus aureus ATCC 25923 infected in neutropenia BALB/c mouse assessed as reduction in lung bacterial load at 10 to 20 mg/kg, ip administered staring from 2 hrs post infection and measured 8 hrs post-infected",F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4706653,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3542355,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
31365,Active,22808625,CHEMBL4713088,"Antimicrobial activity against Staphylococcus aureus ATCC 25923 infected in neutropenia BALB/c mouse assessed as reduction in bacterial load in spleen at 10 to 20 mg/kg, ip administered staring from 2 hrs post infection and measured 8 hrs post-infected",F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4706653,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3542355,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
31366,Active,22808627,CHEMBL4713089,"Antimicrobial activity against Staphylococcus aureus ATCC 25923 infected in neutropenia BALB/c mouse assessed as reduction in bacterial load in kidney at 10 to 20 mg/kg, ip administered staring from 2 hrs post infection and measured 8 hrs post-infected",F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4706653,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3542355,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
31367,Active,22808629,CHEMBL4713090,"Antimicrobial activity against Staphylococcus aureus ATCC 25923 infected in neutropenia BALB/c mouse assessed as reduction in bacterial load in liver at 10 to 20 mg/kg, ip administered staring from 2 hrs post infection and measured 8 hrs post-infected",F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4706653,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3542355,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
31368,,22836491,CHEMBL4718905,Antimicrobial activity against Staphylococcus aureus MTCC 96 assessed as inhibition zone measured after 24 hrs incubation by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715763,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3545983,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.9
31369,,22836511,CHEMBL4718906,Antimicrobial activity against Bacillus subtilis MTCC 121 assessed as inhibition zone measured after 24 hrs incubation by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715763,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3545983,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.9
31370,,22836531,CHEMBL4718907,Antimicrobial activity against Staphylococcus aureus MLS-16 MTCC 2940 assessed as inhibition zone measured after 24 hrs incubation by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715763,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3545983,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.9
31371,,22836552,CHEMBL4718908,Antimicrobial activity against Pseudomonas aeruginosa MTCC 2453 assessed as inhibition zone measured after 24 hrs incubation by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715763,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3545983,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.9
31372,,22836590,CHEMBL4718910,Antimicrobial activity against Micrococcus luteus MTCC 2470 assessed as inhibition zone measured after 24 hrs incubation by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715763,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3545983,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,0.9
31373,,22836610,CHEMBL4718911,Antimicrobial activity against Klebsiella planticola MTCC 530 assessed as inhibition zone measured after 24 hrs incubation by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715763,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3545983,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL613271,Raoultella planticola,Raoultella planticola,575.0,,MIC,ug ml-1,UO_0000274,0.9
31374,,22836631,CHEMBL4718912,Antimicrobial activity against Escherichia coli MTCC 739 assessed as inhibition zone measured after 24 hrs incubation by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715763,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3545983,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.9
31375,,22836652,CHEMBL4718913,Bactericidal activity against Bacillus subtilis MTCC 121 assessed as bacterial killing after 24 hrs incubation by NCCLS protocol-based broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715763,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3545983,=,1,0,=,MBC,ug ml-1,1.17,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MBC,ug ml-1,UO_0000274,1.17
31376,,22836655,CHEMBL4718914,Bactericidal activity against Micrococcus luteus MTCC 2470 assessed as bacterial killing after 24 hrs incubation by NCCLS protocol-based broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715763,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3545983,=,1,0,=,MBC,ug ml-1,1.17,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MBC,ug ml-1,UO_0000274,1.17
31377,,22836658,CHEMBL4718915,Bactericidal activity against Klebsiella planticola MTCC 530 assessed as bacterial killing after 24 hrs incubation by NCCLS protocol-based broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715763,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3545983,=,1,0,=,MBC,ug ml-1,1.17,CHEMBL613271,Raoultella planticola,Raoultella planticola,575.0,,MBC,ug ml-1,UO_0000274,1.17
31378,,22836659,CHEMBL4718916,Bactericidal activity against Escherichia coli MTCC 739 assessed as bacterial killing after 24 hrs incubation by NCCLS protocol-based broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715763,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3545983,=,1,0,=,MBC,ug ml-1,1.17,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,1.17
31379,,22838709,CHEMBL4719245,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 25923 assessed as concentration required to inhibit visible growth by CLSI protocol based serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,=,1,0,=,MBC,ug ml-1,12.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,12.0
31380,,22838725,CHEMBL4719246,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 25923 assessed as bacterial growth inhibition by CLSI protocol based serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,=,1,1,=,MIC,ug.mL-1,6.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,6.3
31381,,22838741,CHEMBL4719247,Antibacterial activity against Enterococcus faecalis ATCC 51299 assessed as concentration required to inhibit visible growth by CLSI protocol based serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,=,1,0,=,MBC,ug ml-1,0.8,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MBC,ug ml-1,UO_0000274,0.8
31382,,22838757,CHEMBL4719248,Antibacterial activity against Enterococcus faecalis ATCC 51299 assessed as bacterial growth inhibition by CLSI protocol based serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,=,1,1,=,MIC,ug.mL-1,0.4,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.4
31383,,22838773,CHEMBL4719249,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 assessed as concentration required to inhibit visible growth by CLSI protocol based serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,=,1,0,=,MBC,ug ml-1,3.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MBC,ug ml-1,UO_0000274,3.1
31384,,22838789,CHEMBL4719250,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 assessed as bacterial growth inhibition by CLSI protocol based serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,=,1,1,=,MIC,ug.mL-1,1.6,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.6
31385,,22838805,CHEMBL4719251,Antibacterial activity against Escherichia coli ATCC 25922 assessed as concentration required to inhibit visible growth by CLSI protocol based serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,=,1,0,=,MBC,ug ml-1,0.8,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.8
31386,,22838821,CHEMBL4719252,Antibacterial activity against Escherichia coli ATCC 25922 assessed as bacterial growth inhibition by CLSI protocol based serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,=,1,1,=,MIC,ug.mL-1,0.4,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.4
31387,,22838837,CHEMBL4719253,Antibacterial activity against Salmonella enterica ATCC 14028 assessed as concentration required to inhibit visible growth by CLSI protocol based serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,<,1,0,<,MBC,ug ml-1,0.2,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MBC,ug ml-1,UO_0000274,0.2
31388,,22838853,CHEMBL4719254,Antibacterial activity against Salmonella enterica ATCC 14028 assessed as bacterial growth inhibition by CLSI protocol based serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,<,1,1,<,MIC,ug.mL-1,0.2,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,0.2
31389,,22838869,CHEMBL4719255,Antibacterial activity against Citrobacter freundii ATCC 8090 assessed as concentration required to inhibit visible growth by CLSI protocol based serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,<,1,0,<,MBC,ug ml-1,0.2,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MBC,ug ml-1,UO_0000274,0.2
31390,,22838885,CHEMBL4719256,Antibacterial activity against Citrobacter freundii ATCC 8090 assessed as bacterial growth inhibition by CLSI protocol based serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,<,1,1,<,MIC,ug.mL-1,0.2,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,0.2
31391,,22838901,CHEMBL4719257,Antibacterial activity against Proteus vulgaris ATCC 6380 assessed as concentration required to inhibit visible growth by CLSI protocol based serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,<,1,0,<,MBC,ug ml-1,0.2,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MBC,ug ml-1,UO_0000274,0.2
31392,,22838917,CHEMBL4719258,Antibacterial activity against Proteus vulgaris ATCC 6380 assessed as bacterial growth inhibition by CLSI protocol based serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,<,1,1,<,MIC,ug.mL-1,0.2,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.2
31393,,22838963,CHEMBL4719261,Antibacterial activity against methicillin-resistant Staphylococcus aureus CEMTC 675 assessed as concentration required to inhibit visible growth by CLSI protocol based serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,>,1,0,>,MBC,ug ml-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,8.0
31394,,22838967,CHEMBL4719262,Antibacterial activity against methicillin-resistant Staphylococcus aureus CEMTC 675 assessed as bacterial growth inhibition by CLSI protocol based serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
31395,,22838971,CHEMBL4719263,Antibacterial activity against methicillin-resistant Staphylococcus aureus CEMTC 707 assessed as concentration required to inhibit visible growth by CLSI protocol based serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,>,1,0,>,MBC,ug ml-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,8.0
31396,,22838975,CHEMBL4719264,Antibacterial activity against methicillin-resistant Staphylococcus aureus CEMTC 707 assessed as bacterial growth inhibition by CLSI protocol based serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
31397,,22838979,CHEMBL4719265,Antibacterial activity against methicillin-resistant Staphylococcus aureus CEMTC 1695 assessed as concentration required to inhibit visible growth by CLSI protocol based serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,>,1,0,>,MBC,ug ml-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,8.0
31398,,22838983,CHEMBL4719266,Antibacterial activity against methicillin-resistant Staphylococcus aureus CEMTC 1695 assessed as bacterial growth inhibition by CLSI protocol based serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
31399,,22838987,CHEMBL4719267,Antibacterial activity against methicillin-resistant Staphylococcus aureus CEMTC 1732 assessed as concentration required to inhibit visible growth by CLSI protocol based serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,=,1,0,=,MBC,ug ml-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,2.0
31400,,22838991,CHEMBL4719268,Antibacterial activity against methicillin-resistant Staphylococcus aureus CEMTC 1732 assessed as bacterial growth inhibition by CLSI protocol based serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
31401,,22838995,CHEMBL4719269,Antibacterial activity against methicillin-resistant Staphylococcus aureus CEMTC 1733 assessed as concentration required to inhibit visible growth by CLSI protocol based serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,>,1,0,>,MBC,ug ml-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,8.0
31402,,22838999,CHEMBL4719270,Antibacterial activity against methicillin-resistant Staphylococcus aureus CEMTC 1733 assessed as bacterial growth inhibition by CLSI protocol based serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
31403,,22839003,CHEMBL4719271,Antibacterial activity against methicillin-resistant Staphylococcus aureus CEMTC 1850 assessed as concentration required to inhibit visible growth by CLSI protocol based serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,>,1,0,>,MBC,ug ml-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,8.0
31404,,22839007,CHEMBL4719272,Antibacterial activity against methicillin-resistant Staphylococcus aureus CEMTC 1850 assessed as bacterial growth inhibition by CLSI protocol based serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3546404,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
31405,,22839150,CHEMBL4719335,"Selectivity index, ratio of CC50 for HEK293T cells assessed as reduction in cell viability measured after 24 hrs by MTT assay to MIC for Staphylococcus aureus ATCC 25923 assessed as bacterial growth inhibition by CLSI protocol based serial microdilution method",T,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3546404,>,1,0,>,Selectivity Index,,10.0,CHEMBL612545,,Unchecked,,,Selectivity Index,,,10.0
31406,,22839159,CHEMBL4719336,"Selectivity index, ratio of CC50 for HEK293T cells assessed as reduction in cell viability measured after 24 hrs by MTT assay to MIC for Enterococcus faecalis ATCC 51299 assessed as bacterial growth inhibition by CLSI protocol based serial microdilution method",T,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3546404,>,1,0,>,Selectivity Index,,150.0,CHEMBL612545,,Unchecked,,,Selectivity Index,,,150.0
31407,,22839168,CHEMBL4719337,"Selectivity index, ratio of CC50 for HEK293T cells assessed as reduction in cell viability measured after 24 hrs by MTT assay to MIC for Pseudomonas aeruginosa ATCC 9027 assessed as bacterial growth inhibition by CLSI protocol based serial microdilution method",T,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3546404,>,1,0,>,Selectivity Index,,38.0,CHEMBL612545,,Unchecked,,,Selectivity Index,,,38.0
31408,,22839177,CHEMBL4719338,"Selectivity index, ratio of CC50 for HEK293T cells assessed as reduction in cell viability measured after 24 hrs by MTT assay to MIC for Escherichia coli ATCC 25922 assessed as bacterial growth inhibition by CLSI protocol based serial microdilution method",T,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3546404,>,1,0,>,Selectivity Index,,150.0,CHEMBL612545,,Unchecked,,,Selectivity Index,,,150.0
31409,,22839186,CHEMBL4719339,"Selectivity index, ratio of CC50 for HEK293T cells assessed as reduction in cell viability measured after 24 hrs by MTT assay to MIC for Citrobacter freundii ATCC 8090 assessed as bacterial growth inhibition by CLSI protocol based serial microdilution method",T,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3546404,>,1,0,>,Selectivity Index,,300.0,CHEMBL612545,,Unchecked,,,Selectivity Index,,,300.0
31410,,22839195,CHEMBL4719340,"Selectivity index, ratio of CC50 for HEK293T cells assessed as reduction in cell viability measured after 24 hrs by MTT assay to MIC for Proteus vulgaris ATCC 6380 assessed as bacterial growth inhibition by CLSI protocol based serial microdilution method",T,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3546404,>,1,0,>,Selectivity Index,,300.0,CHEMBL612545,,Unchecked,,,Selectivity Index,,,300.0
31411,,22839255,CHEMBL4719345,"Selectivity index, ratio of CC50 for HEK293T cells assessed as reduction in cell viability measured after 24 hrs by MTT assay to MIC for Salmonella enterica ATCC 14028 assessed as bacterial growth inhibition by CLSI protocol based serial microdilution method",T,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715780,Bioorg Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3546404,>,1,0,>,Selectivity Index,,300.0,CHEMBL612545,,Unchecked,,,Selectivity Index,,,300.0
31412,,22848049,CHEMBL4722634,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 incubated for 12 to 16 hrs by microtiter method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715840,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547416,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
31413,,22848061,CHEMBL4722635,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis RP62A incubated for 12 to 16 hrs by microtiter method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715840,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547416,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.5
31414,,22848073,CHEMBL4722636,Antibacterial activity against Enterococcus faecalis ATCC 700802 incubated for 12 to 16 hrs by microtiter method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715840,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547416,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
31415,,22848085,CHEMBL4722637,Antibacterial activity against Escherichia coli ATCC 25922 incubated for 12 to 16 hrs by microtiter method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715840,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547416,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
31416,,22848097,CHEMBL4722638,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 incubated for 12 to 16 hrs by microtiter method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715840,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547416,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
31417,Not Determined,22848113,CHEMBL4722640,"Selectivity index, ratio of HC50 for human RBC to MIC for methicillin-resistant Staphylococcus aureus ATCC 33591",T,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715840,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3547416,,1,0,,Selectivity Index,,,CHEMBL612545,,Unchecked,,,Selectivity Index,,,
31418,,22853654,CHEMBL4724285,Inhibition of Mycobacterium tuberculosis DNA gyrase assessed as reduction in DNA supercoiled DNA formation incubated for 30 mins by SDS-PAGE analysis,B,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4715879,J Nat Prod,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3548331,=,1,1,=,IC50,nM,10000.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,10.0
31419,,22875048,CHEMBL4725633,Antibacterial activity against Staphylococcus aureus ATCC 49444 after 24 hrs by CLSI protocol based cup-plate agar diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4725221,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3549532,=,1,1,=,MIC,ug.mL-1,1.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.9
31420,,22875056,CHEMBL4725634,Antibacterial activity against Listeria monocytogenes ATCC 19115 after 24 hrs by CLSI protocol based cup-plate agar diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4725221,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3549532,=,1,1,=,MIC,ug.mL-1,3.9,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC,ug ml-1,UO_0000274,3.9
31421,,22875064,CHEMBL4725635,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by CLSI protocol based cup-plate agar diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4725221,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3549532,=,1,1,=,MIC,ug.mL-1,3.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,3.9
31422,,22875072,CHEMBL4725636,Antibacterial activity against Salmonella typhimurium ATCC 14028 after 24 hrs by CLSI protocol based cup-plate agar diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4725221,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3549532,=,1,1,=,MIC,ug.mL-1,0.97,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,0.97
31423,,22875134,CHEMBL4725643,Antibacterial activity against Escherichia coli AG102,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4725221,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3549532,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
31424,,22890988,CHEMBL4729384,Antibacterial activity against Pseudomonas aeruginosa PAO1 assessed as reduction in bacterial growth by CLSI protocol based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4725368,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3552646,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
31425,,22890993,CHEMBL4729385,Antibacterial activity against Neisseria gonorrhoeae ATCC 49226 assessed as reduction in bacterial growth by CLSI protocol based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4725368,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3552646,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,0.06
31426,,22890998,CHEMBL4729386,Antibacterial activity against fluoroquinolone-resistant Neisseria gonorrhoeae WHO L harboring multiple point mutations at DNA gyrase and topoisomerase IV and porB1b mutation assessed as reduction in bacterial growth by CLSI protocol based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4725368,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3552646,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,4.0
31427,,22891003,CHEMBL4729387,Antibacterial activity against Acinetobacter baumannii ATCC 19606 assessed as reduction in bacterial growth by CLSI protocol based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4725368,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3552646,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,64.0
31428,,22891008,CHEMBL4729388,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 assessed as reduction in bacterial growth by CLSI protocol based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4725368,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3552646,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.5
31429,,22891013,CHEMBL4729389,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in bacterial growth by CLSI protocol based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4725368,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3552646,=,1,1,=,MIC,ug.mL-1,0.003,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.003
31430,,22891018,CHEMBL4729390,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as reduction in bacterial growth by CLSI protocol based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4725368,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3552646,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
31431,,22891023,CHEMBL4729391,Antibacterial activity against Enterococcus faecalis ATCC 29212 assessed as reduction in bacterial growth by CLSI protocol based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4725368,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3552646,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.25
31432,,22891028,CHEMBL4729392,Intrinsic clearance in human liver microsomes,A,BAO_0002759,BAO_0000251,microsome format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4725368,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3552646,<,1,1,<,CL,mL.min-1.g-1,5.0,CHEMBL612558,,ADMET,,,CLH,microL/min/mg,,5.0
31433,,22891063,CHEMBL4729399,Protein binding in human plasma assessed as free fraction,A,BAO_0000179,BAO_0000366,cell-free format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4725368,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3552646,=,1,1,=,Fu,,0.821,CHEMBL612558,,ADMET,,,Fu,%,,82.1
31434,,22891094,CHEMBL4729410,"Selectivity index, ratio of MIC for fluoroquinolone-resistant Neisseria gonorrhoeae WHO L harboring multiple point mutations at DNA gyrase and topoisomerase IV and porB1b mutation to MIC for Neisseria gonorrhoeae ATCC 49226 assessed as reduction in bacterial growth by CLSI protocol based microdilution method",F,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4725368,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3552646,>,1,0,>,Selectivity Index,,66.0,CHEMBL612545,,Unchecked,,,Selectivity Index,,,66.0
31435,,22901696,CHEMBL4731888,Inhibition of Staphylococcus aureus DNA gyrase using relaxed pBR322 as substrate by gel electrophoresis,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4725492,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3555082,=,1,1,=,IC50,nM,13200.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,IC50,uM,UO_0000065,13.2
31436,,22901729,CHEMBL4731889,Antibacterial activity against Staphylococcus aureus D83N by CLSI based agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4725492,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555082,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,64.0
31437,,22901772,CHEMBL4731891,Antibacterial activity against Staphylococcus aureus ATCC 29213 by CLSI based agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4725492,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555082,=,1,1,=,MIC,ug.mL-1,0.00025,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,0.25
31438,,22901805,CHEMBL4731892,Antibacterial activity against Staphylococcus aureus USA300 by CLSI based agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4725492,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555082,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,16.0
31439,,22901838,CHEMBL4731893,Antibacterial activity against Staphylococcus aureus 3527 by CLSI based agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4725492,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555082,>,1,1,>,MIC,ug.mL-1,0.064,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,64.0
31440,,22901871,CHEMBL4731894,Inhibition of Staphylococcus aureus topoisomerase-4 assessed as reduction in decatenation of kinetoplast DNA agarose gel electrophoresis method,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4725492,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3555082,=,1,1,=,IC50,nM,4000.0,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,IC50,uM,UO_0000065,4.0
31441,Active,22901952,CHEMBL4731904,Inhibition of Staphylococcus aureus DNA gyrase assessed as double-strand break at 100 uM using relaxed pBR322 as substrate by ethidium bromide-based gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4725492,ACS Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3555082,,1,0,,Inhibition,%,,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,INH,,UO_0000187,
31442,,22910757,CHEMBL4734231,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as diameter of inhibition zone at 10 mg/ml by disk diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4732090,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3557243,=,1,1,=,IZ,mm,14.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,14.0
31443,,22910799,CHEMBL4734233,Antibacterial activity against Escherichia coli ATCC 25922 assessed as diameter of inhibition zone at 10 mg/ml by disk diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4732090,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3557243,=,1,1,=,IZ,mm,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,24.0
31444,,22910820,CHEMBL4734234,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as diameter of inhibition zone at 10 mg/ml by disk diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4732090,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3557243,=,1,1,=,IZ,mm,0.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,0.0
31445,,22910842,CHEMBL4734235,Antifungal activity against Candida albicans ATCC 90028 assessed as diameter of inhibition zone at 10 mg/ml by disk diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4732090,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3557243,=,1,1,=,IZ,mm,0.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,DIZ,mm,UO_0000016,0.0
31446,,22922222,CHEMBL4736873,Antibacterial activity against Staphylococcus aureus MTCC 96 assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4732167,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3558982,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,50.0
31447,,22922242,CHEMBL4736874,Antibacterial activity against Escherichia coli MTCC 443 assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4732167,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3558982,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,25.0
31448,,22922262,CHEMBL4736875,Antibacterial activity against Pseudomonas aeruginosa MTCC 1688 assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4732167,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3558982,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,25.0
31449,,22922316,CHEMBL4736878,Antibacterial activity against Streptococcus pyogenes MTCC 442 assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4732167,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3558982,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,50.0
31450,,22928272,CHEMBL4737979,Antibacterial activity against Mycobacterium smegmatis mc2155,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4732208,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3560116,=,1,1,=,MIC,nM,15000.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,MIC,uM,UO_0000065,15.0
31451,,22928291,CHEMBL4737980,Antibacterial activity against Mycobacterium smegmatis VKPM Ac-1339,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4732208,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3560116,=,1,1,=,MIC,nM,12000.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,MIC,uM,UO_0000065,12.0
31452,,22928310,CHEMBL4737981,Antibacterial activity against Staphylococcus aureus FDA 209 P,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4732208,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3560116,=,1,1,=,MIC,nM,3000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,3.0
31453,,22928328,CHEMBL4737982,Antibacterial activity against Staphylococcus aureus INA 00761,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4732208,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3560116,=,1,1,=,MIC,nM,12000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,12.0
31454,,22957953,CHEMBL4768106,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as reduction in bacterial growth incubated for 24 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765265,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565093,=,1,1,=,MIC,ug.mL-1,0.49,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.49
31455,,22957960,CHEMBL4768107,Antibacterial activity against Staphylococcus aureus ATCC 6538 assessed as reduction in bacterial growth incubated for 24 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765265,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565093,=,1,1,=,MIC,ug.mL-1,0.24,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.24
31456,,22957967,CHEMBL4768108,Antibacterial activity against Staphylococcus aureus ATCC 43300 assessed as reduction in bacterial growth incubated for 24 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765265,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565093,=,1,1,=,MIC,ug.mL-1,0.24,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.24
31457,,22957974,CHEMBL4768109,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 assessed as reduction in bacterial growth incubated for 24 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765265,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565093,=,1,1,=,MIC,ug.mL-1,0.49,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.49
31458,,22957981,CHEMBL4768110,Antibacterial activity against Micrococcus luteus ATCC 10240 assessed as reduction in bacterial growth incubated for 24 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765265,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565093,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,0.98
31459,,22957988,CHEMBL4768111,Antibacterial activity against Bacillus subtilis ATCC 6633 assessed as reduction in bacterial growth incubated for 24 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765265,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565093,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.03
31460,,22957995,CHEMBL4768112,Antibacterial activity against Bacillus cereus ATCC 10876 assessed as reduction in bacterial growth incubated for 24 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765265,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565093,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,0.12
31461,,22958020,CHEMBL4768116,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in bacterial growth incubated for 24 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765265,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565093,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
31462,,22958026,CHEMBL4768117,Antibacterial activity against Proteus mirabilis ATCC 12543 assessed as reduction in bacterial growth incubated for 24 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765265,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565093,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,0.03
31463,,22958032,CHEMBL4768118,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 assessed as reduction in bacterial growth incubated for 24 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765265,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565093,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.12
31464,,22958038,CHEMBL4768119,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 assessed as reduction in bacterial growth incubated for 24 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765265,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565093,=,1,1,=,MIC,ug.mL-1,0.49,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.49
31465,,22963646,CHEMBL4769030,Antibacterial activity against Staphylococcus aureus ATCC 25923 incubated for 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765295,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565942,=,1,1,=,MIC,ug.mL-1,1250.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1250.0
31466,,22963647,CHEMBL4769030,Antibacterial activity against Staphylococcus aureus ATCC 25923 incubated for 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765295,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3565942,=,1,1,=,MIC,nM,3772446.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,3772.446
31467,,22963730,CHEMBL4769031,Antibacterial activity against Streptococcus pyogenes ATCC 19615 incubated for 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765295,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565942,=,1,1,=,MIC,ug.mL-1,1250.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,1250.0
31468,,22963731,CHEMBL4769031,Antibacterial activity against Streptococcus pyogenes ATCC 19615 incubated for 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765295,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3565942,=,1,1,=,MIC,nM,37772446.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,uM,UO_0000065,37772.446
31469,,22963812,CHEMBL4769032,Antibacterial activity against Salmonella typhimurium ATCC 19430 incubated for 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765295,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565942,=,1,1,=,MIC,ug.mL-1,2.4,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,2.4
31470,,22963813,CHEMBL4769032,Antibacterial activity against Salmonella typhimurium ATCC 19430 incubated for 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765295,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3565942,=,1,1,=,MIC,nM,7243000.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,uM,UO_0000065,7243.0
31471,,22963898,CHEMBL4769033,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 incubated for 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765295,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565942,=,1,1,=,MIC,ug.mL-1,4.8,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.8
31472,,22963899,CHEMBL4769033,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 incubated for 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765295,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3565942,=,1,1,=,MIC,nM,14486000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,14486.0
31473,,22967477,CHEMBL4769875,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as reduction in bacterial growth by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765317,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3566528,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
31474,,22967487,CHEMBL4769876,Antibacterial activity against Staphylococcus aureus USA300 assessed as reduction in bacterial growth by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765317,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3566528,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
31475,,22967498,CHEMBL4769877,Antibacterial activity against cystic fibrosis patient isolate Staphylococcus aureus assessed as reduction in bacterial growth by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765317,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3566528,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
31476,,22967502,CHEMBL4769878,Antibacterial activity against methicillin-resistant Staphylococcus aureus DRL-3161 assessed as reduction in bacterial growth by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765317,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3566528,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
31477,,22967505,CHEMBL4769879,Antibacterial activity against Streptococcus pyogenes LSI-1235 assessed as reduction in bacterial growth by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765317,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3566528,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.25
31478,,22967508,CHEMBL4769880,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae LSI-4234 assessed as reduction in bacterial growth by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765317,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3566528,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
31479,,22967511,CHEMBL4769881,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae LSI-4246 assessed as reduction in bacterial growth by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765317,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3566528,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
31480,,22967514,CHEMBL4769882,Antibacterial activity against Vancomycin-susceptible Enterococcus faecium DRL-4193 assessed as reduction in bacterial growth by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765317,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3566528,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.25
31481,,22967517,CHEMBL4769883,Antibacterial activity against Vancomycin-resistant Enterococcus faecium LSI-3340 assessed as reduction in bacterial growth by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765317,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3566528,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
31482,,22967520,CHEMBL4769884,Antibacterial activity against Enterococcus faecalis ATCC 29212 assessed as reduction in bacterial growth by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765317,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3566528,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
31483,,22967522,CHEMBL4769885,Antibacterial activity against Fluoroquinolone-resistant Staphylococcus aureus assessed as reduction in bacterial growth by CLSI based broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4765317,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3566528,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,32.0
31484,,23168401,CHEMBL4813611,Antibacterial activity against Bacillus subtilis MTCC121 assessed as inhibition of bacterial growth by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4811306,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3602152,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,6.25
31485,,23168413,CHEMBL4813612,Antibacterial activity against Staphylococcus aureus MTCC96 assessed as inhibition of bacterial growth by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4811306,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3602152,=,1,1,=,MIC,ug.mL-1,3.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,3.12
31486,,23168428,CHEMBL4813613,Antibacterial activity against Staphylococcus epidermidis MTCC435 assessed as inhibition of bacterial growth by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4811306,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3602152,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,6.25
31487,,23168438,CHEMBL4813614,Antibacterial activity against Escherichia coli MTCC739 assessed as inhibition of bacterial growth by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4811306,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3602152,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,6.25
31488,,23168452,CHEMBL4813615,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4811306,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3602152,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.56
31489,,23168466,CHEMBL4813616,Antibacterial activity against Klebsiella pneumoniae assessed as inhibition of bacterial growth by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4811306,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3602152,=,1,1,=,MIC,ug.mL-1,3.12,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,3.12
31490,,23177051,CHEMBL4815664,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by microplate alamar blue assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4813957,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3603828,=,1,1,=,MIC,ug.mL-1,3.12,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,3.12
31491,,23177137,CHEMBL4815677,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 5 days by microplate alamar blue assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4813957,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3603828,=,1,1,=,MIC,ug.mL-1,3.12,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,3.12
31492,,23177200,CHEMBL4815692,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 7 days by microplate alamar blue assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4813957,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3603828,=,1,1,=,MIC,ug.mL-1,3.12,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,3.12
31493,,23177277,CHEMBL4815715,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC27294 measured after 28 days by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4813957,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3603828,=,1,1,=,MIC,ug.mL-1,4.71,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,4.71
31494,,23182533,CHEMBL4816900,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as reduction in microbial growth by two fold microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604694,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
31495,,23182555,CHEMBL4816901,Antibacterial activity against Staphylococcus aureus assessed as reduction in microbial growth by two fold microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604694,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
31496,,23182577,CHEMBL4816902,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as reduction in microbial growth by two fold microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604694,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
31497,,23182599,CHEMBL4816903,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as reduction in microbial growth by two fold microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604694,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
31498,,23182621,CHEMBL4816904,Antibacterial activity against Enterococcus faecalis assessed as reduction in microbial growth by two fold microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604694,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.0
31499,,23182643,CHEMBL4816905,Antibacterial activity against Klebsiella pneumonia assessed as reduction in microbial growth by two fold microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604694,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
31500,,23182665,CHEMBL4816906,Antibacterial activity against Acinetobacter baumannii assessed as reduction in microbial growth by two fold microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604694,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,1.0
31501,,23182687,CHEMBL4816907,Antibacterial activity against Escherichia coli assessed as reduction in microbial growth by two fold microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604694,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
31502,,23182709,CHEMBL4816908,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in microbial growth by two fold microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604694,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
31503,,23182731,CHEMBL4816909,Antibacterial activity against Pseudomonas aeruginosa assessed as reduction in microbial growth by two fold microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604694,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
31504,,23182753,CHEMBL4816910,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as reduction in microbial growth by two fold microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604694,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
31505,,23182793,CHEMBL4816938,"Antibacterial activity against Klebsiella pneumonia in presence of (E)-1-cyclopropyl-6-fluoro-7-(4-(2-((2-methoxy-2-oxoethoxy)imino)-2-(thiazol-2-yl)ethyl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (Rvb = 2 ug/ml)",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604694,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.125
31506,,23182794,CHEMBL4816939,"Antibacterial activity against Escherichia coli in presence of (E)-1-cyclopropyl-6-fluoro-7-(4-(2-((2-methoxy-2-oxoethoxy)imino)-2-(thiazol-2-yl)ethyl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (Rvb = 2ug/ml)",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604694,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
31507,,23182795,CHEMBL4816940,"Antibacterial activity against methicillin-resistant Staphylococcus aureus in presence of (E)-1-cyclopropyl-6-fluoro-7-(4-(2-((2-methoxy-2-oxoethoxy)imino)-2-(thiazol-2-yl)ethyl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (Rvb = 8 ug/ml)",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604694,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
31508,,23182796,CHEMBL4816941,"Antibacterial activity against Staphylococcus aureus ATCC 25923 in presence of (E)-1-cyclopropyl-6-fluoro-7-(4-(2-((2-methoxy-2-oxoethoxy)imino)-2-(thiazol-2-yl)ethyl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (Rvb = 2 ug/ml)",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604694,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
31509,,23186988,CHEMBL4817889,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as reduction in bacterial growth by microplate alamar blue assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4814024,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605512,=,1,1,=,MIC,ug.mL-1,3.12,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,3.12
31510,,23190505,CHEMBL4818496,Inhibition of DNA synthesis in Staphylococcus aureus ATCC 29213 at 8 times MIC measured by liquid scintillation counter,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4814057,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3606270,=,1,1,=,Inhibition,%,86.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,INH,%,UO_0000187,86.2
31511,Not Active,23190527,CHEMBL4818514,Antibacterial activity against vancomycin-intermediate resistant Staphylococcus aureus ATCC 700699 assessed as bacterial growth between 7 passages measured 14 to 21 days by broth dilution method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4814057,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3606270,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
31512,Not Active,23190528,CHEMBL4818515,Antibacterial activity against vancomycin-intermediate susceptible Staphylococcus aureus ATCC 25923 assessed as bacterial growth inhibition between 7 passages by broth dilution method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4814057,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3606270,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
31513,Not Active,23190530,CHEMBL4818516,Antibacterial activity against vancomycin-intermediate Enterococcus faecalis ATCC 29212 assessed as bacterial growth inhibition by measuring fold increase in MIC after 7 passages by broth dilution method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4814057,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3606270,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
31514,,23195151,CHEMBL4819587,Antibacterial activity against wild type Escherichia coli JW5503 delta tolC assessed as inhibition of bacterial growth measured after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4818993,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3607224,=,1,1,=,MIC,nM,20.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.02
31515,,23195188,CHEMBL4819589,Antibacterial activity against vancomycin resistant Enterococcus faecalis 51575 assessed as inhibition of bacterial growth measured after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4818993,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3607224,=,1,1,=,MIC,nM,3000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,uM,UO_0000065,3.0
31516,,23195243,CHEMBL4819592,Antibacterial activity against Staphylococcus aureus 29213 assessed as inhibition of bacterial growth measured after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4818993,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3607224,=,1,1,=,MIC,nM,1500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,1.5
31517,,23221077,CHEMBL4824662,Antibacterial activity against Staphylococcus aureus ATCC 25923 incubated for 18 hrs by CLSI based broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4823282,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3611773,=,1,1,=,MIC,nM,8000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,8.0
31518,,23221113,CHEMBL4824663,Antibacterial activity against Bacillus subtilis ATCC 23857 incubated for 18 hrs by CLSI based broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4823282,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3611773,=,1,1,=,MIC,nM,2000.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,uM,UO_0000065,2.0
31519,,23221149,CHEMBL4824664,Antibacterial activity against Enterococcus faecalis ATCC 29212 incubated for 18 hrs by CLSI based broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4823282,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3611773,=,1,1,=,MIC,nM,16000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,uM,UO_0000065,16.0
31520,,23221185,CHEMBL4824665,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 incubated for 18 hrs by CLSI based broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4823282,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3611773,=,1,1,=,MIC,nM,8000.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,8.0
31521,,23221221,CHEMBL4824666,Antibacterial activity against Escherichia coli ATCC 25922 incubated for 18 hrs by CLSI based broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4823282,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3611773,<,1,1,<,MIC,nM,1000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,1.0
31522,,23221257,CHEMBL4824667,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 incubated for 18 hrs by CLSI based broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4823282,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3611773,<,1,1,<,MIC,nM,1000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,1.0
31523,,23221293,CHEMBL4824668,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 incubated for 18 hrs by CLSI based broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4823282,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3611773,=,1,1,=,MIC,nM,4000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,uM,UO_0000065,4.0
31524,,23221329,CHEMBL4824669,Antibacterial activity against Acinetobacter baumannii ATCC 19606 incubated for 18 hrs by CLSI based broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4823282,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3611773,=,1,1,=,MIC,nM,4000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,uM,UO_0000065,4.0
31525,,23231232,CHEMBL4826887,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4825691,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3613709,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
31526,,23231234,CHEMBL4826888,Antibacterial activity against Proteus mirabilis ATCC 25933 assessed as inhibition of bacterial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4825691,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3613709,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,0.25
31527,,23231244,CHEMBL4826893,Antibacterial activity against Escherichia coli ATCC 35218 assessed as inhibition of bacterial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4825691,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3613709,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
31528,Not Active,23241772,CHEMBL4829262,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 43300 persisters assessed as reduction in colony formation at 40 ug/ml incubated for 8 hrs by colony counting method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4828717,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3615642,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
31529,,23244213,CHEMBL4829634,Antibacterial activity against penicillin-susceptible Bacillus subtilis ATCC 9372 assessed as inhibition of bacterial growth measured after 20 hrs by two-fold microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4828726,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615851,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,4.0
31530,,23244244,CHEMBL4829635,Antibacterial activity against penicillin-susceptible Bacillus pumilus CMCC63202 assessed as inhibition of bacterial growth measured after 20 hrs by two-fold microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4828726,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615851,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL612429,Bacillus pumilus,Bacillus pumilus,1408.0,,MIC,ug ml-1,UO_0000274,16.0
31531,,23244275,CHEMBL4829636,Antibacterial activity against erythromycin-susceptible Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth measured after 20 hrs by two-fold microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4828726,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615851,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
31532,,23244306,CHEMBL4829637,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes assessed as inhibition of bacterial growth measured after 20 hrs by two-fold microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4828726,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615851,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,8.0
31533,,23244337,CHEMBL4829638,Antibacterial activity against penicillin-susceptible Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth measured after 20 hrs by two-fold microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4828726,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615851,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
31534,,23244368,CHEMBL4829639,Antibacterial activity against penicillin-susceptible Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth measured after 20 hrs by two-fold microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4828726,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615851,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
31535,,23244399,CHEMBL4829640,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC43300 assessed as inhibition of bacterial growth measured after 20 hrs by two-fold microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4828726,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615851,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
31536,,23244430,CHEMBL4829641,Antibacterial activity against penicillin-resistant Staphylococcus aureus ATCC 31007 assessed as inhibition of bacterial growth measured after 20 hrs by two-fold microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4828726,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615851,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
31537,,23244461,CHEMBL4829642,Antibacterial activity against clinical isolate Staphylococcus aureus C1 assessed as inhibition of bacterial growth measured after 20 hrs by two-fold microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4828726,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615851,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
31538,,23244492,CHEMBL4829643,Antibacterial activity against erythromycin-resistant Streptococcus pyogenes assessed as inhibition of bacterial growth measured after 20 hrs by two-fold microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4828726,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615851,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,64.0
31539,,23244523,CHEMBL4829644,Antibacterial activity against penicillin-resistant Staphylococcus epidermidis assessed as inhibition of bacterial growth measured after 20 hrs by two-fold microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4828726,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615851,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,64.0
31540,,23244535,CHEMBL4829645,Antibacterial activity against Vancomycin-susceptible Enterococcus faecalis ATCC 29212 assessed as inhibition of bacterial growth measured after 20 hrs by two-fold microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4828726,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615851,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,32.0
31541,,23244549,CHEMBL4829646,Antibacterial activity against Vancomycin-susceptible Enterococcus faecium ATCC 19434 assessed as inhibition of bacterial growth measured after 20 hrs by two-fold microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4828726,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615851,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,64.0
31542,,23244563,CHEMBL4829647,Antibacterial activity against Vancomycin-resistant Enterococcus faecium ATCC 51559 assessed as inhibition of bacterial growth measured after 20 hrs by two-fold microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4828726,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615851,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,64.0
31543,,23244577,CHEMBL4829648,Antibacterial activity against Vancomycin-resistant Enterococcus faecalis ATCC 51299 assessed as inhibition of bacterial growth measured after 20 hrs by two-fold microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4828726,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615851,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
31544,,23244693,CHEMBL4829680,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as fold increase in MIC value measured after 9 passages by Multi passage resistance assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4828726,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3615851,=,1,0,=,FC,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,FC,,,64.0
31545,,23244962,CHEMBL4829722,Antibacterial activity against Staphylococcus aureus ATCC65385 assessed as growth inhibition after 20 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4828727,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615876,=,1,1,=,MIC50,ug.mL-1,3.41,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,3.41
31546,,23244983,CHEMBL4829723,Antibacterial activity against Escherichia coli ATCC47076 assessed as growth inhibition after 20 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4828727,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615876,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,0.5
31547,,23245004,CHEMBL4829724,Antibacterial activity against Salmonella enterica subsp.enterica ATCC13076 assessed as growth inhibition after 20 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4828727,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615876,=,1,1,=,MIC50,ug.mL-1,0.37,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,MIC50,ug ml-1,UO_0000274,0.37
31548,,23245025,CHEMBL4829725,Antibacterial activity against Listeria innocua LMG11387 assessed as growth inhibition after 20 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4828727,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615876,=,1,1,=,MIC50,ug.mL-1,137.7,CHEMBL612636,Listeria innocua,Listeria innocua,1642.0,,MIC50,ug ml-1,UO_0000274,137.7
31549,,23254129,CHEMBL4831777,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as inhibition of bacterial growth by CLSI method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4831482,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3617541,=,1,1,=,IC50,ug.mL-1,0.09,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,0.09
31550,,23254130,CHEMBL4831777,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as inhibition of bacterial growth by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4831482,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3617541,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
31551,,23254151,CHEMBL4831778,Antibacterial activity against vancomycin resistant Enterococcus ATCC MP-1 assessed as inhibition of bacterial growth by CLSI method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4831482,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3617541,=,1,1,=,IC50,ug.mL-1,0.15,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,IC50,ug ml-1,UO_0000274,0.15
31552,,23254152,CHEMBL4831778,Antibacterial activity against vancomycin resistant Enterococcus ATCC MP-1 assessed as inhibition of bacterial growth by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4831482,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3617541,=,1,1,=,MIC,ug.mL-1,0.63,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC,ug ml-1,UO_0000274,0.63
31553,,23254168,CHEMBL4831779,Antibacterial activity against Escherichia coli ATCC 35218 assessed as inhibition of bacterial growth by CLSI method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4831482,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3617541,=,1,1,=,IC50,ug.mL-1,0.007,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IC50,ug ml-1,UO_0000274,0.0069999999999999
31554,,23254169,CHEMBL4831779,Antibacterial activity against Escherichia coli ATCC 35218 assessed as inhibition of bacterial growth by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4831482,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3617541,=,1,1,=,MIC,ug.mL-1,0.031,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.031
31555,,23254185,CHEMBL4831780,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth by CLSI method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4831482,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3617541,=,1,1,=,IC50,ug.mL-1,0.09,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IC50,ug ml-1,UO_0000274,0.09
31556,,23254186,CHEMBL4831780,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4831482,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3617541,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
31557,,23282929,CHEMBL4837639,Antibacterial activity against Proteus sp. assessed as reduction in bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837184,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3622758,=,1,1,=,MIC,nM,1500.0,CHEMBL613019,Proteus sp.,Proteus sp.,229037.0,,MIC,uM,UO_0000065,1.5
31558,,23282932,CHEMBL4837640,Antibacterial activity against Bacillus cereus assessed as reduction in bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837184,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3622758,=,1,1,=,MIC,nM,1500.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,uM,UO_0000065,1.5
31559,,23282935,CHEMBL4837641,Antibacterial activity against Mycobacterium phlei assessed as reduction in bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837184,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3622758,=,1,1,=,MIC,nM,780.0,CHEMBL614985,Mycolicibacterium phlei,Mycolicibacterium phlei,1771.0,,MIC,uM,UO_0000065,0.78
31560,,23282938,CHEMBL4837642,Antibacterial activity against Bacillus subtilis assessed as reduction in bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837184,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3622758,=,1,1,=,MIC,nM,390.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,uM,UO_0000065,0.39
31561,,23282941,CHEMBL4837643,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as reduction in bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837184,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3622758,=,1,1,=,MIC,nM,50000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,50.0
31562,,23282944,CHEMBL4837644,Antibacterial activity against Vibrio parahaemolyticus assessed as reduction in bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837184,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3622758,=,1,1,=,MIC,nM,390.0,CHEMBL614403,Vibrio parahaemolyticus,Vibrio parahaemolyticus,670.0,,MIC,uM,UO_0000065,0.39
31563,,23282947,CHEMBL4837645,Antibacterial activity against Escherichia coli assessed as reduction in bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837184,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3622758,=,1,1,=,MIC,nM,780.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.78
31564,,23285346,CHEMBL4838230,Antibacterial activity against penicillin-susceptible Bacillus subtilis ATCC 9372 assessed as bacterial growth inhibition incubated for 24 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837210,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623279,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,2.0
31565,,23285413,CHEMBL4838231,Antibacterial activity against penicillin-susceptible Bacillus pumilus CMCC 63202 assessed as bacterial growth inhibition by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837210,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623279,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL612429,Bacillus pumilus,Bacillus pumilus,1408.0,,MIC,ug ml-1,UO_0000274,16.0
31566,,23285480,CHEMBL4838232,Antibacterial activity against erythromycin-susceptible Staphylococcus aureus ATCC 25923 assessed as bacterial growth inhibition incubated for 24 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837210,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623279,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
31567,,23285547,CHEMBL4838233,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes clinical isolate 1 assessed as bacterial growth inhibition incubated for 24 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837210,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623279,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,8.0
31568,,23285614,CHEMBL4838234,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis ATCC 29212 assessed as bacterial growth inhibition incubated for 24 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837210,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623279,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,32.0
31569,,23285681,CHEMBL4838235,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis ATCC19434 assessed as bacterial growth inhibition incubated for 24 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837210,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623279,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
31570,,23285748,CHEMBL4838236,Antibacterial activity against penicillin-susceptible Pseudomonas aeruginosa ATCC27853 assessed as bacterial growth inhibition incubated for 24 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837210,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623279,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
31571,,23285815,CHEMBL4838237,Antibacterial activity against penicillin-susceptible Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth measured by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837210,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623279,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
31572,,23285882,CHEMBL4838238,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as inhibition of bacterial growth by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837210,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623279,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
31573,,23285949,CHEMBL4838239,Antibacterial activity against penicillin-resistant Staphylococcus aureus assessed as inhibition of bacterial growth measured by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837210,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623279,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
31574,,23286016,CHEMBL4838240,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth measured by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837210,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623279,=,1,1,=,MIC,ug.mL-1,6.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,6.0
31575,,23286083,CHEMBL4838241,Antibacterial activity against penicillin-resistant Staphylococcus epidermidis assessed as inhibition of bacterial growth measured by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837210,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623279,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,64.0
31576,,23286150,CHEMBL4838242,Antibacterial activity against erythromycin-resistant Streptococcus pyogenes 2 assessed as bacterial growth inhibition incubated for 24 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837210,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623279,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,64.0
31577,,23286217,CHEMBL4838243,Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51299 assessed as bacterial growth inhibition incubated for 24 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837210,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623279,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
31578,,23286284,CHEMBL4838244,Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51559 assessed as bacterial growth inhibition incubated for 24 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837210,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623279,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
31579,,23286338,CHEMBL4838272,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as reduction in bacterial growth measured after 9 passages by resistance development assay relative to control,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837210,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3623279,=,1,0,=,FC,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,FC,,,64.0
31580,Not Active,23286837,CHEMBL4838393,Antibacterial activity against Staphylococcus aureus ATCC 6538 assessed as inhibition of bacterial growth measured after 17 passages by turbidity based analysis,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837216,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3623399,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
31581,Not Active,23286840,CHEMBL4838395,Antibacterial activity against Escherichia coli ATCC 8739 assessed as inhibition of bacterial growth measured after 17 passages by turbidity based analysis,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837216,Eur J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3623399,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
31582,,23293417,CHEMBL4840023,Antibacterial activity against Staphylococcus aureus ATCC 29213 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837261,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3624632,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
31583,,23293458,CHEMBL4840024,Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837261,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3624632,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
31584,,23293499,CHEMBL4840025,Antibacterial activity against cystic fibrosis isolate Staphylococcus aureus by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837261,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3624632,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
31585,,23293594,CHEMBL4840031,Inhibition of Staphylococcus aureus Gyrase supercoiling activity assessed as reduction in supercoiling pBR322 DNA by measuring relaxation by bromophenol blue staining based TAE gel method,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837261,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3624632,=,1,1,=,IC50,nM,28000.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,IC50,uM,UO_0000065,28.0
31586,,23293635,CHEMBL4840032,Inhibition of Staphylococcus aureus topoisomerase IV decatenation activity using kDNA as substrate by ethidium bromide/bromophenol blue staining based agarose gel electrophoresis analysis,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837261,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3624632,=,1,1,=,IC50,nM,8600.0,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,IC50,uM,UO_0000065,8.6
31587,,23293676,CHEMBL4840033,"Selectivity index, ratio of IC50 for inhibition of Staphylococcus aureus topoisomerase IV decatenation activity to IC50 for inhibition of Staphylococcus aureus DNA gyrase supercoiling activity",B,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837261,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3624632,=,1,0,=,Ratio IC50,,0.3,CHEMBL612545,,Unchecked,,,Ratio IC50,,,0.3
31588,,23293717,CHEMBL4840034,Inhibition of Staphylococcus aureus DNA Gyrase D83N mutant assessed as reduction in supercoiling pBR322 DNA by measuring relaxation by bromophenol blue staining based TAE gel method,B,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837261,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3624632,=,1,1,=,IC50,nM,580000.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,580.0
31589,Not Determined,23293738,CHEMBL4840035,Selectivity ratio of IC50 for inhibition of Staphylococcus aureus Gyrase D83N mutant to IC50 for inhibition of Staphylococcus aureus Gyrase,B,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837261,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3624632,,1,0,,Ratio IC50,,,CHEMBL612545,,Unchecked,,,Ratio IC50,,,
31590,,23293779,CHEMBL4840036,Antibacterial activity against Staphylococcus aureus 3527 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837261,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3624632,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
31591,,23293820,CHEMBL4840037,Antibacterial activity against Staphylococcus aureus harbouring GyrA D83N mutant by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837261,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3624632,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
31592,Active,23293890,CHEMBL4840049,Inhibition of Staphylococcus aureus DNA Gyrase assessed as reduction in supercoiling pBR322 DNA by measuring induction of single strand breaks at 100 uM by ethidium bromide staining based agarose gel electrophoresis,B,BAO_0000375,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837261,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3624632,,1,0,,Activity,,,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,Activity,,,
31593,Active,23293892,CHEMBL4840050,Inhibition of Staphylococcus aureus DNA Gyrase assessed as reduction in supercoiling pBR322 DNA by measuring induction of double strand breaks at 200 uM by ethidium bromide staining based agarose gel electrophoresis,B,BAO_0000375,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4837261,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3624632,,1,0,,Activity,,,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,Activity,,,
31594,,23302100,CHEMBL4842209,Antimicrobial activity against Bacillus cereus assessed as reduction in bacterial growth by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4840372,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3626364,=,1,1,=,MIC,nM,780.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,uM,UO_0000065,0.78
31595,,23302107,CHEMBL4842210,Antimicrobial activity against Acinetobacter baumannii assessed as reduction in bacterial growth by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4840372,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3626364,=,1,1,=,MIC,nM,25000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,uM,UO_0000065,25.0
31596,,23302114,CHEMBL4842211,Antimicrobial activity against Proteus mirabilis assessed as reduction in bacterial growth by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4840372,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3626364,=,1,1,=,MIC,nM,98.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,uM,UO_0000065,0.098
31597,,23302121,CHEMBL4842212,Antimicrobial activity against Mycobacterium phlei assessed as reduction in bacterial growth by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4840372,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3626364,=,1,1,=,MIC,nM,195.0,CHEMBL614985,Mycolicibacterium phlei,Mycolicibacterium phlei,1771.0,,MIC,uM,UO_0000065,0.195
31598,,23302128,CHEMBL4842213,Antimicrobial activity against Edwardsiella tarda assessed as reduction in bacterial growth by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4840372,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3626364,=,1,1,=,MIC,nM,24.5,CHEMBL614598,Edwardsiella tarda,Edwardsiella tarda,636.0,,MIC,uM,UO_0000065,0.0245
31599,,23302135,CHEMBL4842214,Antimicrobial activity against Escherichia coli assessed as reduction in bacterial growth by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4840372,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3626364,=,1,1,=,MIC,nM,25000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,25.0
31600,,23302142,CHEMBL4842215,Antimicrobial activity against Bacillus subtilis assessed as reduction in bacterial growth by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4840372,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3626364,=,1,1,=,MIC,nM,195.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,uM,UO_0000065,0.195
31601,,23302149,CHEMBL4842216,Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as reduction in bacterial growth by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4840372,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3626364,=,1,1,=,MIC,nM,25000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,25.0
31602,,23302156,CHEMBL4842217,Antimicrobial activity against Vibrio parahaemolyticus assessed as reduction in bacterial growth by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4840372,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3626364,=,1,1,=,MIC,nM,390.0,CHEMBL614403,Vibrio parahaemolyticus,Vibrio parahaemolyticus,670.0,,MIC,uM,UO_0000065,0.39
31603,,23302163,CHEMBL4842218,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococci assessed as reduction in bacterial growth by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4840372,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3626364,=,1,1,=,MIC,nM,25000.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC,uM,UO_0000065,25.0
31604,,23302896,CHEMBL4842412,Antimicrobial activity against Escherichia coli ATCC35218 assessed as growth inhibition after 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4842307,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3626512,<,1,1,<,MIC,ug.mL-1,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.01
31605,,23302903,CHEMBL4842413,Antimicrobial activity against Staphylococcus aureus ATCC12715 assessed as growth inhibition after 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4842307,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3626512,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
31606,,23302910,CHEMBL4842414,Antimicrobial activity against Staphylococcus epidermis CCM628 assessed as growth inhibition after 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4842307,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3626512,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.06
31607,,23302917,CHEMBL4842415,Antimicrobial activity against Bacillus subtilis ATCC9372 assessed as growth inhibition after 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4842307,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3626512,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.06
31608,,23302924,CHEMBL4842416,Antimicrobial activity against Candida albicans SC5314 assessed as growth inhibition after 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4842307,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3626512,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,ug ml-1,UO_0000274,64.0
31609,,23304473,CHEMBL4842702,Antibacterial activity against Bacillus anthracis assessed as minimum inhibitory concentration by alamar blue dye based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4842320,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3626811,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,MIC,ug ml-1,UO_0000274,0.064
31610,,24349530,CHEMBL5031882,Antibacterial activity against Bacillus subtilis ATCC 23857 assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030544,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3772411,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,2.0
31611,,24349534,CHEMBL5031883,Antibacterial activity against Corynebacterium ATCC 49368 assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030544,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3772411,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL613080,Corynebacterium,Corynebacterium,1716.0,,MIC,ug ml-1,UO_0000274,4.0
31612,,24349550,CHEMBL5031887,Antibacterial activity against Staphylococcus aureus ATCC 25922 assessed as zone of inhibition at 5 mg/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030544,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3772411,=,1,1,=,IZ,mm,7.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,7.0
31613,,24349556,CHEMBL5031888,Antibacterial activity against Staphylococcus aureus ATCC 25922 assessed as zone of inhibition at 10 mg/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030544,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3772411,=,1,1,=,IZ,mm,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,10.0
31614,,24349562,CHEMBL5031889,Antibacterial activity against Staphylococcus aureus ATCC 25922 assessed as zone of inhibition at 15 mg/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030544,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3772411,=,1,1,=,IZ,mm,22.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,22.0
31615,,24349568,CHEMBL5031890,Antibacterial activity against Streptococcus pyogenes ATCC 19615 assessed as zone of inhibition at 5 mg/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030544,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3772411,=,1,1,=,IZ,mm,10.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,IZ,mm,UO_0000016,10.0
31616,,24349574,CHEMBL5031891,Antibacterial activity against Streptococcus pyogenes ATCC 19615 assessed as zone of inhibition at 10 mg/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030544,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3772411,=,1,1,=,IZ,mm,13.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,IZ,mm,UO_0000016,13.0
31617,,24349580,CHEMBL5031892,Antibacterial activity against Streptococcus pyogenes ATCC 19615 assessed as zone of inhibition at 15 mg/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030544,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3772411,=,1,1,=,IZ,mm,26.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,IZ,mm,UO_0000016,26.0
31618,,24349586,CHEMBL5031893,Antibacterial activity against Bacillus subtilis ATCC 23857 assessed as zone of inhibition at 5 mg/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030544,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3772411,=,1,1,=,IZ,mm,12.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,IZ,mm,UO_0000016,12.0
31619,,24349591,CHEMBL5031894,Antibacterial activity against Bacillus subtilis ATCC 23857 assessed as zone of inhibition at 10 mg/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030544,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3772411,=,1,1,=,IZ,mm,15.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,IZ,mm,UO_0000016,15.0
31620,,24349597,CHEMBL5031895,Antibacterial activity against Bacillus subtilis ATCC 23857 assessed as zone of inhibition at 15 mg/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030544,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3772411,=,1,1,=,IZ,mm,27.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,IZ,mm,UO_0000016,27.0
31621,,24349602,CHEMBL5031896,Antibacterial activity against Corynebacterium ATCC 49368 assessed as zone of inhibition at 5 mg/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030544,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3772411,=,1,1,=,IZ,mm,10.0,CHEMBL613080,Corynebacterium,Corynebacterium,1716.0,,IZ,mm,UO_0000016,10.0
31622,,24349605,CHEMBL5031897,Antibacterial activity against Corynebacterium ATCC 49368 assessed as zone of inhibition at 10 mg/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030544,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3772411,=,1,1,=,IZ,mm,16.0,CHEMBL613080,Corynebacterium,Corynebacterium,1716.0,,IZ,mm,UO_0000016,16.0
31623,,24349611,CHEMBL5031898,Antibacterial activity against Corynebacterium ATCC 49368 assessed as zone of inhibition at 15 mg/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030544,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3772411,=,1,1,=,IZ,mm,19.0,CHEMBL613080,Corynebacterium,Corynebacterium,1716.0,,IZ,mm,UO_0000016,19.0
31624,,24349616,CHEMBL5031900,Antibacterial activity against Escherichia coli ATCC 25922 assessed as zone of inhibition at 10 mg/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030544,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3772411,=,1,1,=,IZ,mm,11.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,11.0
31625,,24349619,CHEMBL5031901,Antibacterial activity against Escherichia coli ATCC 25922 assessed as zone of inhibition at 15 mg/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030544,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3772411,=,1,1,=,IZ,mm,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,10.0
31626,,24349623,CHEMBL5031903,Antibacterial activity against Salmonella typhi ATCC 6539 assessed as zone of inhibition at 10 mg/kg,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030544,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3772411,=,1,1,=,IZ,mm,15.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,IZ,mm,UO_0000016,15.0
31627,,24349626,CHEMBL5031904,Antibacterial activity against Salmonella typhi ATCC 6539 assessed as zone of inhibition at 15 mg/kg,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030544,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3772411,=,1,1,=,IZ,mm,32.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,IZ,mm,UO_0000016,32.0
31628,,24349631,CHEMBL5031906,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 assessed as zone of inhibition at 10 mg/kg,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030544,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3772411,=,1,1,=,IZ,mm,12.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,IZ,mm,UO_0000016,12.0
31629,,24349634,CHEMBL5031907,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 assessed as zone of inhibition at 15 mg/kg,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030544,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3772411,=,1,1,=,IZ,mm,25.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,IZ,mm,UO_0000016,25.0
31630,,24349637,CHEMBL5031908,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030544,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3772411,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
31631,,24349639,CHEMBL5031909,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as zone of inhibition at 5 mg/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030544,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3772411,=,1,1,=,IZ,mm,15.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IZ,mm,UO_0000016,15.0
31632,,24349642,CHEMBL5031910,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as zone of inhibition at 10 mg/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030544,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3772411,=,1,1,=,IZ,mm,18.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IZ,mm,UO_0000016,18.0
31633,,24349646,CHEMBL5031911,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as zone of inhibition at 15 mg/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030544,Bioorg Med Chem Lett,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3772411,=,1,1,=,IZ,mm,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IZ,mm,UO_0000016,25.0
31634,,24350926,CHEMBL5032138,Antibacterial activity against Pseudomonas aeruginosa BAA 427 assessed as resistance development by measuring fold change in MIC after 30 passages with serially diluted peptides,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030557,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3772645,=,1,0,=,FC,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,64.0
31635,,24351998,CHEMBL5032378,Antibacterial activity against methicillin resistant Staphylococcus aureus USA300 LAC assessed as fold increase in MIC treated over 8 serial passages by resistance development assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5030564,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3772815,=,1,0,=,FC,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,FC,,,4.0
31636,,24372966,CHEMBL5036443,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth by CLSI protocol based microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5036302,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3775860,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
31637,,24372968,CHEMBL5036444,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth by CLSI protocol based microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5036302,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3775860,=,1,1,=,MIC,ug.mL-1,0.15,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.15
31638,,24390247,CHEMBL5041011,Inhibition of Staphylococcus aureus topoisomerase 4 assessed as reduction in decatenation using kDNA as substrate incubated for 30 mins by fluorimetric assay,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5038626,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3778825,=,1,1,=,IC50,nM,550.0,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,IC50,uM,UO_0000065,0.55
31639,,24390267,CHEMBL5041012,Inhibition of Escherichia coli DNA gyrase supercoiling activity using pBR322 as substrate incubated for 30 mins by fluorimetric assay,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5038626,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3778825,=,1,1,=,IC50,nM,830.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,IC50,uM,UO_0000065,0.83
31640,,24390287,CHEMBL5041013,Antibacterial activity against Staphylococcus aureus Newman assessed as inhibition of bacterial growth incubated for 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5038626,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3778825,=,1,1,=,MIC,nM,1359.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,1.359
31641,,24390307,CHEMBL5041014,Antibacterial activity against Escherichia coli ATCC 8739 assessed as inhibition of bacterial growth incubated for 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5038626,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3778825,=,1,1,=,MIC,nM,255.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.255
31642,,24400060,CHEMBL5043611,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5042496,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780927,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
31643,,24400090,CHEMBL5043612,Antibacterial activity against Enterococcus faecium assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5042496,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780927,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,2.0
31644,,24400120,CHEMBL5043613,Antibacterial activity against Staphylococcus aureus assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5042496,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780927,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
31645,,24400150,CHEMBL5043614,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5042496,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780927,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
31646,,24400180,CHEMBL5043615,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5042496,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780927,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
31647,,24400210,CHEMBL5043616,Antibacterial activity against Klebsiella pneumoniae assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5042496,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780927,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
31648,,24400239,CHEMBL5043617,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5042496,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780927,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
31649,,24400268,CHEMBL5043618,Antibacterial activity against Pseudomonas aeruginosa assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5042496,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780927,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
31650,,24400297,CHEMBL5043619,Antibacterial activity against Acinetobacter baumannii assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5042496,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780927,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,2.0
31651,,24400326,CHEMBL5043620,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5042496,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780927,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
31652,,24400355,CHEMBL5043621,Antibacterial activity against Escherichia coli ATCC 25922 assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5042496,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780927,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
31653,,24415005,CHEMBL5047086,Antimicrobial activity against Klebsiella pneumoniae clinical isolate T2301 expressing NDM-1 assessed as inhibition of bacterial growth by CLSI protocol based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5046233,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3783391,=,1,1,=,MIC,ug.mL-1,0.128,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug/L,UO_0000274,128.0
31654,Not Determined,24415013,CHEMBL5047087,Antimicrobial activity against Escherichia coli clinical isolate T2228 expressing VIM-1 assessed as inhibition of bacterial growth by CLSI protocol based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5046233,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3783391,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
31655,,24416822,CHEMBL5047586,Antibacterial activity against Proteus species assessed as reduction in bacterial growth by double dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5046246,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3783753,<,1,1,<,MIC,ug.mL-1,0.1,CHEMBL613019,Proteus sp.,Proteus sp.,229037.0,,MIC,ug ml-1,UO_0000274,0.1
31656,,24416829,CHEMBL5047587,Antibacterial activity against Mycobacterium phlei assessed as reduction in bacterial growth by double dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5046246,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3783753,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL614985,Mycolicibacterium phlei,Mycolicibacterium phlei,1771.0,,MIC,ug ml-1,UO_0000274,0.1
31657,,24416836,CHEMBL5047588,Antibacterial activity against Bacillus subtilis assessed as reduction in bacterial growth by double dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5046246,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3783753,<,1,1,<,MIC,ug.mL-1,0.1,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.1
31658,,24416843,CHEMBL5047589,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus assessed as reduction in bacterial growth by double dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5046246,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3783753,=,1,1,=,MIC,ug.mL-1,32.1,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC,ug ml-1,UO_0000274,32.1
31659,,24416850,CHEMBL5047590,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as reduction in bacterial growth by double dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5046246,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3783753,=,1,1,=,MIC,ug.mL-1,128.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.4
31660,,24416922,CHEMBL5047613,Antibacterial activity against Pseudomonas aeruginosa PAO1 assessed as bacterial growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5046248,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3783788,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
31661,,24416925,CHEMBL5047614,Antibacterial activity against Pseudomonas aeruginosa 1121 assessed as bacterial growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5046248,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3783788,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
31662,,24416928,CHEMBL5047615,Antibacterial activity against Pseudomonas aeruginosa 1129 assessed as bacterial growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5046248,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3783788,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
31663,,24416931,CHEMBL5047616,Antibacterial activity against Pseudomonas aeruginosa 1167 assessed as bacterial growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5046248,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3783788,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
31664,,24416934,CHEMBL5047617,Antibacterial activity against Pseudomonas aeruginosa FB assessed as bacterial growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5046248,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3783788,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
31665,,24507729,CHEMBL5054958,Antimicrobial activity against Bacillus cereus assessed as inhibition of bacterial growth incubated for 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5053538,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3837376,=,1,1,=,MIC,ug.mL-1,0.26,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,0.26
31666,,24507737,CHEMBL5054959,Antimicrobial activity against Proteus sp. assessed as inhibition of bacterial growth incubated for 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5053538,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3837376,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL613019,Proteus sp.,Proteus sp.,229037.0,,MIC,ug ml-1,UO_0000274,0.06
31667,,24507745,CHEMBL5054960,Antimicrobial activity against Bacillus subtilis assessed as inhibition of bacterial growth incubated for 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5053538,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3837376,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.06
31668,,24507753,CHEMBL5054961,Antimicrobial activity against Escherichia coli assessed as inhibition of bacterial growth incubated for 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5053538,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3837376,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
31669,,24507761,CHEMBL5054962,Antimicrobial activity against Pseudomonas assessed as inhibition of bacterial growth incubated for 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5053538,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3837376,=,1,1,=,MIC,ug.mL-1,1.04,CHEMBL612498,Pseudomonas,Pseudomonas,286.0,,MIC,ug ml-1,UO_0000274,1.04
31670,,24507769,CHEMBL5054963,Antimicrobial activity against Mycobacterium phlei assessed as inhibition of bacterial growth incubated for 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5053538,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3837376,=,1,1,=,MIC,ug.mL-1,0.26,CHEMBL614985,Mycolicibacterium phlei,Mycolicibacterium phlei,1771.0,,MIC,ug ml-1,UO_0000274,0.26
31671,,24507777,CHEMBL5054964,Antimicrobial activity against Edwardsiella tarda assessed as inhibition of bacterial growth incubated for 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5053538,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3837376,=,1,1,=,MIC,ug.mL-1,0.02,CHEMBL614598,Edwardsiella tarda,Edwardsiella tarda,636.0,,MIC,ug ml-1,UO_0000274,0.02
31672,,24507785,CHEMBL5054965,Antimicrobial activity against Acinetobacter baumannii assessed as inhibition of bacterial growth incubated for 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5053538,J Nat Prod,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3837376,=,1,1,=,MIC,ug.mL-1,2.07,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,2.07
31673,,24513085,CHEMBL5056331,Antimicrobial activity against Pseudomonas aeruginosa PA01 assessed as inhibition of microbial growth measured after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5055634,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3838215,=,1,1,=,MIC,ug.mL-1,1.82,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.82
31674,,24513114,CHEMBL5056333,Cytotoxicity against human WH1 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,A,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5055634,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3838215,=,1,1,=,IC50,nM,14200.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,14.2
31675,,24513199,CHEMBL5056348,"Resistance index, ratio of IC50 for antitumor activity against human MCF7 cells to IC50 for antitumour activity against dox resistant human MCF7/ADR cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay",F,BAO_0000179,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5055634,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3838215,=,1,0,=,Ratio IC50,,2.2,CHEMBL612545,,Unchecked,,,Ratio IC50,,,2.2
31676,,24670929,CHEMBL5099770,Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as growth inhibition after 14 to 16 hrs by CLSI based broth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5096228,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3844565,<,1,0,<,MIC99,ug ml-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC99,ug ml-1,UO_0000274,0.5
31677,,24670941,CHEMBL5099771,Antimicrobial activity against Enterococcus faecium assessed as growth inhibition after 14 to 16 hrs by CLSI based broth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5096228,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3844565,=,1,0,=,MIC99,ug ml-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC99,ug ml-1,UO_0000274,4.0
31678,,24670953,CHEMBL5099772,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as growth inhibition after 14 to 16 hrs by CLSI based broth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5096228,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3844565,<,1,0,<,MIC99,ug ml-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC99,ug ml-1,UO_0000274,0.5
31679,,24670968,CHEMBL5099773,Antimicrobial activity against Vancomycin-resistant Enterococcus faecium ATCC 51559 assessed as growth inhibition after 14 to 16 hrs by CLSI based broth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5096228,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3844565,=,1,0,=,MIC99,ug ml-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC99,ug ml-1,UO_0000274,4.0
31680,ND,24670994,CHEMBL5099775,Hemolytic activity in human RBC at 50 ug/ml,T,BAO_0000375,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5096228,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3844565,,1,0,,Activity,,,CHEMBL4296518,,Erythrocyte,,,Activity,,,
31681,,24690718,CHEMBL5105660,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 assessed as bacterial growth inhibition by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849821,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
31682,,24690737,CHEMBL5105661,Antibacterial activity against Enterococcus faecalis assessed as bacterial growth inhibition by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849821,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
31683,,24690756,CHEMBL5105662,Antibacterial activity against Staphylococcus aureus assessed as bacterial growth inhibition by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849821,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
31684,,24690775,CHEMBL5105663,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as bacterial growth inhibition by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849821,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
31685,,24690794,CHEMBL5105664,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849821,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
31686,,24690813,CHEMBL5105665,Antibacterial activity against Klebsiella pneumoniae assessed as bacterial growth inhibition by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849821,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
31687,,24690832,CHEMBL5105666,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849821,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
31688,,24690851,CHEMBL5105667,Antibacterial activity against Escherichia coli ATCC 25922 assessed as bacterial growth inhibition by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849821,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
31689,,24690870,CHEMBL5105668,Antibacterial activity against Pseudomonas aeruginosa assessed as bacterial growth inhibition by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849821,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
31690,,24690889,CHEMBL5105669,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as bacterial growth inhibition by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849821,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
31691,,24690908,CHEMBL5105670,Antibacterial activity against Acinetobacter baumannii assessed as bacterial growth inhibition by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849821,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,1.0
31692,,24690949,CHEMBL5105684,Induction of drug resistance in Enterococcus faecalis assessed as fold increase in MIC measured for 16 passages relative to control,F,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3849821,=,1,0,=,FC,,7.0,CHEMBL612545,,Unchecked,,,FC,,,7.0
31693,,24692546,CHEMBL5106090,Inhibition of Escherichia coli DNA gyrase supercoiling activity using pBR322 as substrate incubated for 30 mins measured by gel-based assay,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5104153,RSC Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3850221,=,1,1,=,IC50,nM,600.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,IC50,uM,UO_0000065,0.6
31694,,24692553,CHEMBL5106091,Inhibition of Escherichia coli topoisomerase 4 assessed as relaxation of supercoiled plasmid pBR322 DNA and measured after 30 mins,B,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5104153,RSC Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3850221,=,1,1,=,IC50,nM,5700.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,5.7
31695,,24692561,CHEMBL5106092,Antibacterial activity against Escherichia coli K12 MG1655 measured by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5104153,RSC Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3850221,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
31696,,24692568,CHEMBL5106093,Antibacterial activity against Staphylococcus aureus NCIMB 50080 measured by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5104153,RSC Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3850221,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
31697,,24692575,CHEMBL5106094,Antibacterial activity against Escherichia coli K12 MG1655 S83L measured by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5104153,RSC Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3850221,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
31698,,24700622,CHEMBL5107492,Drug uptake in wild type Escherichia coli ATCC 25922 assessed as drug accumulation across outer membrane,A,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5104205,RSC Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3851604,=,1,0,=,Drug uptake,nmol,2.4,CHEMBL612558,,ADMET,,,Drug uptake,nmol,UO_0000041,2.4
31699,,24700628,CHEMBL5107493,Drug uptake in Pseudomonas aeruginosa ATCC 9027 assessed as drug accumulation across outer membrane,A,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5104205,RSC Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3851604,=,1,0,=,Drug uptake,nmol,1.8,CHEMBL612558,,ADMET,,,Drug uptake,nmol,UO_0000041,1.8
31700,,24700781,CHEMBL5107521,Antibacterial activity against intracellular multidrug-resistant Salmonella typhimurium ATCC14028 infected in mouse RAW264.7 cells assessed as reduction in intracellular bacterial survival level by RFP staining based high-content image analysis,F,BAO_0000188,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5104210,RSC Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3851703,=,1,1,=,EC50,nM,150.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,EC50,uM,UO_0000065,0.15
31701,,24704647,CHEMBL5108358,Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 assessed as fold increase in MIC incubated for 30 days by resistance development based broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5107946,RSC Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3852326,=,1,0,=,FC,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,FC,,,16.0
31702,,24704650,CHEMBL5108359,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 assessed as fold increase in MIC incubated for 30 days by resistance development based broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5107946,RSC Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3852326,=,1,0,=,FC,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,FC,,,64.0
31703,,24705394,CHEMBL5108501,Inhibition of DNA synthesis in Staphylococcus aureus ATCC 29213 at 8 times MIC preincubated for 30 mins followed by [3H]-thymidine and measured after 30 mins by [3H]-thymidine incorporation based beta scintillation counter analysis,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5107949,RSC Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3852376,=,1,1,=,Inhibition,%,86.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,INH,%,UO_0000187,86.2
31704,,24710067,CHEMBL5109849,Antimicrobial activity against Mycobacterium tuberculosis H37Rv incubated for 24 hrs and measured by MTT assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108008,Bioorg Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3853640,=,1,1,=,MIC,nM,1250.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,1.25
31705,,24712698,CHEMBL5110605,Antibacterial activity against ciprofloxacin-resistant Staphylococcus aureus 1199B overexpressing norA and harboring A116E grlA mutant assessed as inhibition of bacterial growth by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108024,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854243,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,10.0
31706,,24712720,CHEMBL5110608,Antibacterial activity against ciprofloxacin-susceptible wild type Staphylococcus aureus 1199 assessed as inhibition of bacterial growth by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108024,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854243,=,1,1,=,MIC,ug.mL-1,0.08,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.08
31707,,24712727,CHEMBL5110609,Antibacterial activity against Staphylococcus aureus K2378 harbouring norA promoting and coding region assessed as inhibition of bacterial growth by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108024,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854243,=,1,1,=,MIC,ug.mL-1,0.63,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.63
31708,,24712734,CHEMBL5110610,Antibacterial activity against norA deleted Staphylococcus aureus K1902 assessed as inhibition of bacterial growth by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108024,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854243,=,1,1,=,MIC,ug.mL-1,0.15,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.15
31709,,24712821,CHEMBL5110633,Antibacterial activity against Staphylococcus aureus 1199B overexpressing norA and harboring A116E grlA mutant assessed as post-antibiotic effect at 10 ug/ml preincubated for 1 hr followed by compound washout and measured after 5 hrs,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108024,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3854243,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
31710,,24713175,CHEMBL5110689,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 measured by Muller-Hinton broth based microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108027,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854320,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
31711,,24713225,CHEMBL5110690,Antibacterial activity against Enterococcus faecalis measured by Muller-Hinton broth based microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108027,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854320,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.0
31712,,24713275,CHEMBL5110691,Antibacterial activity against Staphylococcus aureus measured by Muller-Hinton broth based microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108027,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854320,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
31713,,24713325,CHEMBL5110692,Antibacterial activity against Staphylococcus aureus ATCC 25923 measured by Muller-Hinton broth based microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108027,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854320,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
31714,,24713375,CHEMBL5110693,Antibacterial activity against Staphylococcus aureus ATCC 29213 measured by Muller-Hinton broth based microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108027,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854320,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
31715,,24713425,CHEMBL5110694,Antibacterial activity against Klebsiella pneumoniae measured by Muller-Hinton broth based microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108027,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854320,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
31716,,24713474,CHEMBL5110695,Antibacterial activity against Escherichia coli measured by Muller-Hinton broth based microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108027,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854320,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
31717,,24713523,CHEMBL5110696,Antibacterial activity against Pseudomonas aeruginosa measured by Muller-Hinton broth based microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108027,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854320,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
31718,,24713572,CHEMBL5110697,Antibacterial activity against Acinetobacter baumannii measured by Muller-Hinton broth based microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108027,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854320,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,2.0
31719,,24713621,CHEMBL5110698,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 measured by Muller-Hinton broth based microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108027,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854320,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
31720,,24713670,CHEMBL5110699,Antibacterial activity against Escherichia coli ATCC 25922 measured by Muller-Hinton broth based microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108027,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854320,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
31721,,24714525,CHEMBL5110986,Antibacterial activity against Staphylococcus aureus ATCC 9144 incubated for 48 hrs and measured by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108036,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854505,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
31722,,24714590,CHEMBL5110987,Antibacterial activity against Bacillus subtilis 168 incubated for 48 hrs and measured by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108036,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854505,<,1,1,<,MIC,ug.mL-1,0.03,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.03
31723,,24714651,CHEMBL5110988,Antibacterial activity against Escherichia coli ATCC 25922 incubated for 48 hrs and measured by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108036,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854505,<,1,1,<,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
31724,,24714716,CHEMBL5110989,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 incubated for 48 hrs and measured by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108036,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854505,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
31725,,24719005,CHEMBL5112270,Antibacterial activity against Pseudomonas aeruginosa PA14 assessed inhibition of bacterial growth preincubated for 10 mins in PBS buffer followed by overnight grown bacterial culture addition incubated for 18 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108061,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3855266,=,1,1,=,MIC,nM,125.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,0.125
31726,,24719012,CHEMBL5112271,Antibacterial activity against Pseudomonas aeruginosa PA14 assessed inhibition of bacterial growth preincubated for 3 hrs in PBS buffer followed by overnight grown bacterial culture addition incubated for 18 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108061,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3855266,=,1,1,=,MIC,nM,125.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,0.125
31727,,24719019,CHEMBL5112272,Antibacterial activity against Pseudomonas aeruginosa PA14 assessed inhibition of bacterial growth preincubated for 10 mins in matrix containing human blood plasma spiked with Pseudomonas aeruginosa cell culture supernatant in PBS buffer followed by overnight grown bacterial culture addition incubated for 18 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108061,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3855266,=,1,1,=,MIC,nM,250.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,0.25
31728,,24719026,CHEMBL5112273,Antibacterial activity against Pseudomonas aeruginosa PA14 assessed inhibition of bacterial growth preincubated for 3 hrs in matrix containing 50% human blood plasma and 10% Pseudomonas aeruginosa cell culture supernatant in PBS followed by overnight grown bacterial culture addition incubated for 18 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108061,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3855266,=,1,1,=,MIC,nM,156.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,0.156
31729,,24719033,CHEMBL5112274,Antibacterial activity against Pseudomonas aeruginosa PA14 assessed inhibition of bacterial growth preincubated for 3 hrs in matrix containing human blood plasma spiked with Pseudomonas aeruginosa cell culture supernatant in PBS buffer followed by overnight grown bacterial culture addition incubated for 18 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108061,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3855266,=,1,1,=,MIC,nM,125.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,0.125
31730,,24719040,CHEMBL5112275,Antibacterial activity against Pseudomonas aeruginosa PA14 assessed inhibition of bacterial growth preincubated for 3 hrs in matrix containing Pseudomonas aeruginosa cell culture supernatant in PBS buffer followed by overnight grown bacterial culture addition incubated for 18 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108061,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3855266,=,1,1,=,MIC,nM,125.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,0.125
31731,,24719047,CHEMBL5112276,Antibacterial activity against Pseudomonas aeruginosa PA14 assessed inhibition of bacterial growth preincubated for 10 mins in matrix containing human blood plasma spiked with fresh LB medium in PBS followed by overnight grown bacterial culture addition incubated for 18 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108061,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3855266,=,1,1,=,MIC,nM,156.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,0.156
31732,,24719054,CHEMBL5112277,Antibacterial activity against Pseudomonas aeruginosa PA14 assessed inhibition of bacterial growth preincubated for 3 hrs in matrix containing human blood plasma spiked with fresh LB medium in PBS followed by overnight grown bacterial culture addition incubated for 18 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108061,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3855266,=,1,1,=,MIC,nM,156.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,0.156
31733,,24719061,CHEMBL5112278,Antibacterial activity against Pseudomonas aeruginosa PA14 assessed inhibition of bacterial growth incubated for 18 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5108061,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3855266,=,1,1,=,MIC,nM,125.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,0.125
31734,,24742015,CHEMBL5118092,"In vivo antibacterial activity against Staphylococcus aureus ATCC 43300 in septicemia mouse model assessed as reduction in bacterial load in liver at 5 mg/kg, administered every 12 hrs for 3 days",F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5113489,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3859626,=,1,0,=,Activity,%,99.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,99.0
31735,,24742016,CHEMBL5118093,"In vivo antibacterial activity against Staphylococcus aureus ATCC 43300 in septicemia mouse model assessed as reduction in bacterial load in spleen at 5 mg/kg, administered every 12 hrs for 3 days",F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5113489,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3859626,=,1,0,=,Activity,%,96.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,96.4
31736,,24742017,CHEMBL5118094,"In vivo antibacterial activity against Staphylococcus aureus ATCC 43300 in septicemia mouse model assessed as reduction in bacterial load in kidney at 5 mg/kg, administered every 12 hrs for 3 days",F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5113489,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3859626,=,1,0,=,Activity,%,97.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,97.2
31737,,24755138,CHEMBL5122351,Antimicrobial activity against Staphylococcus aureus JE2 ssessed as reduction in bacterial growth and measured for 24 hrs by resazurin dye based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120805,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862225,=,1,1,=,MIC,ug.mL-1,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,12.5
31738,,24755191,CHEMBL5122353,Antimicrobial activity against Pseudomonas aeruginosa PA14 assessed as reduction in bacterial growth and measured for 24 hrs by resazurin dye based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120805,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862225,<,1,1,<,MIC,ug.mL-1,0.04,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.04
31739,,24759203,CHEMBL5123318,Antibacterial activity against Staphylococcus aureus ATCC 29213 incubated for 16 to 20 hrs by CLSI protocol based assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120843,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862885,=,1,1,=,IC50,ug.mL-1,0.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,0.13
31740,,24759206,CHEMBL5123319,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as minimum inhibitory concentration incubated for 16 to 20 hrs by CLSI protocol based assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120843,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862885,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
31741,,24759209,CHEMBL5123320,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as minimum bactericidal concentration incubated for 16 to 20 hrs by CLSI protocol based assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120843,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862885,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.5
31742,,24759213,CHEMBL5123321,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 incubated for 16 to 20 hrs by CLSI protocol based assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120843,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862885,=,1,1,=,IC50,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,0.12
31743,,24759216,CHEMBL5123322,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as minimum inhibitory concentration incubated for 16 to 20 hrs by CLSI protocol based assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120843,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862885,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
31744,,24759219,CHEMBL5123323,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as minimum bactericidal concentration incubated for 16 to 20 hrs by CLSI protocol based assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120843,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862885,=,1,0,=,MFC,ug ml-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MFC,ug ml-1,UO_0000274,0.5
31745,,24759223,CHEMBL5123324,Antibacterial activity against Escherichia coli ATCC 35218 incubated for 16 to 20 hrs by CLSI protocol based assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120843,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862885,=,1,1,=,IC50,ug.mL-1,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IC50,ug ml-1,UO_0000274,0.01
31746,,24759224,CHEMBL5123325,Antibacterial activity against Escherichia coli ATCC 35218 assessed as minimum inhibitory concentration incubated for 16 to 20 hrs by CLSI protocol based assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120843,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862885,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
31747,,24759225,CHEMBL5123326,Antibacterial activity against Escherichia coli ATCC 35218 assessed as minimum bactericidal concentration incubated for 16 to 20 hrs by CLSI protocol based assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120843,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862885,=,1,0,=,MBC,ug ml-1,0.13,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.13
31748,,24759294,CHEMBL5123350,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862919,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
31749,,24759320,CHEMBL5123351,Antibacterial activity against Streptococcus pneumoniae 07P390 by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862919,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
31750,,24759346,CHEMBL5123352,Antibacterial activity against Streptococcus pneumoniae PU09 by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862919,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
31751,,24759372,CHEMBL5123353,Antibacterial activity against Streptococcus pyogenes 12-206 by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862919,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.25
31752,,24759398,CHEMBL5123354,Antibacterial activity against Staphylococcus aureus 15B196 by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862919,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
31753,,24759424,CHEMBL5123355,Antibacterial activity against Staphylococcus aureus PU32 by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862919,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
31754,,24759450,CHEMBL5123356,Antibacterial activity against Haemophilus influenzae ATCC 49247 by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862919,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.03
31755,,24767899,CHEMBL5125448,Antibacterial activity against wild type methicillin resistant Staphylococcus aureus 4561/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120927,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,8.0
31756,,24767905,CHEMBL5125449,Antibacterial activity against wild type methicillin resistant Staphylococcus aureus 4968/C assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120927,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,8.0
31757,,24767911,CHEMBL5125450,Antibacterial activity against wild type methicillin resistant Staphylococcus aureus 5017/C assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120927,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,8.0
31758,,24767921,CHEMBL5125451,Antibacterial activity against wild type Staphylococcus aureus 4557/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120927,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
31759,,24767932,CHEMBL5125452,Antibacterial activity against wild type Staphylococcus aureus 4463/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120927,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
31760,,24767943,CHEMBL5125453,Antibacterial activity against wild type Staphylococcus aureus 4904/C assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120927,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
31761,,24767954,CHEMBL5125454,Antibacterial activity against wild type Staphylococcus aureus 4862/C assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120927,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
31762,,24767965,CHEMBL5125455,Antibacterial activity against wild type Staphylococcus aureus 4883/C assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120927,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
31763,,24767976,CHEMBL5125456,Antibacterial activity against wild type Staphylococcus aureus 4880/C assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120927,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
31764,,24767987,CHEMBL5125457,Antibacterial activity against wild type Staphylococcus aureus 4460/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120927,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.125
31765,,24767998,CHEMBL5125458,Antibacterial activity against wild type Staphylococcus aureus 4482/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120927,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.125
31766,,24768009,CHEMBL5125459,Antibacterial activity against wild type Staphylococcus aureus 4566/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120927,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
31767,,24768020,CHEMBL5125460,Antibacterial activity against wild type Staphylococcus aureus 4504/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120927,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
31768,,24768030,CHEMBL5125461,Antibacterial activity against wild type Staphylococcus aureus 4740/B assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120927,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.5
31769,,24768040,CHEMBL5125462,Antibacterial activity against wild type Staphylococcus aureus 4717/B assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120927,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
31770,,24768051,CHEMBL5125463,Antibacterial activity against wild type Staphylococcus aureus 4738/B assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120927,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
31771,,24768062,CHEMBL5125464,Antibacterial activity against wild type Staphylococcus aureus 4461/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120927,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
31772,,24768073,CHEMBL5125465,Antibacterial activity against wild type Staphylococcus aureus 4679/B assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120927,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
31773,,24768083,CHEMBL5125466,Antibacterial activity against wild type Staphylococcus aureus 4502/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120927,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.125
31774,,24768093,CHEMBL5125467,Antibacterial activity against wild type Staphylococcus aureus 4515/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120927,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.125
31775,,24768104,CHEMBL5125468,Antibacterial activity against wild type Staphylococcus aureus 5079/C assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120927,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
31776,,24768115,CHEMBL5125469,Antibacterial activity against wild type Staphylococcus aureus 4788/B assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120927,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,MIC,ug.mL-1,0.063,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.063
31777,,24768126,CHEMBL5125470,Antibacterial activity against wild type Staphylococcus aureus 78/CF assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120927,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
31778,,24768137,CHEMBL5125471,Antibacterial activity against wild type Staphylococcus aureus 77/CF assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120927,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.5
31779,,24768167,CHEMBL5125480,Antibacterial activity against Pseudomonas aeruginosa assessed as reduction in microbial growth measured after 20 cycles by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5120927,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,2.0
31780,,24786050,CHEMBL5130755,Antibacterial activity against Staphylococcus aureus ATCC 6538 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5126636,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3868853,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
31781,,24786067,CHEMBL5130756,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 43300 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5126636,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3868853,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
31782,,24793181,CHEMBL5133093,Antibacterial activity against methicillin-resistant Staphylococcus aureus 197,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,32.0
31783,,24793193,CHEMBL5133094,Antibacterial activity against Acinetobacter baumannii ATCC 19606,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mg/L,UO_0000274,0.5
31784,,24793205,CHEMBL5133095,Antibacterial activity against Acinetobacter baumannii 139,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mg/L,UO_0000274,32.0
31785,,24793217,CHEMBL5133096,Antibacterial activity against Acinetobacter baumannii 140,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mg/L,UO_0000274,32.0
31786,,24793229,CHEMBL5133097,Antibacterial activity against Escherichia coli ATCC 35218,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,0.008
31787,,24793241,CHEMBL5133098,Antibacterial activity against Escherichia coli 202,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,0.06
31788,,24793253,CHEMBL5133099,Antibacterial activity against Escherichia coli 203,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,32.0
31789,,24793265,CHEMBL5133100,Antibacterial activity against Neisseria gonorrhoeae ATCC 19424,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,mg/L,UO_0000274,0.004
31790,,24793277,CHEMBL5133101,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,0.25
31791,,24793289,CHEMBL5133102,Antibacterial activity against Pseudomonas aeruginosa 142,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,32.0
31792,,24793301,CHEMBL5133103,Antibacterial activity against Pseudomonas aeruginosa 143,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,32.0
31793,,24793313,CHEMBL5133104,Antibacterial activity against Streptococcus pneumoniae ATCC 49169,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,mg/L,UO_0000274,0.5
31794,,24793325,CHEMBL5133105,Antibacterial activity against Staphylococcus aureus ATCC 29213,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
31795,,24793337,CHEMBL5133106,Antibacterial activity against methicillin-resistant Staphylococcus aureus 196,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,32.0
31796,,24793349,CHEMBL5133107,Antibacterial activity against Neisseria gonorrhoeae WHO K,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,>=,1,1,>=,MIC,ug.mL-1,32.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,mg/L,UO_0000274,32.0
31797,,24793353,CHEMBL5133108,Antibacterial activity against Neisseria gonorrhoeae WHO G,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,mg/L,UO_0000274,0.125
31798,,24793357,CHEMBL5133109,Antibacterial activity against Neisseria gonorrhoeae Barla194,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,mg/L,UO_0000274,32.0
31799,,24793361,CHEMBL5133110,Antibacterial activity against Neisseria gonorrhoeae WHO Q,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,mg/L,UO_0000274,0.008
31800,,24793365,CHEMBL5133111,Antibacterial activity against Neisseria gonorrhoeae WHO O,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,mg/L,UO_0000274,0.004
31801,,24793369,CHEMBL5133112,Antibacterial activity against Neisseria gonorrhoeae WHO M,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,mg/L,UO_0000274,2.0
31802,,24793373,CHEMBL5133113,Antibacterial activity against Neisseria gonorrhoeae WHO E,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,mg/L,UO_0000274,0.002
31803,,24793377,CHEMBL5133114,Antibacterial activity against Neisseria gonorrhoeae WHO C,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,mg/L,UO_0000274,0.004
31804,,24793381,CHEMBL5133115,Antibacterial activity against Neisseria gonorrhoeae WHO B,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,mg/L,UO_0000274,0.008
31805,,24793385,CHEMBL5133116,Antibacterial activity against Neisseria gonorrhoeae WHO A,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,mg/L,UO_0000274,0.002
31806,,24793389,CHEMBL5133117,Antibacterial activity against Neisseria gonorrhoeae WHO Z,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,mg/L,UO_0000274,32.0
31807,,24794662,CHEMBL5133361,Inhibition of Staphylococcus aureus DNA gyrase supercoiling activity using pNO1 plasmid DNA as substrate incubated for 30 mins by fluorescence based microtiter plate reader assay,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131416,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3870462,=,1,1,=,IC50,nM,3840.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,IC50,uM,UO_0000065,3.84
31808,,24794673,CHEMBL5133362,Inhibition of Staphylococcus aureus topoisomerase 4 using pNO1 plasmid DNA as substrate incubated for 30 mins by fluorescence based microtiter plate reader assay,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131416,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3870462,=,1,1,=,IC50,nM,9160.0,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,IC50,uM,UO_0000065,9.16
31809,,24794678,CHEMBL5133363,Inhibition of Escherichia coli DNA gyrase by fluorescence based microtiter plate reader assay,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131416,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3870462,=,1,1,=,IC50,nM,230.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,IC50,uM,UO_0000065,0.23
31810,,24795270,CHEMBL5133455,Antibacterial activity against Staphylococcus aureus NCTC 4163,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
31811,,24795283,CHEMBL5133456,Antibacterial activity against Staphylococcus aureus ATCC 25923,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
31812,,24795296,CHEMBL5133457,Antibacterial activity against Staphylococcus aureus ATCC 6538,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
31813,,24795309,CHEMBL5133458,Antibacterial activity against Staphylococcus aureus ATCC 29213,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
31814,,24795322,CHEMBL5133459,Antibacterial activity against Staphylococcus epidermidis ATCC 12228,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.5
31815,,24795335,CHEMBL5133460,Antibacterial activity against Staphylococcus epidermidis ATCC 35984,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
31816,,24795348,CHEMBL5133461,Antibacterial activity against Escherichia coli NCTC 10538,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
31817,,24795361,CHEMBL5133462,Antibacterial activity against Escherichia coli ATCC 25922,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
31818,,24795374,CHEMBL5133463,Antibacterial activity against Pseudomonas aeruginosa ATCC 15442,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,<,1,1,<,MIC,ug.mL-1,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.125
31819,,24795387,CHEMBL5133464,Antibacterial activity against Pseudomonas aeruginosa NCTC 27853,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,<,1,1,<,MIC,ug.mL-1,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.125
31820,,24795400,CHEMBL5133465,Antibacterial activity against Staphylococcus epidermidis 825/19,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,4.0
31821,,24795413,CHEMBL5133466,Antibacterial activity against Staphylococcus epidermidis 829/19,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
31822,,24795426,CHEMBL5133467,Antibacterial activity against Staphylococcus epidermidis 830/19,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,64.0
31823,,24795439,CHEMBL5133468,Antibacterial activity against Staphylococcus epidermidis 834/19,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
31824,,24795452,CHEMBL5133469,Antibacterial activity against Staphylococcus epidermidis 840/19,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
31825,,24795465,CHEMBL5133470,Antibacterial activity against Staphylococcus epidermidis 845/19,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,16.0
31826,,24795478,CHEMBL5133471,Antibacterial activity against Staphylococcus epidermidis 848/19,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
31827,,24795491,CHEMBL5133472,Antibacterial activity against Staphylococcus epidermidis 851/19,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
31828,,24800209,CHEMBL5134763,Antibacterial activity against pET28a-NDM-1 positive Escherichia coli BL21(DE3) isolates assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131475,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871463,=,1,1,=,MIC,ug.mL-1,0.4267,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug/L,UO_0000274,426.67
31829,,24800224,CHEMBL5134764,Antibacterial activity against NDM-1 positive Escherichia coli ZC-YN3 isolates assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131475,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871463,=,1,1,=,MIC,ug.mL-1,0.00667,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug/L,UO_0000274,6.67
31830,,24801794,CHEMBL5135013,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth measured after repeated 30 day serial passage treatment by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131487,Bioorg Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3871787,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
31831,,24809378,CHEMBL5136537,Antibacterial activity against cystic fibrosis isolate Staphylococcus aureus by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131562,ACS Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
31832,,24809394,CHEMBL5136538,Antibacterial activity against Staphylococcus aureus ATCC 29213 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131562,ACS Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
31833,,24809410,CHEMBL5136539,Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131562,ACS Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
31834,,24809426,CHEMBL5136540,Antibacterial activity against Staphylococcus aureus 3527 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131562,ACS Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
31835,,24809442,CHEMBL5136541,Antibacterial activity against Staphylococcus aureus harbouring GyrA D83N mutant by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131562,ACS Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
31836,,24809457,CHEMBL5136542,Inhibition of Staphylococcus aureus DNA gyrase supercoiling activity incubated for 25 min by ethidium bromide/bromophenol blue staining based agarose gel electrophoresis analysis,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131562,ACS Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,1,http://www.openphacts.org/units/Nanomolar,3873274,=,1,1,=,IC50,nM,28000.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,IC50,uM,UO_0000065,28.0
31837,,24809472,CHEMBL5136543,Inhibition of Staphylococcus aureus DNA topoisomerase 4 decatenation activity using kDNA as substrate incubated for 10 to 20 min by ethidium bromide/bromophenol blue staining based agarose gel electrophoresis analysis,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131562,ACS Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,1,http://www.openphacts.org/units/Nanomolar,3873274,=,1,1,=,IC50,nM,8600.0,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,IC50,uM,UO_0000065,8.6
31838,,24809487,CHEMBL5136544,Selectivity ratio of IC50 for inhibition of Staphylococcus aureus DNA topoisomerase 4 decatenation activity to IC50 for inhibition of Staphylococcus aureus DNA gyrase supercoiling activity,B,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131562,ACS Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3873274,=,1,0,=,Ratio IC50,,0.31,CHEMBL612545,,Unchecked,,,Ratio IC50,,,0.31
31839,,24809507,CHEMBL5136545,Antimicrobial activity against Neisseria gonorrhoeae G strain harbouring type 2 topoisomerase GyrA S91F and ParE G410V mutant incubated for 20 to 24 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131562,ACS Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,0.12
31840,,24809528,CHEMBL5136546,Antimicrobial activity against wild type Neisseria gonorrhoeae ATCC 49226 incubated for 20 to 24 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131562,ACS Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,0.002
31841,,24809549,CHEMBL5136547,Antimicrobial activity against wild type Neisseria gonorrhoeae F strain incubated for 20 to 24 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131562,ACS Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,0.002
31842,,24809570,CHEMBL5136548,"Antimicrobial activity against Neisseria gonorrhoeae K strain harbouring type 2 topoisomerase GyrA S91F, D95N and ParC S87R, S88P mutant incubated for 20 to 24 hrs by CLSI protocol based broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131562,ACS Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,>,1,1,>,MIC,ug.mL-1,1.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,1.0
31843,,24809591,CHEMBL5136549,Antimicrobial activity against wild type Neisseria gonorrhoeae O strain incubated for 20 to 24 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131562,ACS Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,0.03
31844,,24809612,CHEMBL5136550,Antimicrobial activity against wild type Neisseria gonorrhoeae P strain incubated for 20 to 24 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131562,ACS Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,0.004
31845,,24809633,CHEMBL5136551,"Antimicrobial activity against wild type Neisseria gonorrhoeae V strain harbouring type 2 topoisomerase GyrA S91F, D95G and ParC S87R mutant incubated for 20 to 24 hrs by CLSI protocol based broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131562,ACS Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,>,1,1,>,MIC,ug.mL-1,1.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,1.0
31846,,24809654,CHEMBL5136552,"Antimicrobial activity against wild type Neisseria gonorrhoeae Y strain harbouring type 2 topoisomerase GyrA S91F, D95G and ParC S87R mutant incubated for 20 to 24 hrs by CLSI protocol based broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131562,ACS Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,>,1,1,>,MIC,ug.mL-1,1.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,1.0
31847,,24809660,CHEMBL5136553,Antimicrobial activity against wild type Neisseria gonorrhoeae ATCC 49226 incubated for 20 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131562,ACS Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,0.004
31848,,24809663,CHEMBL5136554,Antimicrobial activity against Neisseria gonorrhoeae G strain harbouring type 2 topoisomerase GyrA S91F and ParE G410V mutant incubated for 20 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131562,ACS Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,0.12
31849,,24809666,CHEMBL5136555,"Antimicrobial activity against Neisseria gonorrhoeae M strain harbouring type 2 topoisomerase GyrA S91F,D95G mutant incubated for 20 hrs by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131562,ACS Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,2.0
31850,,24809669,CHEMBL5136556,"Antimicrobial activity against Neisseria gonorrhoeae L strain harbouring type 2 topoisomerase GyrA S91F,D95N and ParC D86N,S88P mutant incubated for 20 hrs by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5131562,ACS Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,8.0
31851,,24814670,CHEMBL5138131,Antibacterial activity against methicillin-resistant Staphylococcus aureus TCH1516 assessed as growth inhibition incubated for 20 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5136988,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3874644,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.2
31852,,24814676,CHEMBL5138132,Antibacterial activity against Escherichia coli LptD4213 assessed as growth inhibition incubated for 20 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5136988,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3874644,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
31853,ND,24819161,CHEMBL5139928,Antibacterial activity against Bacillus cereus ATCC 14579 incubated for 20 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5137029,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3875792,,1,0,,MIC,,,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,,,
31854,,24819199,CHEMBL5139929,Antibacterial activity against Bacillus cereus ATCC 10987 incubated for 20 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5137029,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3875792,=,1,1,=,MIC,nM,10700.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,uM,UO_0000065,10.7
31855,ND,24819236,CHEMBL5139930,Antibacterial activity against Enterococcus faecalis LMG 08222 incubated for 20 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5137029,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3875792,,1,0,,MIC,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,,,
31856,ND,24819274,CHEMBL5139931,Antibacterial activity against Enterococcus faecalis LMG 16216 incubated for 20 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5137029,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3875792,,1,0,,MIC,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,,,
31857,,24819312,CHEMBL5139932,Antibacterial activity against Enterococcus faecalis V583 incubated for 20 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5137029,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3875792,=,1,1,=,MIC,nM,26700.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,uM,UO_0000065,26.7
31858,ND,24819349,CHEMBL5139933,Antibacterial activity against Enterococcus faecalis LMG 11423 incubated for 20 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5137029,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3875792,,1,0,,MIC,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,,,
31859,,24819387,CHEMBL5139934,Antibacterial activity against Enterococcus faecalis LMG 16003 incubated for 20 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5137029,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3875792,=,1,1,=,MIC,nM,32000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,uM,UO_0000065,32.0
31860,,24819425,CHEMBL5139935,Antibacterial activity against Staphylococcus aureus LMG 8224 incubated for 20 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5137029,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3875792,=,1,1,=,MIC,nM,20800.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,20.8
31861,ND,24819465,CHEMBL5139936,Antibacterial activity against Staphylococcus aureus LMG 10147 incubated for 20 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5137029,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3875792,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
31862,ND,24819503,CHEMBL5139937,Antibacterial activity against Staphylococcus aureus LMG 15975 incubated for 20 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5137029,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3875792,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
31863,ND,24819541,CHEMBL5139938,Antibacterial activity against Clostridium beijerinckii B504 incubated for 24 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5137029,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3875792,,1,0,,MIC,,,CHEMBL5209646,Clostridium beijerinckii,Clostridium beijerinckii,1520.0,,MIC,,,
31864,ND,24819579,CHEMBL5139939,Antibacterial activity against Clostridium botulinum CECT551 incubated for 24 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5137029,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3875792,,1,0,,MIC,,,CHEMBL614963,Clostridium botulinum,Clostridium botulinum,1491.0,,MIC,,,
31865,,24819617,CHEMBL5139940,Antibacterial activity against Clostridium difficile CECT531 incubated for 24 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5137029,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3875792,>,1,1,>,MIC,nM,32000.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,uM,UO_0000065,32.0
31866,ND,24819654,CHEMBL5139941,Antibacterial activity against Clostridium-ihumii AP5 incubated for 24 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5137029,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3875792,,1,0,,MIC,,,CHEMBL612545,,Unchecked,,,MIC,,,
31867,,24819692,CHEMBL5139942,Antibacterial activity against Clostridium perfringens CECT376 incubated for 24 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5137029,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3875792,=,1,1,=,MIC,nM,500.0,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,MIC,uM,UO_0000065,0.5
31868,ND,24819731,CHEMBL5139943,Antibacterial activity against Clostridium tetani CECT 4629 incubated for 24 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5137029,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3875792,,1,0,,MIC,,,CHEMBL613073,Clostridium tetani,Clostridium tetani,1513.0,,MIC,,,
31869,,24819766,CHEMBL5139944,Antimicrobial activity against Escherichia coli LMG 8224 incubated for 20 hrs by CLSI based broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5137029,J Nat Prod,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3875792,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
31870,,24837158,CHEMBL5144782,Antibacterial activity against rifampicin resistant Staphylococcus aureus harboring RpoBH481Y mutant assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879307,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
31871,,24837193,CHEMBL5144783,Antibacterial activity against wild type Staphylococcus aureus assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879307,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
31872,,24837228,CHEMBL5144784,Antibacterial activity against ciprofloxacin resistant Staphylococcus aureus harboring ParCS80F and GyrAS84L double mutant assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879307,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
31873,,24837263,CHEMBL5144785,Antibacterial activity against Staphylococcus aureus harboring RpoBH481Y/ParCS80F/GyrAS84L triple mutant assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879307,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
31874,,24837298,CHEMBL5144786,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879307,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
31875,,24838922,CHEMBL5144980,Antibacterial activity against Staphylococcus aureus 1199B measured after 24 hrs by Muller Hinton broth based MTT assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5143555,Bioorg Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879624,=,1,1,=,MIC,ug.mL-1,0.21,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.21
31876,,24838954,CHEMBL5144981,Antibacterial activity against Staphylococcus aureus 1199 measured after 24 hrs by Muller Hinton broth based MTT assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5143555,Bioorg Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879624,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.05
31877,,24838983,CHEMBL5144982,Antibacterial activity against Staphylococcus aureus K1758 measured after 24 hrs by Muller Hinton broth based MTT assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5143555,Bioorg Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879624,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.05
31878,,24841340,CHEMBL5145634,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5143581,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3880169,=,1,1,=,MIC,nM,4730.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,4.73
31879,,24841355,CHEMBL5145635,Cytotoxicity in African green monkey Vero cells assessed as reduction in cell viability,T,BAO_0000181,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5143581,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3880169,>,1,0,>,Activity,uM,100.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,Activity,uM,UO_0000064,100.0
31880,,24843785,CHEMBL5146125,Inhibition of Escherichia coli DNA gyrase supercoiling activity,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3880659,=,1,1,=,IC50,nM,45.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,IC50,uM,UO_0000065,0.045
31881,,24843794,CHEMBL5146126,Inhibition of Escherichia coli topoisomerase 4 assessed as reduction in decatenation,B,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3880659,=,1,1,=,IC50,nM,30.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,0.03
31882,,24843836,CHEMBL5146128,Antibacterial activity against Acinetobacter baumannii NCTC 13420 assessed as bacterial growth inhibition by CLSI protocol based assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880659,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,64.0
31883,,24843864,CHEMBL5146129,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 assessed as bacterial growth inhibition by CLSI protocol based assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880659,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
31884,,24843892,CHEMBL5146130,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as bacterial growth inhibition by CLSI protocol based assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880659,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
31885,,24843920,CHEMBL5146131,Antibacterial activity against Escherichia coli W4573 assessed as bacterial growth inhibition by CLSI protocol based assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880659,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
31886,,24843948,CHEMBL5146132,Antibacterial activity against Escherichia coli N43 assessed as bacterial growth inhibition by CLSI protocol based assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880659,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
31887,,24843976,CHEMBL5146133,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition by CLSI protocol based assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880659,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
31888,ND,24844121,CHEMBL5146149,Resistance development in Escherichia coli ATCC25922 assessed as spontaneous resistance frequency at 4 times MIC by resistance development assay,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3880659,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
31889,,24844140,CHEMBL5146160,Antibacterial activity against Escherichia coli ATCC25922 assessed as bacterial growth inhibition by CLSI protocol based assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880659,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
31890,,24846071,CHEMBL5146737,Antibacterial activity against Staphylococcus aureus ATCC 25293 assessed as inhibition of bacterial growth incubated for 18 hrs by CLSI based serial agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5143624,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881072,=,1,1,=,MIC,ug.mL-1,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.8
31891,,24846078,CHEMBL5146738,Antibacterial activity against methicillin resistant Staphylococcus aureus 5076 assessed as inhibition of bacterial growth incubated for 18 hrs by CLSI based serial agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5143624,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881072,=,1,1,=,MIC,ug.mL-1,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,100.0
31892,,24846085,CHEMBL5146739,Antibacterial activity against methicillin resistant Staphylococcus aureus 5076 harbouring DNA gyrase and topoisomerase IV mutant and efflux pump assessed as inhibition of bacterial growth incubated for 18 hrs in presence of efflux inhibitor by CLSI based serial agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5143624,Bioorg Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881072,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,25.0
31893,ND,24871486,CHEMBL5153104,Antibacterial activity against Escherichia coli ATCC25922 assessed as prevention of visible growth by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5150045,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3886720,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
31894,,24871512,CHEMBL5153105,Antibacterial activity against Shigella flexneri CMCC51572 assessed as prevention of visible growth by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5150045,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3886720,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614396,Shigella flexneri,Shigella flexneri,623.0,,MIC,ug ml-1,UO_0000274,2.0
31895,ND,24871538,CHEMBL5153106,Antibacterial activity against Salmonella typhi CMCC50094 assessed as prevention of visible growth by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5150045,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3886720,,1,0,,MIC,,,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,MIC,,,
31896,ND,24871564,CHEMBL5153107,Antibacterial activity against methicillin-resistant Staphylococcus aureus 252 assessed as prevention of visible growth by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5150045,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3886720,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
31897,ND,24871590,CHEMBL5153108,Antibacterial activity against methicillin-resistant Staphylococcus aureus R3708 assessed as prevention of visible growth by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5150045,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3886720,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
31898,ND,24871616,CHEMBL5153109,Antibacterial activity against Staphylococcus aureus ATCC29213 assessed as prevention of visible growth by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5150045,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3886720,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
31899,ND,24871642,CHEMBL5153110,Antibacterial activity against Staphylococcus aureus ATCC25923 assessed as prevention of visible growth by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5150045,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3886720,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
31900,,24871666,CHEMBL5153124,Resistance development in Escherichia coli ATCC25922 assessed as fold increase in resistance after 15 days serial passage upto 256 ug/ml,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5150045,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3886720,=,1,0,=,FC,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,16.0
31901,,24876663,CHEMBL5155010,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate 2 assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154634,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3887678,>,1,1,>,MIC,nM,100000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,100.0
31902,,24876669,CHEMBL5155011,Antibacterial activity against methicillin-resistant Staphylococcus aureus 129 assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154634,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3887678,>,1,1,>,MIC,nM,100000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,100.0
31903,,24876682,CHEMBL5155013,Antibacterial activity against methicillin-resistant Staphylococcus aureus 138 assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154634,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3887678,>,1,1,>,MIC,nM,100000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,100.0
31904,ND,24884036,CHEMBL5156738,Hemolytic activity in human RBC assessed as hemolysis incubated for 2 hrs by spectrophotometer analysis,T,BAO_0000375,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3889015,,1,0,,Activity,,,CHEMBL4296518,,Erythrocyte,,,Activity,,,
31905,,24884058,CHEMBL5156739,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 incubated for 24 hrs by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,MIC,ug.mL-1,3.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,3.1
31906,,24884099,CHEMBL5156740,Antibacterial activity against Staphylococcus aureus ATCC 29213 incubated for 24 hrs by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,MIC,ug.mL-1,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.5
31907,,24884140,CHEMBL5156741,Antibacterial activity against Pseudomonas aeruginosa ATCC 27883 incubated for 24 hrs by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,MIC,ug.mL-1,0.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.7
31908,,24884181,CHEMBL5156742,Antibacterial activity against Escherichia coli ATCC 25922 incubated for 24 hrs by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,MIC,ug.mL-1,0.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.7
31909,ND,24884203,CHEMBL5156743,Antibacterial activity against Enterococcus faecium ATCC 27270 incubated for 24 hrs by microtiter plate method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3889015,,1,0,,Activity,,,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,,,
31910,ND,24884210,CHEMBL5156744,Antibacterial activity against vancomycin-resistant Enterococcus faecium ATCC 700221 incubated for 24 hrs by microtiter plate method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3889015,,1,0,,Activity,,,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,,,
31911,ND,24884217,CHEMBL5156745,Antibacterial activity against Enterococcus faecalis ATCC 29212 incubated for 24 hrs by microtiter plate method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3889015,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
31912,ND,24884224,CHEMBL5156746,Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51575 incubated for 24 hrs by microtiter plate method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3889015,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
31913,ND,24884231,CHEMBL5156747,Antibacterial activity against Staphylococcus pneumonia ATCC 49619 incubated for 24 hrs by microtiter plate method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3889015,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
31914,ND,24884238,CHEMBL5156748,Antibacterial activity against multidrug resistant Staphylococcus pneumonia ATCC 700677 incubated for 24 hrs by microtiter plate method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3889015,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
31915,ND,24884245,CHEMBL5156749,Antibacterial activity against Bacillus subtilis ATCC 6633 incubated for 24 hrs by microtiter plate method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3889015,,1,0,,Activity,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,Activity,,,
31916,ND,24884252,CHEMBL5156750,Antibacterial activity against Bacillus cereus ATCC 13061 incubated for 24 hrs by microtiter plate method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3889015,,1,0,,Activity,,,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,Activity,,,
31917,,24884259,CHEMBL5156751,Antibacterial activity against Escherichia coli NDM-1-resistant ATCC BAA-2452 incubated for 24 hrs by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,MIC,ug.mL-1,0.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.7
31918,,24884266,CHEMBL5156752,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 ATCC BAA-2470 incubated for 24 hrs by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,MIC,ug.mL-1,1.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.5
31919,,24884273,CHEMBL5156753,Antibacterial activity against carbapenem-resistant Klebsiella pneumoniae ATCC BAA-2470 incubated for 24 hrs by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,MIC,ug.mL-1,0.7,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.7
31920,,24884280,CHEMBL5156754,Antibacterial activity against ciprofloxacin resistance Acinetobacter baumannii ATCC BAA1605 incubated for 24 hrs by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,MIC,ug.mL-1,0.7,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.7
31921,,24884287,CHEMBL5156755,Antibacterial activity against Pseudomonas aeruginosa ATCC 10145 incubated for 24 hrs by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,MIC,ug.mL-1,0.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.7
31922,,24884294,CHEMBL5156756,Antibacterial activity against imipenem resistant Pseudomonas aeruginosa ATCC BAA-1744 incubated for 24 hrs by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,MIC,ug.mL-1,0.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.7
31923,,24884301,CHEMBL5156757,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 incubated for 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,0,=,MBC,ug ml-1,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,50.0
31924,,24884306,CHEMBL5156758,Antibacterial activity against Escherichia coli ATCC 25922 incubated for 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,0,=,MBC,ug ml-1,12.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,12.5
31925,,24884310,CHEMBL5156759,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 after 24 hrs in presence of 150 mM of NaCl by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,MIC,ug.mL-1,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.5
31926,,24884314,CHEMBL5156760,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 after 24 hrs in presence of 4.5 mM of KCl by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,MIC,ug.mL-1,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.5
31927,,24884318,CHEMBL5156761,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 after 24 hrs in presence of 6 mM of NH4Cl by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,MIC,ug.mL-1,0.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.7
31928,,24884322,CHEMBL5156762,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 after 24 hrs in presence of 1 mM of by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,MIC,ug.mL-1,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.5
31929,,24884326,CHEMBL5156763,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 after 24 hrs in presence of 2 mM of CaCl2 by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,MIC,ug.mL-1,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.5
31930,,24884330,CHEMBL5156764,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 after 24 hrs in presence of fetal bovine serum by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,MIC,ug.mL-1,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.5
31931,,24884333,CHEMBL5156765,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs in presence of 150 mM NaCl by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,MIC,ug.mL-1,0.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.3
31932,,24884337,CHEMBL5156766,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs in presence of 4.5 mM of KCl at by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,MIC,ug.mL-1,0.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.3
31933,,24884341,CHEMBL5156767,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in microbial growth after 24 hrs in presence of 6 mM of NH4Cl at by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,MIC,ug.mL-1,0.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.3
31934,,24884345,CHEMBL5156768,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs in presence of 1 mM of MgCl2 at by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,MIC,ug.mL-1,0.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.7
31935,,24884349,CHEMBL5156769,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs in presence of 2 mM CaCl2 at by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,MIC,ug.mL-1,0.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.3
31936,,24884353,CHEMBL5156770,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs in presence of fetal bovine serum by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,MIC,ug.mL-1,0.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.3
31937,Tde,24884382,CHEMBL5156784,Bactericidal activity against Escherichia coli ATCC BAA-2452 assessed as reduction of bacterial growth at 4 times MIC by counting formed colonies,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3889015,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
31938,Tde,24884387,CHEMBL5156785,Bactericidal activity against Escherichia coli ATCC BAA-2452 assessed as reduction of bacterial growth at MIC by counting formed colonies,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3889015,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
31939,Tde,24884392,CHEMBL5156786,Bactericidal activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 assessed as reduction of bacterial growth at 4 times MIC by counting formed colonies,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3889015,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
31940,Tde,24884397,CHEMBL5156787,Bactericidal activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 assessed as reduction of bacterial growth at MIC by counting formed colonies,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3889015,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
31941,Active,24884406,CHEMBL5156790,Bactericidal activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 assessed as time required for complete reduction of bacterial growth at MIC by counting formed colonies,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3889015,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
31942,Active,24884413,CHEMBL5156791,Bactericidal activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 assessed as time required for complete reduction of bacterial growth at 4 times MIC by counting formed colonies,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154681,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3889015,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
31943,,24894661,CHEMBL5159206,Antibacterial activity against Methicillin-drug resistant Staphylococcus aureus C0621 incubated for 18 hrs by by disc diffusion method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154746,ACS Med Chem Lett,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3890909,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
31944,,24898443,CHEMBL5159910,"Antibacterial activity against Salmonella typhimurium ATCC 14028 infected in 129X1/SvJ NRAMP +/+ mouse gallstone model assessed as reduction in bacterial burden in gallblader at 2 mg/kg/day, ip administered from 5 to 15 consecutive days and measured on day 15",F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154764,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3891386,,1,0,,Activity,,,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,Activity,,,
31945,Active,24898456,CHEMBL5159917,"Antibacterial activity against Salmonella typhimurium ATCC 14028 infected in 129X1/SvJ NRAMP +/+ mouse gallstone model assessed as reduction in bacterial burden in liver at 2 mg/kg/day, ip administered from 5 to 15 consecutive days and measured on day 15",F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154764,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3891386,,1,0,,Activity,,,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,Activity,,,
31946,Active,24898457,CHEMBL5159918,"Antibacterial activity against Salmonella typhimurium ATCC 14028 infected in 129X1/SvJ NRAMP +/+ mouse gallstone model assessed as reduction in bacterial burden in spleen at 2 mg/kg/day, ip administered from 5 to 15 consecutive days and measured on day 15",F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154764,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3891386,,1,0,,Activity,,,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,Activity,,,
31947,,24909965,CHEMBL5162990,Antibacterial activity against Methicillin resistant Staphylococcus aureus ATCC BAA -1556 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154823,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893128,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
31948,,24909978,CHEMBL5162991,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154823,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893128,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
31949,,24909995,CHEMBL5162993,Antibacterial activity against imipenem resistant Klebsiella pneumoniae ATCC BAA 1705 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154823,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893128,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,256.0
31950,,24910008,CHEMBL5162994,Antibacterial activity against Pseudomonas aeruginosa ATCC 27883 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154823,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893128,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
31951,,24912746,CHEMBL5163877,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154842,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893676,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
31952,,24912782,CHEMBL5163878,Antibacterial activity against Enterococcus faecalis assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154842,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893676,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.125
31953,,24912818,CHEMBL5163879,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154842,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893676,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
31954,,24912854,CHEMBL5163880,Antibacterial activity against Staphylococcus aureus 25923 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154842,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893676,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
31955,,24912890,CHEMBL5163881,Antibacterial activity against Staphylococcus aureus 29213 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154842,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893676,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
31956,,24912926,CHEMBL5163882,Antibacterial activity against Klebsiella pneumonia assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154842,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893676,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
31957,,24912961,CHEMBL5163883,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154842,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893676,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
31958,,24912996,CHEMBL5163884,Antibacterial activity against Escherichia coli 25922 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154842,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893676,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
31959,,24913031,CHEMBL5163885,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154842,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893676,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.125
31960,,24913066,CHEMBL5163886,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154842,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893676,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
31961,,24913101,CHEMBL5163887,Antibacterial activity against Acinetobacter baumannii assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154842,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893676,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.5
31962,,24914362,CHEMBL5164231,Antibacterial activity against vancomycin-susceptible methicillin-susceptible Staphylococcus aureus Newman incubated for 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154852,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893975,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
31963,,24914385,CHEMBL5164232,Antimicrobial activity against methicillin-resistant Staphylococcus aureus USA300 LAC incubated for 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154852,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893975,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
31964,,24914408,CHEMBL5164233,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus Mu50 incubated for 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154852,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893975,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
31965,,24914471,CHEMBL5164246,"Selectivity index, ratio of IC50 for L02 cell cytotoxicity over MIC for vancomycin-susceptible methicillin-susceptible Staphylococcus aureus Newman",T,BAO_0000193,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154852,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3893975,>,1,0,>,Ratio,,16.0,CHEMBL612558,,ADMET,,,Ratio,,,16.0
31966,,24915737,CHEMBL5164691,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154863,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
31967,,24915761,CHEMBL5164692,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154863,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
31968,,24915785,CHEMBL5164693,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154863,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
31969,,24915809,CHEMBL5164694,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC BAA-1720 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154863,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
31970,,24915833,CHEMBL5164695,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus Mu50 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154863,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
31971,,24915857,CHEMBL5164696,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154863,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,1.0
31972,,24915881,CHEMBL5164697,Antibacterial activity against Bacillus subtilis CMCC (B) 63501 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154863,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.25
31973,,24915905,CHEMBL5164698,Antibacterial activity against Enterococcus faecium ATCC 49624 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154863,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,32.0
31974,,24915929,CHEMBL5164699,Antibacterial activity against Enterococcus faecalis ATCC 29212 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154863,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,4.0
31975,,24915953,CHEMBL5164700,Antibacterial activity against vancomycin resistant Enterococcus faecium ATCC 700221 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154863,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,64.0
31976,ND,24915977,CHEMBL5164701,Antibacterial activity against vancomycin-resistant Enterococcus faecium clinical isolate assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154863,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3894259,,1,0,,MIC,,,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,,,
31977,,24915999,CHEMBL5164702,Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154863,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
31978,,24916021,CHEMBL5164703,Antibacterial activity against Escherichia coli ATCC 8739 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154863,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,<,1,1,<,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
31979,,24916043,CHEMBL5164704,Antibacterial activity against NDM-1 expressing Escherichia coli ATCC BAA2469 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154863,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
31980,,24916065,CHEMBL5164705,Antibacterial activity against multi-drug resistant Acinetobacter baumannii ATCC 19606 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154863,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,64.0
31981,,24916087,CHEMBL5164706,Antibacterial activity against penicillin-susceptible Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154863,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
31982,,24916109,CHEMBL5164707,Antibacterial activity against NDM-1 expressing Klebsiella pneumoniae ATCC BAA 2470 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154863,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
31983,,24916206,CHEMBL5164742,Induction of drug resistance against Staphylococcus aureus ATCC 29213 assessed as fold increase in MIC after 16 passage,F,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154863,Eur J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3894259,=,1,0,=,FC,,512.0,CHEMBL612545,,Unchecked,,,FC,,,512.0
31984,,24920998,CHEMBL5166294,Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 assessed as reduction in bacterial growth by measuring fold increase in MIC after 65 passages by multistep resistance based broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5154895,J Med Chem,2022.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3895184,=,1,0,=,FC,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,FC,,,128.0
31985,,24959674,CHEMBL5215481,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as bacterial growth inhibition incubated for 16 hrs by microplate reader assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5214897,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3898908,=,1,1,=,MIC,ug.mL-1,0.24,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.24
31986,,24959686,CHEMBL5215482,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as bacterial growth inhibition incubated for 16 hrs by microplate reader assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5214897,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3898908,=,1,1,=,MIC,ug.mL-1,0.45,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.45
31987,,24959698,CHEMBL5215483,Antibacterial activity against vancomycin-resistant Enterococcus faecalis assessed as bacterial growth inhibition incubated for 16 hrs by microplate reader assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5214897,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3898908,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.9
31988,,24959714,CHEMBL5215484,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition incubated for 16 hrs by microplate reader assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5214897,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3898908,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.12
31989,,24959726,CHEMBL5215485,Antibacterial activity against Pseudomonas aeruginosa assessed as bacterial growth inhibition incubated for 16 hrs by microplate reader assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5214897,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3898908,=,1,1,=,MIC,ug.mL-1,0.45,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.45
31990,,24959738,CHEMBL5215486,Antibacterial activity against Klebsiella pneumoniae assessed as bacterial growth inhibition incubated for 16 hrs by microplate reader assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5214897,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3898908,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.9
31991,,24959775,CHEMBL5215499,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as reduction in bacterial growth at 16 ug/ml measured after 2 hrs by time-kill assay,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5214897,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3898908,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
31992,,24959781,CHEMBL5215505,Induction of drug resistance in methicillin-resistant Staphylococcus aureus assessed as fold change measured after 14 passages,F,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5214897,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3898908,=,1,0,=,FC,,33.0,CHEMBL612545,,Unchecked,,,FC,,,33.0
31993,Active,24959794,CHEMBL5215517,"Antibacterial activity in ICR mouse infected with methicillin-resistant Staphylococcus aureus assessed as presence of erythema at 5 mg/ml,sc measured after 48 hrs",F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5214897,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3898908,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
31994,Active,24959796,CHEMBL5215519,"Antibacterial activity in ICR mouse infected with methicillin-resistant Staphylococcus aureus assessed as reduction in skin inflammatory cells at 5 mg/ml,sc measured after 48 hrs by H and E staining based analysis",F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5214897,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3898908,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
31995,Active,24959800,CHEMBL5215522,"Antibacterial activity in ICR mouse infected with methicillin-resistant Staphylococcus aureus assessed as reduction in TNF-alpha level at 5 mg/ml,sc measured after 48 hrs by ELISA assay",F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5214897,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3898908,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
31996,Active,24959802,CHEMBL5215523,"Antibacterial activity in ICR mouse infected with methicillin-resistant Staphylococcus aureus assessed as reduction in IL-6 level at 5 mg/ml,sc measured after 48 hrs by ELISA assay",F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5214897,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3898908,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
31997,,24959805,CHEMBL5215525,"Antibacterial activity in ICR mouse infected with methicillin-resistant Staphylococcus aureus assessed as reduction in microbial burden at 5 mg/ml,sc measured after 48 hrs",F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5214897,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3898908,=,1,0,=,Activity,%,81.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,81.1
31998,,24959808,CHEMBL5215527,"Antibacterial activity in ICR mouse infected with methicillin-resistant Staphylococcus aureus assessed as reduction in colony growth at 5 mg/ml,sc measured after 48 hrs",F,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5214897,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3898908,=,1,0,=,Activity,log10CFU/ml,0.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,log10CFU/ml,,0.7
31999,Toxic,24959817,CHEMBL5215535,"Toxicity in ICR mouse infected with methicillin-resistant Staphylococcus aureus assessed as histopathological abnormalities in liver at 5 mg/kg,sc measured after 48 hrs by H and E staining based assay",T,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL5214897,J Med Chem,2021.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3898908,,1,0,,Activity,,,CHEMBL612558,,ADMET,,,Activity,,,
